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Guanacastepene A 1 is a diterpene natural product, isolated in 2000 by Clardy, which 
showed excellent antibiotic activity against both Methicillin resistant Straphylococcus 
aureus (MRSA) and Vancomycin resistant Enterococcus faecium (\TREF). The novel 
tricyclic structure and biological activity make it an excellent target for synthetic 
chemists, with over fifteen approaches reported in the literature to date. 
Our retrosynthetic analysis is based on the rearrangement of epoxy ketone 360, to afford 
the hydro-azulene core in a single transformation. Initial efforts on our racemic approach 
confirmed a photochemical rearrangement strategy as a suitable method for the synthesis 







360 	 212 	 1 
A chiral variant, based on Jacobsen's asymmetric conjugate addition, with malononitrile 
366 afforded nitrile 395 in >99% e.e. The serendipitous discovery of a diastereoselective 
nitrile reduction afforded the corresponding aldehyde, which was subjected to an 
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I Introduction 
1.1 The Guanacastepenes 
In 2000 Clardy et al. reported the isolation of guanacastepene A, 1, from an endophytic fungal 
strain growing in a branch of a Daphnopsis americana tree in the Guanacaste rainforest of Costa 
Rica.' The natural product was isolated as part of a screening program which assayed fungal 
extracts for activity against drug-resistant strains of Straphylococcus aureus and Enterococcus 
faecium. Structural characterisation using NM1R spectroscopy was complicated by the presence 
of a conformational equilibrium operating at room temperature. A single crystal could be grown, 
however, and the structure was established by X-ray diffraction as the novel [5-7-6] tricyclic 





18 	 16 
Figure 1.1. guanacastepene A. 
The tricyclic structure comprises a highly oxidised top half containing alkene and oxygen 
functionalities, and a hydrophobic lower half containing two quaternary methyl groups at ring 
junctions, one of which is cis to a neighbouring isopropyl group. The conformational 
equilibrium in 1 arises from flexibility in the C9-C10 region of the central cycloheptane B-ring. 
The name guanacastane was proposed for this new diterpene carbon skeleton, which can be seen 
to resemble two well-characterised diterpene families; the dolastanes and the neodolabellanes. 
The marine-derived dolastanes are related by a 1,2-methyl shift across the Cl-Cl 1 ring fusion, 
and the neodolabellanes are formal precursors through macrocyclisation (Scheme 1.1). 
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Scheme 1.1. The new guanacastane skeleton and its relation to the known dolastanes and 
neodolabellanes. 
Following the initial report on guanacastepene A, Clardy reported the isolation and 
characterisation of an additional fourteen structurally and chemically diverse guanacastepenes 
from the same fungus (Figure 1 .2)  .2   The structures, which were all characterised through X-ray 
crystallography, represent a remarkably diverse family of natural products all of which contain 
the same guanacastane carbon skeleton. The diversity is even greater when one considers the 
tautomeric and conformational equilibria that operate in these metabolites. Clardy identified 
guanacastepenes A-C as being the simplest structures, varying only in oxidation pattern in the A 
and C rings. All other guanacastepenes likely arise from these compounds, with the key 
functionalisation being the addition of either an oxygen or nitrogen nucleophile at C2 to form an 
additional heterocyclic ring. The pentacyclic guanacastepenes K, L and M undergo a further 
cyclisation via an oxidised isopropyl methyl group. 
The absolute configurations of guanacastepenes E and L were determined using anomalous 
dispersion of the C5 p-bromobenzoyl derivative, and are as drawn in Figure 1.2. It is likely, 
therefore, that the absolute configuration of guanacastepene A is also correct. Only 
guanacastepene I showed any antibacterial activity when assayed against S. aureus. 
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Figure 1.2. Guanacastepenes A-O. 
The potential of guanacastepene A as a possible lead structure for antibiotic development was 
attenuated by the subsequent discovery that it exhibited strong haemolytic activity against 
human red blood cells, coupled with only moderate activity against gram-positive bacteria and 
poor activity against gram-negative bacteria; all factors that would limit its further development 
as an antibacterial therapeutic .3  Further investigations into the biological activity of the 
guanacastepenes are dependent on the development of a chemical synthesis, as the fungus 
CR1 15 is no longer producing the natural product. 
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The novel carbon skeleton coupled with the highly promising antibiotic activity of 
guanacastepene A made the guanacastepenes excellent targets for chemical synthesis, and an 
intense level of synthetic activity ensued. 4 By the close of 2006 the Danishefsky group had 
completed the synthesis of racemic guanacastepene A, 5 and formal syntheses have been recorded 
by the research groups of Snider '6  Hanna  '7  and Sorensen .8  While the research groups of Mehta, 9 
Overman' 0  and Trauner" have reported the total syntheses of other members of the 
guanacastepene family (guanacastepenes C, N and E respectively). A further eight research 
groups have reported their synthetic efforts towards this diverse family of natural products. The 
remainder of this chapter will focus on the synthetic studies towards the guanacastepenes 
reported by the close of 2006. 
1.2 Total synthesis of the Guanacastepenes 
The first total synthesis of guanacastepene A was published by Danishefsky et al. in 2002, just 
two years after the natural product structure was published. Subsequently, three formal syntheses 
have been reported by the research groups of Snider, Hanna and Sorensen. The groups of Mehta, 
Overman and Trauner have reported total syntheses of (+1-) guanacastepene C, (+) 
guanacastepene N and (-) guanacastepene E respectively. 
4 
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1.2.1 Danishefsky's total synthesis of guanacastepene A. 
Danishefsky identified the hydroazulene AB ring system 7 of guanacastepene A as a key 
intermediate. 12  The synthesis begins with the copper-catalysed conjugate addition of isopropyl 
Grignard to the commercially available 2-methylcyclopentenone in the presence of TMSC1. The 
silyl enol ether 3 was then treated with methyl lithium, and the resulting lithium enolate 
alkylated with an excess of the di-iodide 4 to produce the cyclopentanone 5, displaying the 
isopropyl and methyl groups in their correct cis orientation. Addition of a TI{F solution of iodide 
5 to five equivalents of 'BuLi led to an efficient lithium-halogen exchange, with ensuing 
cyclisation producing the tertiary alcohol 6. Treatment with PCC induced oxidative 
rearrangement to afford the hydroazulene core of guanacastepene A in only four steps from 
commercially available starting materials (Scheme 1.2). 1 
a 	
OSiMe3 	b 	 0 CC I 	 ----- 10- 1 	 " I I 	 I 
2 	 3 	 I 4q5' 
4 
OH 
C 	 d 5 
6 	 7 
(a) (i) 'PrMgBr, CuBr.Me2S, TMSCI, THF, HMPA, (ii) Et 3N, pentane, H20, (94%); (b) (i) MeLi, THF, 0°C, 4, 
(ii) HMPA, -78°C to ii, (74-76%); (c) °BuLi, THF, 0°C, (62-65%); (d) PCC, 0CM, ii, powdered sieves, (71-
92%). 
Scheme 1.2. Danishefsky's synthesis of the hydroazulene core of guanacastepene A. 
With an efficient synthesis of the hydroazulene core in hand they turned their attention towards 
the introduction of the stereocentre at the C8 position and construction of the C ring to complete 
the tricyclic core. 14  Dialkylation of 7 at C8 was problematic owing to difficulties generating the 
a'-enolate. These problems were solved by working with the exo-methylene ketone 8, which 
underwent vinylcuprate addition and subsequent trapping with TMSC1 to yield the silyl enol 
ether 9. Treatment of 9 with methyllithium revealed the lithium enolate that could not be 
generated via direct deprotonation, and alkylation with methyl iodide provided the desired 
Introduction 
product 10. Crucially, 10 was formed as a single diastereoisomer having the correct relative 
stereochemistry between the C8 and Cli methyl groups for the guanacastepenes, the methyl 
group having entered the hydroazulene system from the face anti to the angular Cli methyl 
group. Formation of the ketal, resulting in double bond migration to the cyclopentanone ring, 
followed by hydroboration/peroxide oxidation of the terminal alkene afforded the alcohol 11, 
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(a) (i) LHMDS, THF, -78°C, (ii) Me2NCH2I, THF, -78°C to rt; (b) mCPBA, DCM/NaHCO3(a q), (2:1), (60-70% 
for two steps); (c) CH2=CHMgBr, Cul, HMPA, TMSCI, THF, -78°C, (77%); (d) (i) MeLi, THE, 0°C, (ii) Mel, 
HMPA, -78°C to rt, (96% for 2 steps); (e) Ethylene glycol, PTSA, benzene, reflux (-H20), (88%); (f) (i) 9 
BBN, THF, rt, (ii) NaOH, H202, rt, (71%); (g) Dess-Martin periodinane, DCM, rt, (83%). 
Scheme 1.3. Alkylation of the hydroazulene core to install the C8 stereocentre. 
Completion of the C-ring synthesis from 12, ostensibly a straightforward matter, proved more 
difficult than anticipated. A direct Knoevenagel cyclisation of the 0—keto ester 13 was identified 
as a suitable method as it would generate the six membered ring complete with a precursor to the 
C15 aldehyde. The required fl—keto ester was synthesised from the aldehyde 12 without incident 
in two steps. Upon exposure to sodium ethoxide in ethanol at 60°C a mixture of products was 
formed, none of which were the desired cyclisation product 14. The major product of the 
reaction was identified as the truncated ester 15. A further two minor products were identified as 
ON 
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the tricyclic alcohol 16 and the tricyclic ketone 17 (Scheme 1.4). The cyclisation products 16 
and 17 exist at room temperature as two slowly interconverting conformers, similar to the 


















(a) N 2CHCOOEt, SnCl2, DCM, rt, (b) PTSA, H20/acetone, 70°C, (80% for 2 steps); (c) NaOEt, ethanol, 
60°C. 
Scheme 1.4. Results from the Knoevenagel cyclisation. 
Further studies into the formation of these products identified two likely reaction pathways 
leading to the truncated ester 15 and the oxidised tricycles 16 and 17. The major difference 
between substrate 12 and typical Knoevenagel precursors is the increased acidity of the C2 
protons. Deprotonation at this position generates the hydroazulene enolate which undergoes 
cyclisation onto the fi-keto ester to yield a lactone, ethanolysis under the reaction conditions 
produces the observed truncated ester 15. Tricycles 16 and 17 arise from air oxidation of the 
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Scheme 1.5. Proposed mechanism for the products formed in the Knoevenagel cyclisation. 
The side products 16 and 17 of the attempted Knoevenagel cyclisation represent ideal substrates 
for further elaboration towards guanacastepene A. With this in mind, the Danishefsky group set 
about purposefully synthesising the tricycle 16, through ring opening of epoxide 18 via /1-
elimination and Knoevenagel cyclisation. In this case the desired cyclisation occurred without 
incident, producing the ABC tricycle 16 in high yield (Scheme 1.6). The procedure could be 
further improved by direct conversion of the epoxide to the tricycle by means of a tandem 











(a) mCPBA, 0CM, 0°C, (89%); (b) NaOEt, ethanol, rt, (82%); (c) NaOEt, ethanol, 50°C, (74%). 
Scheme 1.6. Construction of the tricyclic system. 
Converting the advanced intermediate 16 into guanacastepene A requires a coherent sequence of 
oxidation and reduction steps, with stereocontrol at C13 and C5.4 After considerable 
experimentation, the sequence outlined in Scheme 1.7 was developed. Following protection of 
the free hydroxyl group as a TES ether, work began on the C-ring functionality at C5 and C15. 
Reduction with DIBALH yielded the diol 20 as a 4:1 mixture of C5 diastereoisomers in favour 
of the undesired a-epimer. Mitsunobu inversion of the allylic alcohol was successful, and the 
ensuing diol 20b was protected as an acetonide. Cleavage of the TES group and oxidation 













20a a epimer 
20b 3 epimer 
d e,f 
0. 
(a) Et3SiOTf, pyridine, DCM, 0°C, (80-85%); (b) OIBALH, 0CM, -78°C to 0°C; (c) Ph 3P, benzoic acid, DIAD, 
THF, -78°C to rt; (d) 2,2-dimethoxypropane, PPTS, 0CM, (67% for 4 steps); (e) TBAF, THF, 0°C, (91-
98%); (f) Dess-Martin periodiane, pyridine, 0CM, (90%); 
Scheme 1.7. Introduction of the C5 stereocentre. 
Attention was then directed towards the A-ring, which began with a Rubottom oxidation to 
introduce the C13 acetoxy group.' 5  Conversion of 22 to the silyl enol ether and epoxidation with 
DMDO gave the hydroxy ketone, which was acetylated to provide the protected guanacastepene 
23. The epoxidation is highly selective for the fl-face, indicating that the pseudo-equatorial 
isopropyl group does not exert any steric control over the facial selectivity of the enolate. 
Hydrolysis of the acetomde group provided an unstable diol which was quickly purified and 
subjected to TEMIPO-catalysed oxidation of the primary alcohol to yield the aldehyde 1. The 









(a) (I) Et3SiOTf, Et3N, DCM; (ii) DM00/acetone, 0CM, -78°C, then Me2S, (82-90% for 2 steps) (iii) Ac20, 
pyridine, DMAP, 0CM, (96%); (b) (i) PPTS, methanol, 70°C; (ii) Phl(OAc)2, TEMPO, 0CM, (59-65% for 2 
steps). 
Scheme 1.8. Total synthesis. 
The Danishefsky group were the first to report the total synthesis of guanacastepene A just two 
years after the reports of its isolation. They identified the hydroazulene 7 as their key 
intermediate for which they developed an efficient four step synthesis. Annulation of the third C 
ring was achieved via a tandem epoxide opening fl-eliminationfKnovenagel cyclisation reaction 
of 18. Further elaboration towards the natural product was achieved via a Rubottom oxidation 
followed by deprotection and selective oxidation. More recently they have published an 
enantioselective synthesis of intermediate 7 based on an enantioselective conjugate addition. 16 
1.2.2 Snider's formal synthesis of guanacastepene A. 
Concurrent with Danishefsky's work on guanacastepene A, the group of Snider were also 
developing their own approach to the natural product. Their initial report" 7 which was the first 
publication in the area, outlined a linear retrosynthetic strategy broadly similar in scope to 
Danishefsky's (Scheme 1.9). The simplified tricycle 24 is disconnected from the AB 
hydroazulone 25 through a Robinson-type annulation. The hydroazulone ring could be 
synthesised by an intramolecular aldol reaction of a trisubstituted cyclopentanone related to 26. 
Cyclopentanone 26 could in turn be prepared stereospecifically through a Lewis acid-initiated 
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Scheme 1.9. Snider's retrosynthetic analysis. 
The cyclisation substrate 28 was prepared using a three step sequence starting from 5-iodo-1 - 
pentene in high yield. As postulated, treatment of 28 with EtA1C12 in DCM led to the desired 
cyclopentenone 26 as the only cyclisation product (Scheme 1.10). The initial cyclisation 
occurred stereoselectively, whereby the bulky Et 2A10 group adopts a configuration that is cis to 
the adjacent hydrogen atom (27 in Scheme 1.9). Stereospecific 1,2-hydride and methyl shifts 
produced the cyclopentenone, with the correct Cli -Cl 2 relative stereochemistry of the 
guanacastepenes. 
0 
a-c 	 d 
__4\ 
29 	 28 	 26 
(a) tB uLi, Et20, 2-isopropylacrolein, -78°C, (89%); (b) diketene, DMAP, -15°C; (c) (I) LDA, THF, -78°C to 
reflux, (ii) toluene, 80°C, (67% for 2 steps); (d) EtAICI2, 0CM, 0°C to rt, (70%). 
Scheme 1.10. Snider's synthesis of the cyclopentanone. 
Further elaboration of 26 towards the key hydroazulene ring system using the desired aldol 
reaction was unsuccessful, and the acetyl-hydropentalene 31 was the only aldol product isolated. 
12 
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An intramolecular endocyclic Heck cyclisation was also attempted, but this too was unsuccessful 
due to the facile 6-exo ring closure giving 33 (Scheme 1.11). 









A  7"" 33 
—Flo 
34 
(a) PdCl2, Cu(OAc)2, O, DMF/H20, (88%); (b) LDA, THF, -78°C to rt, (42%); (c) Tf20, DCM, proton 
sponge, -78°C, (86%); (d) Pd(OAc)2, "Bu4NCI, KOAc, DMF, reflux. 
Scheme 1.11. Intramolecular Aldol reaction. 
Formation of the cycloheptenone B ring was eventually achieved using olefin metathesis. 
Palladium-mediated coupling of the enol triflate 32 with vinyl magnesium bromide under 
conditions optimised to suppress 6-exo Heck cyclisation afforded triene 35. Treatment of 35 with 
Grubbs' I catalyst in refluxing DCM produced the hydroazulene 34 in 80% yield (Scheme 1.12). 
	
OTf 	a 
32 	 35 	 \ 	34 
(a) H2CCH2MgBr, Pd2dba3, TFP, THF, (80%); (b) Grubb's I (20 mol%), DCM, (80%). 
Scheme 1.12. Synthesis of the hydroazulene core via RCM. 
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Functionalisation of the hydroazulene system began with epoxidation in the A ring with 
mCPBA. Opening of the epoxide with acetic acid and catalytic Pd 2dba3 gave the cis acetoxy 
alcohol 37 in 51% yield. Elaboration to hydroazulenone 38 was achieved after protection of the 
alcohol as a THP or TBS derivative, followed by selective hydrolysis of the acetate and 
oxidation to give 38a and 38b in high yields (Scheme 1.13). 
0 










38a R = THP 
38b R = TBS 
(a) mCPBA, DCM, 0°C; (b) Pd2dba3, dppb, AcOH, THE, 25°C, (51%); (c) For R=THP; (i) DHP, DCM, 
PPTS; (ii) (1) K2CO3, methanol, (2) Dess Martin periodiane, (93% over 3 steps) For R=TBS; (i)TBSCI, 
imidazole, DMF; (ii) K2CO3, NaHCO3, methanol, (2) Dess Martin periodiane, (90% over 3 steps). 
Scheme 1.13. Functionalisation of the hydroazulene core. 
With the synthesis of the hydroauzlene ring system complete the next stage involved the 
construction of the six membered C ring to complete the synthesis of the 5-7-6 tricyclic core. 
Model studies conducted by the Snider group had concentrated on developing a novel Stork-
Jung vinylsilane Robinson protocol,  18  whereby iodide 39, containing all of the carbon atoms 
required for C-ring construction, could be introduced via enolate alkylation. Mindful of 
Danishefsky' s studies on C8 alkylation of related hydroazulenes, alkylation with the C-ring 
precursor must take place first, followed by a second alkylation with methyl iodide from the 
bottom face. In the event, alkylation of the enolate of TBS-protected hydroazulenone 38b with 
39 afforded the desired product, which underwent a second alkylation with methyl iodide to 
afford 40. The choice of protecting group at both C14 and on the side chain was found to be 
critically important for the second alkylation to be successful. The OTBS group is required on 
14 
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the A ring in order to retard non-productive ketone enolisation at the yposition. Conversely, an 
OTBS group on the side chain lead to low yields of the desired a-methylated compound, 
whereas a coordinating OTHP group was necessary for high yields of the required product 
(Scheme 1.14). 
....-OTHP 
TBSO 	 TBSO  
a 	 (,7._S1Me2Ph /   
	













(a) LDA, DMPU, 39, (94%); (b) LDA, DMPU, Mel, (90% of 41 and 5% of 42) 
Scheme 1.14. Alkylation of the hydroazulene. 
The guanacastepene skeleton was completed by epoxidation of the vinylsilane and subsequent 
protodesilyation, leading to ketone 43. Cyclisation of 43 with ten equivalents of sodium 








(a) mCPBA then pyridine/HF, (64% for 2 steps); (b) NaOMe, benzene/MeOH (4:1), rt, (85%). 
Scheme 1.15. Formation of the tricyclic core. 
At this point in their investigations, Danishefsky's group reported the total synthesis of 
guanacastepene A. Given the similarity of Snider's keto-diol 44 to late-stage intermediates in 
Danishefsky' s synthesis, and also the efficiency of the final stages of that work, it was thought 
appropriate to complete a formal synthesis of the natural product.' Accordingly, reduction of the 
ketone with LiA1H(O-'Bu) 3  gave diol 45 as a 4:1 mixture in favour of the desired 8-alcohol, a 
very surprising result in light of the opposite diastereoselectivity observed on reduction of 
Danishefsky's keto-ester 16 (Scheme 1.7). The ester in 16 and the primary alcohol in the present 
case apply quite different directing effects to the hydride reduction of the ketone group. As a 
result, Mitsunobu inversion of the expected a-alcohol was no longer necessary, and keto-diol 44 
may be reduced directly to the triol without any prior protection steps. It was convenient to 
separate this mixture after acetonide protection, and Dess-Martin oxidation of the major product 
yielded the ketone acetonide 22, having spectra identical to that of Danishefsky's intermediate 






(a) LiAIH(OtB u )3,  THE, -78°C; (b) Me2C(OMe)2, PPTS, DCM, 0°C, (48% for 2 steps); (c) Dess Martin 
periodiane, DCM, pyridine, 0 °C, (86%). 
Scheme 1.16. Completion of the formal synthesis. 
Snider completed the formal synthesis of guanacastepene A in seventeen steps with an overall 
yield of 4%. The key features of the synthesis were the EtA1C1 2-induced stereospecific 
cyclisation to cyclopentenone 26 followed by the use of vinylmagnesium bromide in the 
palladium-catalysed coupling with triflate 32 to give the triene 35, which after a RCM reaction 
yielded the hydroazulene core. Construction of the tricyclic ring system was achieved by 
developing a novel extension to the Stork-Jung vinylsilane Robinson annulation. Danishefsky 
reported problems with dialkylating the hydroazulene core, which was overcome by synthesising 
an exo methylene compound. Snider overcame a similar problem with the correct combination of 
protecting groups and thereby obtained almost exclusively ct-alkylation in high yields. Selective 
reduction of ketone 44 yielded the diol as a 4:1 mixture, in favour of the correct stereochemistry 
for the natural product. Formation of the acetonide allowed for separation, which after oxidation 
afforded 22, an intermediate in Danishefsky's total synthesis. 
1.2.3 Hanna's formal synthesis of guanacastepene A 
Hanna et al. have published a formal total synthesis of guanacastepene A based around an A - 
ABC approach to the natural product ring system, whereby the six and seven membered rings 
are formed simultaneously from a suitably functionalised A-ring precursor. 19 This strategy 
contrasts with those syntheses previously discussed, which have all relied on a linear A --> AB 
-* ABC route that identifies the AB hydroazulene as the key intermediate. Hanna's 
retrosynthetic analysis incorporates a tandem RCM reaction of a dienyne in the key cyclisation 
step. The approach is based on the assumption that the formation of a metal carbene on 48 
should first occur at the mono-substituted alkene which could then cyclise first to form the 5-7 
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bicyclic intermediate 47, which could then undergo a second RCM reaction to give the desired 
















Scheme 1.17. Hanna's Retrosyntheic analysis. 
The synthesis began from racemic 3-isopropyl-2-methylcyclopentanone. Addition of 
acrylonitrile took place on the face opposite to the isopropyl group, affording the cyano ketone 
50 as a single diastereomer. This reaction has generated the C 1 quaternary centre of the target 
molecule and the correct relative stereochemistry between the isopropyl and methyl groups in 
the C 1 and Cl 2 positions. The desired trienyne RCM substrates were generated in four steps: 
Stille coupling followed by two Grignard additions and protection of the resulting tertiary 
alcohol 55. The tertiary alcohols were formed as a 1:1 mixture of diastereomers in all cases. 
Exposure of the trienynes to Grubbs' II catalyst in DCM at room temperature afforded the 
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56a R = H (80%) 
561b R =Me (70%) 
56c R = CO2Me (93%) 
55a R = H (73% 2 steps) 
55b R = Me (78% 2 steps) 
55c R = CO2Me (75% 2 steps) 
(a) CH2=CHCN, NaOMe, Et20, (44%); (b) i) Tf20, DBMP, 0CM, 0°C to rt, ii) Pd(PPh3)4, LiCI, vinyltributyl 
tin, THF, reflux, (71%); (c) (CH 3)2C=CHCH2CH2MgBr, Et20, reflux, (74%); (d) 53, THF, 0°C to rt; (e) 
Et3SiOTf, 2,6-lutidine, 0CM, 0°C to ii; (f) Grubb's II catalyst (10 mol%), DCM, rt. 
Scheme 1.18. Investigations into the tandem RCM reaction. 
The tricyclic ester 56c was taken on further in the synthesis. The required A-ring oxygenation 
could be introduced through epoxidation with mCPBA, producing a separable mixture of two 
diastereomeric a- epoxides 57. Reductive opening of the epoxide under Luche conditions 
unexpectedly produced alcohol 58, arising from Lewis-acid promoted SN2'  addition of methanol, 
which was then oxidised to ketone 59 using the Dess-Martin periodiane. The serendipitous 
discovery that the requisite C5 hydroxyl group could be introduced with the correct 
stereochemistry in this fashion effectively sets up the entire functionality of the top-half of 
guanacastepene A. However, it was not possible to elaborate this series of molecules on further 
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owing to the absence of a methyl group at C8, which could not be introduced from the existing 
hydroxyl functionality (Scheme 1.19). 
Me02C 	 Me02C 
cc?j3 
OTES 
56c 	 57 
HO Me02C 	 o Me02C OMe OMe 
b 	 C POTES OTES 
58 	 59 
(a) mCPBA, DCM, NaHCO3, 0°C; (b) NaBH4, CeCI3.7H20, methanol, rt, (52% for 2 steps); (c) Dess-Martin 
periodiane, DCM, pyridine, rt, (80%); 
Scheme 1.19. Functionality of the tricyclic core. 
In order to overcome this problem Hanna et al. set about installing the methyl group in the C8 
position before the key RCM step.' The previously prepared nitrile 51 was treated with methyl 
magnesium bromide to afford the methyl ketone, which was then converted into nitrile 61. 
Alkylation with homoprenyl iodide installed the nascent C1 5 quaternary centre as a 1:1 mixture 
of diastereoisomers, as with the previous systems. Reduction with DIBALH afforded the 
aldehyde, which upon treatment with the Ohira reagent yielded the desired RCM precursor 63. 
As before, RCM proceeded in an excellent 82% yield, affording the ABC tricycle 64 as a 1:1 





















(a) MeMgBr, Et20 reflux, (72%); (b) TosMIC, tBuOK,  DMSO, methanol, rt, (58%); (c) (CH3)2C=CHCH2CH2I, 
LHMDS, THF, rt, (92%); (d) DIBALH, Et20, -70°C, (92%); (e) (i) Ohira reagent, K2CO3,  methanol; (ii) BuLi, 
CICO2Me, THF, -78°C to rt (81% 2 steps); (f) Grubb's II catalyst, DCM, reflux, (82%); 
Scheme 1.20. Introduction of the C8 methyl group. 
With the tricyclic core of the natural product in hand, the next step was the introduction of the 
oxygen functionalities at the C5 and C14 position. Oxidation with mCPBA afforded the two 
epoxides as before, which upon treatment with ytterbium triflate in the presence of allyl alcohol 
underwent SN2 ' ring-opening to give the alcohol 66 as a separable 3:2 mixture in 52% combined 
yield; the major product being the desired trans C8-C1 1. 
With the correct stereochemistry of the tricyclic core in place the last phase of the synthesis was 
the conversion of 66 into ketone 22 (a late intermediate in Danishefsky's total synthesis). 
Protection of the alcohol followed by a nickel(0)-catalysed hydroalumination in the presence of 
excess DIBALH simultaneously cleaved the allyl ether and reduced the ester to give diol 67. 
Cleavage of the TBS group, acetomde protection of the diol and oxidation yielded the desired 
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compound 22, having identical NMR spectra to that described by Danishefsky and Snider 
(Scheme 1.21). 
Me02C 	 Me02C 	 HO Me02C 
11 8 
	
a 4 	 b$y 
64 	 65 	 66 
OH 
TBSO 	 OH 
c-e 	 f-g 
67 22 
(a) mCPBA, DCM, NaHCO3, 0°C; (b) allyl alcohol, Yb(OTf)3, rt, (56% for 2 steps, 3:2 d.r.); (c) TBSOTf, 
pyridine, 0°C, (81%); (d) DIBALH, [N1C[2(dppp)], Et20, 0°C to rt, (71%); (e) TBAF, THF, rt, (81%); (f) 
Me2C(OMe)2, PPTS, 0CM, 0°C; (9)  Dess Martin periodiane, pyridine, 0°C to rt. 
Scheme 1.21. Completion of Hanna's formal synthesis of guanacastepene A. 
The Hanna group published the first convergent formal synthesis of the guanacastepene A in 
which both the B and C rings are formed in a tandem ring closing metathesis reaction of the 
intermediate 63. The discovery of a Lewis-acid promoted SN2' addition of an alcohol to the 




1.2.4 Sorensen's formal synthesis of guanacastepene A 
Sorensen et al. have reported a convergent A + C -), AC -p ABC approach to guanacastepene A 
based on the union of appropriately functionalised five and six membered rings to furnish an AC 
enone that can undergo an intramolecular [2±2] photocycloaddition reaction to form the putative 
B-ring. 21  This tetracyclic product contains a cyclobutane ring having one bond more conjugated 
with the ketone carbonyl than the other. It was hoped that this bias might permit a selective 
fragmentation reaction following one electron reduction of the ketone group, accessing the 
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Scheme 1.22. Sorensen's retrosynthetic analysis. 
The six membered C-ring counterpart was synthesised from commercially available 2-
methylcyclohexenone 73. TMS trapping of the kinetic enolate followed by Diels-Alder reaction 
with dimethylacetylenedicarboxylate gave a bridged bicyclic ketone after hydrolysis of the silyl 
enol ether. Baeyer-Villiger oxidation followed by acid catalysed methanolysis of the bridged 
lactone and protection of the resulting alcohol as a PMB ether yielded 75. Complete reduction of 
all three esters yielded the corresponding triol which was selectively converted to the PUT 
acetal. The alkene side chain was installed by reaction of the o-nitrophenylselenide derived from 
the alcohol with hydrogen peroxide to give compound 76. Methanolysis of the PUT benzylidene 
acetal followed by DDQ oxidation revealed the desired alcohol, which was converted to the 
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76 	 77 
(a) LDA, TMSCI, THF, -15°C to it, (98%); (b) Dimethylacetylenedicarboxylate, THE, 0°C to it; then I N aq 
HCl, 0°C to it, (99%); (c) mCPBA, NaHCO3, DCM, it, (96%); (d) CSA, methanol, reflux, (100%); (e) p-
methoxybenzyl trichioroacetimidate, CSA, DCM, it; (f) LAH, Et20, 0°C to ii, (87% over 2 steps); (g) 
Anisaldehyde dimethyl acetal, PPTS, DCM, it, (80%); (h) o-nitrophenylselenocyanate, BUR, THE, 0°C to 
it; then 30% aq H202, 'Pr2EtN, 0°C to 45°C, (71%); (i) PPTS, methanol, it, (85%); (j)  DDQ, 0CM, ii, (69% 
and 9% starting material); (k) Ac20, DMAP, pyridine, it, (100%). 
Scheme 1.23. Synthesis of the C ring fragment. 
In order to investigate the feasibility of the photocyclisationlfragmentation strategy a simpler 
cyclopentenone, lacking the C 12 isopropyl group and C 13 oxygen functionality, was synthesised 
to allow model studies to be conducted. Starting with 2-methyl cyclopentenone, iodination 
followed by palladium catalysed coupling to hexamethylditin yielded the simplified A-ring 
precursor 78. Palladium catalysed ir-allyl Stille coupling of the stannane to the allylic alcohol 
proceeded smoothly, affording the cycloaddition substrate 79 in excellent yield. Upon exposure 
to ultraviolet radiation the desired cyclobutyl ketone 80 was isolated as a single diastereoisomer 
in 76% yield. With the successful demonstration of the key photoaddition the Sorensen group 
were now in the position to explore the cyclobutane fragmentation. Treatment of adduct 80 with 
samarium diiodide in THF/HMIPA afforded the desired cyclobutane fragmentation product in 
72% yield, having the tricyclic guanacastepene skeleton. Even better, the putative, regiodefined 
samarium(111) enolate generated in the fragmentation could be trapped with phenylselenyl 
bromide, as compound 81, which underwent elimination to 82, having the characteristic tricyclic 
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(a) Lid, Pd2dba3, NMP, 50°C, (87%); (b) hu, 'Pr 2NEt, Et20, (76%); (c) Sm12, HMPA, THF, ii, then PhSeBr, 
rt, (44%); (d) mCPBA, DCM, -78°C, (84%). 
Scheme 1.24. Formation of the tricyclic core. 
Having successfully prepared tricycle 82 the Sorensen group concentrated their efforts on an 
enantioselective total synthesis .8  In order to access the desired enantiopure A ring fragment, a 
one carbon contraction of (S)-(+)-Carvone was envisaged, setting the absolute and relative 
stereochemistry of the densely substituted cyclopentenone ring. The synthesis began with a 
selective hydrogenation of the less hindered alkene with Adams' catalyst followed by a-
methylation to give 84 as a 5.5:1 mixture of diastereoisomers. Ozonolysis of the enone yielded 
the linear aldehyde carboxylic acid 85, which was easily converted into the corresponding 
cyanohydrin 86. Lactomsation with EDCI yielded the a-acyloxy nitriles 87 as a mixture of four 
diastereoisomers, which upon treatment with LHN{DS afforded the keto enol 88 as a single 
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(a) Pt02, H2, rt, (100%); (b) LDA, THF, -78°C to 0°C, then Mel, 0°C to rt, (96% as 5.5:1 mixture of 
diastereoisomers); (c) 03, EtOAc, -78°C, then H2, Pd/C, rt, (48-54%); (d) NaCN, PTSA, THF-H20, rt, (99%); 
(e) EDCI, 0°C to rt, DCM, (79%); (f) LHMDS, THF, rt, then 1  HCI(a q), (50-58%). 
Scheme 1.25. Formation of the A ring fragment. 
Conversion of the keto enol 88 to the desired A-ring vinylstannane for the Stille coupling 
proceeded smoothly with the formation of the vinyl nonaflate 89. However, the following Wuiff-
Stille reaction repeatedly failed, probably due to the steric hindrance imparted by the isopropyl 
group. Acceptable yields were accomplished with the addition of [1,1 '-bis(diphenylphosphino) 
ferrocene] dichloropalladium-(H) as a catalyst (Scheme 1.26). 
	










(a) Et3N, NW, 0CM, it, (94%); (b) Pd(dppf)C12, Me 3SnSnMe3, NMP, 60°C, (63%) 
Scheme 1.26. Formation of vinylstannane 90. 
With the desired vinyistannane A ring fragment in hand they turned their attention towards 
obtaining an enantiomerically pure C ring fragment. A classical resolution of the ester, formed 
between the alcohol intermediate 91 and the 0-acetate of (S)-(+)-mandelic acid 92, afforded a 
separable mixture of diastereoisomers 93 and 94. Hydrolysis of the mandelate ester 93 followed 
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by acetylation yielded the enantiopure allylic acetate 95 setting the stage for the Stille coupling 



















(a) 92, DMAP, DCC, 0CM, 0°C to ii, (98%); (b) K2CO3, methanol, rt, (97%); (c) Ac20, DMAP, pyridine, ii, 
(100%). 
Scheme 1.27. Classical resolution. 
Having previously encountered problems with Stille couplings, arising from the steric hindrance 
of the isopropyl group, it was with some caution that they proceeded with the it—allyl Stille 
coupling of both enantiopure fragments. The reaction conditions optimised in the model systems 
proved unsuccessful, while the cuprous-chloride-accelerated Stille couplings developed by the 
Corey group yielded the desired product in good yield. The coupling could also be performed 
with the mandelate ester 93, reducing the number of steps (Scheme 1.28). 
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(a) LiCI, CuCI, Pd(PPh3)4, DMSO, it to 60°C, (78%) 
Scheme 1.28. Stille coupling. 
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Having been thwarted twice already by the isopropyl group, it was again with some anxiety that 
they proceeded to investigate the [2+2] photocycloaddition/fragmentation strategy. However, 
irradiation of 96 proved more facile and efficient than in any of the model systems examined 
previously and the presence of the isopropyl group reinforced the outstanding diastereofacial 
selectivity previously noted in these earlier systems. Treatment of 97 with samarium diiodide 
induced a selective, reductive fragmentation which was again trapped with phenyl selenenyl 
bromide to form organoselenide 98 as a mixture of diastereoisomers. Elimination was achieved, 
via oxidation to the selenoxide with mCPBA, to yield the complete [5-7-6] tricyclic ring system 
of the guanacastepenes. A formal synthesis was achieved by warming a solution of the 
benzylidene acetal in 2,2-dimethoxypropane and catalytic PPTS, to yield the isopropylidene 
ketal 22, a late intermediate in Danishefsky' s total synthesis. The NIIVIR spectrum of 22 exactly 













98 	 22 
(a) ho, 'Pr2NEt, Et20, (82%); (b) Sm12, HMPA, THF, rt; then PhSeBr, (50%); (c) mCPBA, 0CM, -78°C, 
(86%); (d) PPTS, 2,2-dimethoxypropane, 60°C, (77%). 
Scheme 1.29. Sorensen's formal synthesis of guanacastepene A. 
This tricycle 99 could also be readily converted to guanacastepene E 101 by a Rubottom 
oxidation, to install the C13 acetoxy group. Deprotection of 100 yielded a diol, which upon 
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(i) Et3N, Et3S1OTf, DCM, -78°C; (ii) mCPBA, DCM, -78°C; (ii) Ac20, DMAP, pyridine, rt, (45%, 3 steps); 
PPTS, methanol, 70°C, (88%); (c) Si02, DCM, rt, (78%). 
Scheme 1.30. Enantioselective total synthesis of guanacastepene E. 
The Sorensen group have reported a convergent formal synthesis of (+) guanacastepene A and 
the first total synthesis of (+) guanacastepene E. Their approach is based on a [2+2] 
photocycloadditionlfragmentation strategy of the A and C ring precursor 96, synthesised from a 
it-ally! Stille reaction of the enantiomencally pure fragments 90 and 93. 
1.2.5 Mehta's total synthesis of guanacastepene C 
Mehta's initial report on guanacastepene A described the stereoselective synthesis of the 
hydroazulene core, starting from the readily available Diels-Alder adduct endo-
tricyclo[5.2. 1 .O]deca-3 ,8-dien-5-one 102 .22,23 Copper(I) promoted 1,4-addition of 
isopropylmagnesium iodide was completely selective for the exo-face, and two sequential 
alkylations afforded the A-ring precursor 104. A retro-Diels-Alder reaction under flash vacuum 
pyrolysis (FVP) revealed the desired cyclopentenone having the correct cis stereochemistry 
between the C 12 isopropyl and C 11 methyl groups (Scheme 1.31). 
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(a) 'PrMgl, Cul, Et20, 0°C, (90%); (b) (i) LDA, THF, HMPA, ally[ bromide, (60%), (ii) NaH, THF, Mel, (82%); 
(c) FVP, 500°C, (85-90%). 
Scheme 1.31. Mehta's synthesis of the cyclopentanone 
With a suitable A ring fragment they turned their attention towards constructing the 
hydroazulene core via RCM. 1,2-addition of 4-bromo-1-butene furnished the carbinol as a 
mixture of diastereoisomers 106 and 107, which rearranged when oxidised to yield the enone 
108. Exposure to Grubbs' I catalyst, in refluxing benzene, yielded the hydroazulenone 109 in 
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(a) 4-bromo-1-butene, Li, ))), (76%); (b) PCC, DCM, (90%); (c) Grubbs I, benzene, reflux, (95%). 
Scheme 1.32. Mehta's synthesis of the hydroazulene core of guanacastepene A. 
A number of functionalisation studies were carried out on hydroazulenes related to 109 with the 
intention of installing oxygen functionality into both the A and B rings. 24 The eventual strategy 
adopted, via allylic alcohol 110 is shown in Scheme 1.33, whereby hydroazulenone 109 is 
converted to the diol 111 in three steps. Protection of the diol as an acetomde permits an allylic 
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oxidation to be carried out, introducing the critical C3 oxidation required for the installation of 














(a) 10% Pd/C, H2, EtOAc, (98%); (b) DIBALH, 0CM, (98%); (c) mCPBA, DCM, (92%); (d) pyridine, 
TMSOTf, DMAP, (75-80%); (e) DMP, acetone, PPTS, (95%); (f) 3,5-dimethylpyrazole, Cr03, DCM, (50%); 
Scheme 1.33. C2 alkylation followed by cyclisation 
Mehta et al. decided that the stereochemistry of these advanced fragments is more suitable for 
the preparation of guanacastepene C and subsequently reported its total synthesis. 8 
Their synthetic studies began from enone 112 which could be carboethoxylated in the a-position 
with Manders reagent. A second alkylation, with methyl iodide, proceeded cleanly to give 114. 
The second alkylation is exclusively directed to the lower face by the angular methyl group at 








(a) LDA, THF-HMPA, CNCO2Et, -78°C, (75%); (b) NaH, THF, Mel, (85-90%). 
Scheme 1.34. Oxidation at C3. 
Cyclisation attempts using RCM and Prins-type cyclisations were unsuccessful so they turned 
their attention towards a Knoevenagel condensation strategy for the C ring annulation. The 
synthesis began with reduction of the keto ester 114 to the corresponding diol. Selective 
protection of the secondary alcohol was unsuccessful so they opted for an orthogonal protecting 
group strategy in which the primary alcohol was protected as the PMB ether. Protection of the 
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secondary alcohol as the TBS ether allowed for a selective deprotection of the primary alcohol 
and oxidation with IBX to afford aldehyde 115. A five carbon fragment, in the form of ethyl 4-
diphenylphosphinoyl-3 -oxobutanoate, was condensed onto the aldehyde followed by 
regioselective hydrogenation. Deprotection of 116 also resulted in the cleavage of the acetonide, 
as well as hemiketalisation. The resulting diol was reprotected as the acetonide before PCC 
oxidation to afford 118, the Knoevenagel precursor. When 118 was treated with DBU a smooth 
cyclisation took place to produce the tricycle 119, possessing the complete carbon skeleton and 
required functionality for further elaboration to guanacastepene C (Scheme 1.35). 
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(a) LAH, THF, 0°C to rt, (55%); (b) (i) PMBCI, THF, NaH, TBAI, 0°C to it, (67%), (ii) TBSOTf, 2,6-lutidine, 
DCM, 0°C, (68%), (iii) DDQ, DCM-1-120, it, (95%); (c) IBX, toluene/DMSO, rt, (92%), (d) 
Ph2POCH2COCH2CO2Et, NaI-1, BuLi, THF, 0°C to rt, (86%); (e) H2, EtOAc, 5% Pd/C, it, (quant.); (f) (i) 6N 
H2SO4, THF/H20, it, (80%), (ii) 2,2-DMP, PPTS, it, (91%); (g) PCC, NaOAc, 4 A MS, DCM, it, (80%); (h) 
DBU, benzene, 65°C, (82%) 
Scheme 1.35. Synthesis of the tricyclic core of guanacastepene C. 
Conversion to guanacastepene C 123 began with reduction of both the ethyl ester and the enone 







hydroxyl group. Standard Mitsunobu reaction inversion afforded the dibenzoate 121 in fair yield. 
Deprotection of the acetomde followed by selective oxidation of the allylic alcohol and 
deprotection of the resulting dibenzoate, if successful, would lead to the target compound. 
However hydrolysis of the benzoates in 121 proved problematic and a protecting group switch to 
the diacetate 122 was required before the acetomde deprotection to yield the desired natural 









(a) LAH, THF, -78°C to rt, (65%); (b) PPh3, PhCO2H, DIAD, THE, -78°C to rt, (78%); (c) LAH, THF, 0°C to 
rt, (84%); (d) Ac20, Et3N, DMAP, 0CM, rt (90%); (e) 4N 1-12SO4, THF/1-120, rt, (44%); (f) DDQ, THF, 65°C, 
(85%); (g) K2CO3, MeOH, 0°C to 15°C, (79%) 
Scheme 1.36. Synthesis of guanacastepene C. 
Mehta's synthesis of guanacastepene C is based on a ring closing metathesis reaction to form the 
seven membered ring. A Knovenagel cyclisation afforded the key tricycle 119 which was 
elaborated to guanacastepene C. A shorter synthesis was thwarted by protecting group issues. 
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1.2.6 Overman's total synthesis of guanacastepene N 
The Overman group proposed to tackle the central seven membered ring of the guanacastepenes 
via a 7-endo Heck cyclisation. 9  Previous work carried out within the group, directed at the 
synthesis of complex cardenolides such as ouabain, 25 suggested that such a strategy was feasible. 
Their retrosynthetic analysis identified two key steps. The first was the union of enantiopure A 
and C rings via a cuprate conjugate addition between 127 and 128. Conversion to the dienyl 
triflate 126 would yield the desired precursor to the second key transformation, a 7-endo Heck 
cyclisation, to form tricycle 125, which could potentially be converted into several of the 
guanacastepenes (Scheme 1.37). 
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Scheme 1.37. Overman's retrosynthetic strategy towards guanacastepene N. 
The synthesis began with the formation of enantiopure A and C ring fragments. (5)-cyclohexenyl 
iodide 128 was prepared by a straightforward sequence of transformations, beginning with (R)
3-methylcyclohex-2-yl acetate, which is obtained in 95% ee and 36% overall yield by a known 
procedure. Ireland Claisen rearrangement of the ketene silyl acetal derived from acetate 129, 
followed by reduction of the resulting silyl ester with DIBALH, provided alcohol 130, which 
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(a) LDA, THF, -78°C, then DMPU, TBSCI, -78°C to rt; (b) toluene, 80°C; (c) DIBALH, toluene, -78°C to rt; 
(d) 12, Ph3P, imidazole, DCM, 0°C to rt, (69% overall, 80% ee). 
Scheme 1.38. C ring synthesis. 
A short synthesis, based on a chiral auxiliary modified Stork-Danheiser reaction, was developed 
to prepare enantiopure (R)4isopropyl-3-methhylcyclopeflt-2-efl-1-one 127. Condensation of (+) 
menthol with 1 ,3-cyclopentadione 131 followed by addition of 2-iodopropane to the zinc enolate 
furnished 132 in 71% yield as 1.5:1 ratio of separable diastereoisomers. Treatment with methyl 
lithium followed by acidic work up provided the (R)-cyclopentenone 127 in 79% yield and 88% 
ee (Scheme 1.39). 
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(a) Menthol, PTSA, benzene, 80°C, (76%); (b) LDA, THF, -78°C, then Et2Zn, 2-iodopropane, DMPU, -78°C 
to rt, (71%, 1.5:1 dr); (c) MeLi, THF, -78°C to 0°C, aq. NaHSO4, (79%, 88% ee) 
Scheme 1.39. A ring synthesis. 
With the two chiral building blocks in hand, they turned their attention towards the sterically 
hindered conjugate addition. They had originally anticipated this to be a difficult transformation, 
due to the steric interactions arising from the neighbouring isopropyl group. This proved to be 
the case with initial results, using a higher order cuprate, yielding the desired product in low 
yields with poor reproducibility. A number of alternative coupling conditions were examined 
which led to a set of optimised conditions that were eventually employed in the synthesis. The 
cyanocuprate was generated from iodide 128 by sequential addition at -78°C of tert-butyl 
lithium and copper cyanide. After the cuprate formation the reaction was allowed to warm to - 
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30°C before it was then re-cooled to -78°C and Me 3SiBr along with enone 127 were added. The 
crude silyl enol ether was reacted with Eschenmoser's salt at room temperature to yield the 
Mannich base 134 which was quarternised with Me!. Base promoted elimination of this 




128 	 133 
NMe2 bJL,() cf,c 12 
134 	 135 
(a) tBuLi, Et20-pentane, -78°C; (b) CuCN, -78°C to -30°C; (c) Me3S1Br, THF, -78°C, then add 127 (0.7 
equiv.), -78°C; (d) Me2NCH21- , 2,6-lutidine, DMF, 0°C; (e) Mel, Et20, rt; (f) K2CO3, DCM/MeOH/H20 
(4:1:3), rt, (53-58% overall). 
Scheme 1.40. Conjugate addition. 
The dienone 135 was converted to the Heck cyclisation precursor 138 in a series of nine efficient 
transformations, which required only one purification step. Regioselective epoxidation with 
mCPBA furnished an epoxide, as a mixture of epimers, which were reduced under Luche 
conditions and the corresponding alcohol protected, as a TBS ether. Reduction with LiEt 3BH 
followed by oxidation afforded the ketone 137 in 83% overall yield for the five steps. 
Alkoxycarbonylation of the lithium enolate with benzyl cyanoformate furnished the 
corresponding -keto ester, which existed as a mixture of keto and enol tautomers. After much 
experimentation suitable conditions for the triflate formation were derived and the corresponding 
product was treated with aqueous HF and subsequently oxidised to furnish the Heck cyclisation 
precursor 138 (Scheme 1.41). 
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138 
(a) mCPBA, DCM, 0°C; (b) NaBH4, CeCI3.71-120, methanol, -78°C; (c) TBSCI, imidazole, DCM, rt; (d) 
LiEt3131-1, THF, 0°C; (e) NMO, TPAP, DCM, rt, (83% over 5 steps); (f) LHMDS, THF, -78°C to rt, then 
DMPU, benzyl cyanoformate, -78°C to it; (g) KHMDS, THF, -78°C, then Tf20, -78°C; (h) HF, 
MeCN/MeOH/H20 (8:2:1), 0°C; (I) NMO, TPAP, 0CM, II, (47-53% over 4 steps). 
Scheme 1.41. Heck substrate formation. 
With the required precursor in hand they turned their efforts towards the second key step in the 
synthesis, the Heck cyclisation. To their delight they discovered that when triflate 138 was 
heated at 80°C in DMA in the presence of catalytic Pd 2(dba) 3 .CHC13 and dppb, with an excess of 
KOAc, the desired tricyclic dienone 139 was formed in 75% yield. Elaboration towards the 
guanacastepene structure began with the introduction of the 3-acetoxy substiuent at C13, via the 
procedure developed by the Danishefsky group, leading to intermediate 140 as a separable 9:1 
mixture of diastereoisomers (Scheme 1.42). 






139 	 140 
(a) Pd2(dba)3.CHCI3 (12 mol%), dppb (24 mol%), KOAc, DMA, 80°C, (75%); (b) TESOTf, Et3N, 0CM, - 
78°C; (c) DM00, 0CM/acetone, -78°C, (dr = 9:1); (d) Ac20, Et3N, DMAP, it, (67% over 3 steps). 
Scheme 1.42. Synthesis of intermediate X. 
The intermediate 140 could potentially be converted into several of the guanacastepenes via a 
series of synthetic transformations, however several attempts to hydrolyse the benzyl ester 












the presence of triethylsilane cleanly produced the tetracyclic lactone 141 in 77% yield as a 
mixture of all four possible diastereoisomers. Treatment of 141 with NBS in the presence of 
benzoyl peroxide in refluxing carbon tetrachloride selectively introduced a s-bromine at C5 and 
reinstalled the central unsaturation, the latter presumably occurring as a result of allylic 
bromination at C2 followed by elimination of HiBr. The high diastereoselectivity (20:1) of this 
bromination must be controlled by the a-orientated axial methyl substituent at C8, as the B and 
C rings of the delocalised radical would be nearly planar. Several attempts for retentive 
replacement of the Br substituent with a hydroxyl group via solvolysis in acetone/water in the 
presence of silver salts were examined, but lead to the preferential formation of the un-natural 
C5 epimer of guanacastepene N. Useful levels of stereocontrol could be obtained by 
regeneration of the delocalised radical from the bromide 142 by reaction with Bu3Sn}T in the 
presence of air, followed by in situ reduction of the allylic peroxide intermediate with Ph 3P. This 
sequence generated guanacastepene N 143, and its C5 epimer in a 10:1 ratio and 47% yield. 
Separation provided pure samples of each and the NMR spectrum of the major diastereoisomer 
matched that of the natural product (Scheme 1.43). 
(a) Et3SiH, Pd(OAc)2, Et3N, 0CM, it, (77%); (b) NBS, benzoyl peroxide, CCI4, reflux, (64%, dr = 10:1); (c) 
Bu3SnH, air, toluene, it, then Ph3P, chloroform, it, (47%, dr= 10:1). 
Scheme 1.43. Synthesis of guanacastepene N. 
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In conclusion, the Overman group successfully synthesised (+)-guanacastepene N, and its C5 
epimer, via a convergent sequence utilising a 7-endo Heck cyclisation to construct the central 
seven membered ring, from two enantiopure A and C ring precursors. 
1.2.7 Trauner's total synthesis of guanacastepene E 
Trauner et al. have developed a convergent A + C -+ AC -+ ABC enantioselective synthesis of 
guanacastepene B. 26  Their strategy involved the joining of two enantiomerically pure A and C 
ring precursors, 145 and 146 respectively, to yield the tethered bicyclic structure 144, from 
which the central seven membered ring is constructed by forming the C  -C2 bond of the tricycle 
(Scheme 1.44). 
	
0HC 15 	 0 	0 	 0 0 OH 
AcO II 5 	> 	 .oP 	+ OP 
1 	 144 	 145 	146 
Scheme 1.44. Trauner's retrosynthetic analysis. 
Work began with the development of an asymmetric synthesis of the furanocyclohexanol 146, 
starting from the readily available 2,3-di-iodofuran 147. Mono-lithiation followed by addition to 
(E)-4-methylhex-4-enal and oxidation afforded the corresponding ketone, which underwent an 
enantioselective reduction, using Brown's DIPC1 reagent, gave the alcohol 148 in 75% yield and 
94% e.e. Construction of the cyclohexyl ring was achieved via an intramolecular Heck reaction 
yielding 149 as a 5:1 mixture of diastereoisomers at C8. The diastereoselectivity of this reaction 
was found to be dependant on the presence of the free hydroxyl group, as protected versions 
cyclised with either decreased or even inverted selectivity. Protection of the alcohol followed by 
hydroboration/oxidation gave the desired alcohol 150 as a separable mixture of diastereomeric 
alcohols. (Scheme 1.45). 
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147 	 148 	 149 	 150 
(a) "BuLi, Et20, -78°C, then (E)-4-methylhex-4-enal, (62%); (b) DMP, DCM, rt, (88%); (c) (-)-DIPCI, THF, - 
20°C, (75%); (d) Pd(OAc)2, Et3N, ("Bu) 4NBr, MeCN, H20, 75°C, (83%); (e) TBDPSCI, imidazole, DMAP, 
0CM, 0°C, (98%); (f) (I) 9-1313N, THF, reflux., (ii) ethanol, NaOH, H202, it, (81%). 
Scheme 1.45. Formation of the furyl compound. 
Furan 150 was taken on to a model study into the formation of the central seven-membered B-
ring, where the key carbon-carbon bond forming step was envisaged to arise from a rhodium-
carbenoid addition. The furyl diazo ester 152 was prepared in seven standard steps from alcohol 
150, via aldehyde 151, in an overall 53% yield. Exposure to rhodium acetate in DCM produced 
the bicyclic aldehyde 153 in an un-optimised yield of 50% (Scheme 1.46). Compound 153 
represents the entire unsaturated lower half of the guanacastepenes and the fully substituted 
cyclohexene ring. 


















(a) (COCI)2, DMSO, Et3N, 0CM, -78°C, (91%); (b) MePPh3Br, "BuLi, THF, 0°C, (95%); (c) (i) 9-1313N, THF, 
it, (ii) ethanol, NaOH, H202, it, (92%); (d) (COCI)2, DMSO, Et 3N, DCM, -78°C; (e) ethyl diazoacetate, DBU, 
MeCN, it, (76% for 2 steps); (f) Rh2(OAc)4, DCM, it, (95%); (g) p-ABSA, Et 3N, MeCN, it, (92%); (h) 
Rh2(OAc)4, DCM, it, (50%). 
Scheme 1.46. Formation of the seven membered ring. 
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With a successful ring closure in place, they focused on the synthesis of the enantiomerically 
pure A ring fragment required for the natural product. For practical reasons these model studies 
were carried out on the non-natural enantiomeric series. The synthesis started with the 
enantiopure alcohol 154, which is readily available from the corresponding achiral diacetate, 
using an electric eel acetylcholineesterase (EEAC). Oxidation afforded the cyclopentenone, 
which underwent conjugate addition of isopropyl-magnesium bromide, in the presence of copper 
bromide dimethyl sulphide complex, to yield the desired product as a single diastereoisomer. 
Upon treatment with acid, elimination occurred to furnish the cyclopentenone in 90% e.e. A 
second conjugate addition was carried out using Me 2CuLi, with in situ trapping of the enol ether 
with chlorotrimethylsilane, which then underwent a Saegusa oxidation to regenerate the enone 
155. Reaction of the lithium enolate with the camphor-based oxaziridine developed by Davis et 
al. gave the acyloin, which was subsequently protected as the silyl ether 156 (Scheme 1.47). 
OH 	 0 	
0 
a-c 	 d-e 	TBSOa.ç 
/ 	 12/ 
6-VoAc  
154 	 155 	 156 
(a) (COd)2, DMSO, Et3N, 0CM, -78°C (94%); (b) (i) rMgBr, CuBr.DMS, HMPA, TMSCI, THF, -78°C to - 
40°C, (ii) CSA, H20, 0CM, reflux, (63%); (c) (i) Me 2CuLi, TMSCI, Et20, -40°C, (ii) Pd(OAc)2, MeCN, rt, 
(70%); (d) LDA, THF, -78°C, then (IR)-(-)-(10-camphorsulfoflyl)-oXaZiridifle -30°C, (85%); (e) TBSCI, 
imidazole, DMF, rt, (93%) 
Scheme 1.47. Asymmetric synthesis of the A ring fragment. 
Conversion of the previously synthesised alcohol 150 to the corresponding iodide, furnished the 
desired C ring coupling partner 157, which was coupled to the cyclopentenone 156 via a 
challenging cuprate conjugate addition. Lithiation of the iodide 157 followed by treatment with 
lithium 2-thienylcyanocuprate produced a mixed, higher-order heterocuprate, which in the 
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158 
(a) tBu L ,  Et20, -78°C, then (2-thienyl)Cu(CN)Li, THF, then 156, BF3.OEt2, -40°C, (50%). 
Scheme 1.48. Conjugate addition of A and C ring fragments. 
With a suitable cyclisation precursor in hand their synthetic efforts turned towards the synthesis 
of the diazo ketone 159, which is required for the rhodium catalysed cyclopropanation 
rearrangement. Unfortunately, despite numerous attempts using a variety of reaction conditions 
the desired product could not be isolated. This is possibly due to the steric congestion arising 
from the presence of the adjacent quaternary centre (Scheme 1.49). 
N2 	"NOTBDPS 




Scheme 1.49. Attempted diazo formation. 
With all their efforts towards the synthesis of the diazo ketone proving unsuccessful they turned 
their attention towards alternative ways of forming the central seven membered ring. Realising 
that coupling of the nucleophilic furan to the enol form of the cyclopentanone would require 
some form of "umpolung" reactivity, which is most easily achieved via oxidation to the 
corresponding radical cation, they concentrated on the electro-oxidative coupling methodology 
developed by the groups of Moeller and Wright. 
The silyl enol ether 160 was synthesised by trapping the kinetic enolate of 158 with TBSOTf, 
which under anodic oxidation yielded the acetal 161 in 70% yield as a single diastereoisomer, 
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(a) LDA, TBSOTf, THF, HMPA, -78CC, (93%); (b) RVC anode (0.2 mA), 2,6-lutidine, 0.06M 1-004, 20% 
MeOH, 0CM, rt, 2.44 F mol', (70%); (c) HCI, H20, THF, rt, (85%). 
Scheme 1.50. Electro oxidative coupling to form the tricycle 162. 
With a suitable method for the formation of the tricyclic core, their attention turned towards 
completing the synthesis of (-)guanacastepene E.' ° The first step involved the asymmetric 
synthesis of the A ring fragment, with the correct stereochemistry for the natural product. This 
was achieved in six steps by employing the chiral auxiliary mediated carbonyl-ene methodology 
developed by Whitesell et al. Starting from the known chiral glyoxylate 163, treatment with 2,4-
dimethyl-2-pentene 164 in the presence of tin(1V) chloride yielded the anti adduct 165 as the 
major product. Removal of the auxiliary followed by benzylation afforded aldehyde 166, which 
was treated with vinyl magnesium bromide in the presence of CeC1 3, and the resulting alcohol 
was oxidised to give diene 167. Treatment of 167 with Grubbs II catalyst afforded the A ring 
cyclopentanone fragment 168 in 86% yield (Scheme 1.51). 
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166 	 167 	 168 
(a) SnCI4, 0CM, -78°C, (64%, 10:1 dr); (b) NaH, benzyl bromide, ( °Bu)4N1, THF, (100%); (c) DIBALH, 0CM, 
-78°C, (85%); (d) vinylmagnesium bromide, CeCI3, THF, -78 °C, (82%); (e) Dess-Martin periodinane, 0CM, 
(86%); (f) Grubbs II, PhMe, reflux, (86%). 
Scheme 1.51. Synthesis of A ring fragment. 
Conjugate addition of 157 to 168 followed by silyl enol ether formation, afforded the electro-
cyclisation precursor 169, which under the previously optimised conditions, cyclised to give the 
desired tricycle 170 in 81% yield (Scheme 1.52). 
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(a) tB u Li, Et20, -78°C, then (2-thienyl)Cu(CN)Li, THF, then 168, BF3.OEt2, -40°C, (54%); (b) KHMDS, 18-
crown-6, TBSOTf, THF, -78°C, (94%); (c) RVC anode (0.9 mA), 2,6-lutidine, 0.1 M LiCI04, 20% methanol in 
0CM, it, 2.61 F moi1 , (81%). 
Scheme 1.52. Formation of the tricycle 170. 
With the desired tricycle in hand all that remained for the synthesis of guanacastepene B was 
reduction of the methoxy group, removal of all the protecting groups, and acetylation of the Cl 3 
alcohol. However, what seemed like a relatively straightforward sequence of synthetic steps 
turned out to be more challenging than expected. Reduction of the methoxy group was achieved 
with a large excess of DIBALH, but resulted in reduction of the C14 ketone. All efforts to avoid 
this unwanted reduction proved unsuccessful, resulting in aromatisation of the furan ring. 
Oxidation of the secondary alcohol 171 restored the cyclopentanone, however, all attempts to 
remove the benzyl group resulted in poor yields. Protection of the secondary alcohol in 171, as 
the MOM ether, then facilitated the desired de-benzylation. Acetylation of the free hydroxyl 
groups followed by cleavage of the MOM ether and oxidation of the resulting alcohol afforded 






















h 	AcOsç  14 
174 
(a) DIBALH, PhMe, -78°C to ii, (61%); (b) MOMCI, 'Pr 2NEt, Nal, THF, reflux, (95%); (c) TBAF, THE, 
(100%); (d) Na, NH3(l), THF, -78°C, (94%); (e) Ac20, DMAP, p-xylene, reflux, (93%); (f) BF 3.OEt2, DMS, 
DCM, -20°C; (g) Dess-Martin periodinane, 0CM, (69% 2 steps); (h) K2CO3, methanol, (28%). 
Scheme 1.53. Synthesis of (-) guanacastepene E. 
Trauner et al. have developed an A -* AC - ABC approach towards the guanacastepene 
tricyclic structure and have successfully applied this methodology to the asymmetric synthesis of 
guanacastepene E. Their approach is based on the union of two enantiomerically pure A and C 
ring fragments followed by the construction of the central seven membered ring by forming the 
C1-C2 bond. Initial model studies focused on a rhodium-catalysed 
cyclopropanation/rearrangement, however attempts to form the required diazo ketone of the 
advanced substrate 158 proved unsuccessful. Instead they turned their attention towards an 
electrochemical cyclisation approach and successfully synthesised the tricyclic core. This 
intermediate was advanced further to complete the asymmetric synthesis of guanacastepene E. 
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1.3 Approaches towards the synthesis of guanacastepene 
A 
The completed syntheses of Danishefsky and Snider established the hydroazulene core as an 
important sub-target en route to the natural product. This linear strategy, which aims to complete 
the synthesis in an A -+ AB -p ABC sense, has been pursued by a number of research groups 
engaged in the synthesis of the guanacastepene family. Hanna's approach is also linear, but 
constructs two rings simultaneously in a tandem fashion (A - ABC). Alternatively, a convergent 
approach, such as those of Sorensen and Overman, can be taken whereby two rings are 
synthesised separately and joined to give the tricycle. Both approaches, linear and convergent, 
are discussed separately in the following two sections. 
1.3.1 Linear approaches to the synthesis of guanacastepene A. 
1.3.1.1 Magnus' approach 
Magnus' strategy was the first to advance an asymmetric approach to the natural product. 27 The 
strategy focuses on the construction of the hydroazulene portion of guanacastepene A through a 





1 	 175 	 176 
Scheme 1.54. Magnus's retrosynthesis. 
Aldehyde 182 was identified as a suitable precursor to the requisite pyrylium ylide, and could be 
prepared as a single enantiomer via chiral separation. Addition of isopropyl magnesium chloride 
to 2-methyl-2-cyclopenten-1-one followed by methylation of the resulting enolate afforded 177. 
Application of the Johnson sulfoximine ketone resolution methodology produced the separable 
adducts 178 and 179 in high yield; the structure and absolute stereochemistiy of which was 
established by X-ray crystallography. Both adducts were then taken forward separately through a 
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three step sequence to yield nitrile 181 as a single enantiomer. Only the (+)-enantiomer of 181 
was required for the synthesis, and this was reduced with DIBALH to yield the target aldehyde 
182 (Scheme 1.55). 
a 	 b 	
OH 
HO 
2 	 177 	 180 	 181 	 182 
(+) and  (-) 	 (+) and  (-) 
)'(sOHNMe 	 sOHNMe 
L)\ 11 —Ph + L..J\._ S—Ph
11 
0 	 0 
178 	 179 
(a) (i) 'PrMgCI, Gui, THF, -30 to -5°C; (ii) Mel, -5 to 23°C, (74%); (b) NH20HHCl, pyridine, ethanol, 23°C, 
(96%); (c) PCI5, 2,6-lutidine, Et 20, 23°C, (77%); (d) (+)-N,S-dimethyl-S-phenylsulfOximifle, BuLj, THF, - 
78°C, (88%, 1:1); (e) (I) PrOH reflux, (ii) NH20HHCl, pyridine, (86%); (f) DIBALH, DCM, -78°C, (83%). 
Scheme 1.55. Asymmetric synthesis of aldehyde 122 for guanacastepene synthesis. 
Addition of 2-lithiofuran to aldehyde 182 gave 183 which oxidatively rearranged on treatment 
with VO(acac)2, which after acetylation gave 184. Heating 184 in benzene successfully produced 
the hydoazulene 175 as essentially a single stereoisomer, with the crucial cis-relationship 





182 	 183 
b-c 




(a) 2-lithiofuran, THE, -78°C, (92%); (b) VO(acac)2, tB u02H, 0CM, (71%); (c) Ac20, Et3N; (d) benzene, 
reflux, (80%, 2 steps); (e) H2, Pd/C, (100%); 
Scheme 1.56. Formation of the hydroazulene core. 
The oxide bridge of 175 could be opened with a number of reagents, but the best strategy 
involved conversion to vinyl sulfide 185. Treatment with LAH resulted in conjugate reduction 
and cleavage of the oxide-bridge to afford a vinyl sulphide, which after protection of the alcohol, 
was oxidised to the sulfoxide 186. Treatment with DBU/EtCN resulted in sulfoxide-sulfenate 
rearrangement to give the alcohol 187 as a 4:1 mixture of epimenc secondary alcohols. 
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(a) PhSH, HCI, H2SO4, 25°C, (77%); (b) mCPBA, DCM, 0°C, (91%); (c) LAH, THE, -78°C to 23°C, (49%); 
(d) NaH, BnBr, Bu4NI, THE, (93%); (e) mCPBA, 0CM, 0°C, (88%); (f) DBU, EtCN, reflux, (92%); (g) Dess 
Martin penodiane, DCM, 23°C, (83%). 
Scheme 1.57. Functionalisation of the hydroazulene core. 
Studies were conducted on the introduction of the guanancastepene C13 hydroxyl group. 28 
Treatment of ketone 188 with KHIVIDS followed by (10-camphorsulfonyl)oxaziridine led to the 
formation of the expected alcohol 189, along with the over oxidised product 190. The 
configuration at C13 of 189 is correct for guanacastepene C and attempts to epimerise the C13 
hydroxyl group to the guanacastepene A configuration, via the enediolate 191, were 

















qb B n 
191 
(a) (i) KHMDS, THF degassed, -78°C, (iii) (IR)-(-)-(1O-camphorsulfonyl)oxaziridine, (78%,93:7); (b) tB uOK, 
THF, 02, P(OEt)3, -78°C, (46%, 3:7); (c) BuOK, tBuOH, 02, THF, 23°C, (89%). 
Scheme 1.58. Attempts to insert the C13 hydroxyl group. 
An alternative Rubottom-type oxidation of the silyl enol ethers 192 and 194 was also 
problematic. Epoxidation of the silyl enol ether 192 with mCPBA afforded epoxide 193. 
Whereas oxidation of silyl enol ether 194 with DMDO followed by camphor sulfonic acid gave 
195. These results suggested that the acid catalysed equilibration of the kinetic silyl enol ether to 
give the thermodynamic (extended conjugation) silyl enol ether is more rapid then epoxidation 
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194 	 195 
(a) 'Pr3SiOTf, Et3N, 0CM, 23°C; (b) mCPBA, DCM, -78°C to 0°C, then Me2S, (61%); (c) Et3SiOTf, Et3N, 
DCM; (d) (I) DMDO, DCM, -78°C, then Me2S, (47%, 2 steps); (ii) camphor sulfonic acid, acetone/H20, 
reflux. 
Scheme 1.59. Attempts to introduce the C13 hydroxyl group. 
1.3.1.2 Tius' Approach 
Tius et al. have applied their allenyllithium cyclopentannulation methodology to the synthesis of 
guanacastepene A in an A -* AB strategy. 29  Work began with the a,fi-unsaturated morpholino 
amide 197, prepared in a single operation from tribromoethylene 196. Cyclopentannelation was 
achieved in good yield through the addition of the allenyl compound 198 followed by an in situ 


















196 	 197 	 198 	 199 
(a) (i) Li-morpholinamide, THF, -78°C; (ii) isobutyraldehyde, THF, reflux, (71-73%); (b) 198, THF, -78°C, 
then HCl/ethanol, 0°C, (75%); 
Scheme 1.60. Cyclopenta none synthesis. 
With the A-ring complete, the plan was to form the guanacastepene B-ring using RCM. 
Protection, reduction and alkylation produced the trans cyclopentenone 201 as a mixture of Z 
and E isomers around the TBS-enol ether. Addition of 2-ethoxyvinyllithium to the carbonyl 
group provided Cl and C2 of the natural product in the form of an enol ether. Treatment with 
TBAF followed by trichioroacetic acid hydrolysed two of the three enol ether functions to give 
the enal 203 as a 3:1 mixture of Z and E isomers around the enal double bond. A double Wittig 
methylenation produced the cyclisation precursor 204 (Scheme 1.61). 
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(a) MOM-Cl, 'Pr2NEt, DCM, 0°C, (91%); (b) 5% Rh on A1203, ethanol, H2, rt, (81%); (c) (i) THF, LDA, 200, - 
78°C to 0°C, ii) MVK, -78°C to -40°C, (iii) TBSOTf, -78°C, (62%); (d) 2-ethoxyvinyllithium, THF, -78°C to - 
30°C; (e) TBAF, THF, 0°C; (f) CI3CCO2H, DCM/H20, 0°C, (75% (E + Z) for 3 steps); (g) Ph3P=CH2, THF, - 
78 to 0°C, (71%) 
Scheme 1.61. Formation of the RCM substrate 204. 
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Treatment with Grubbs' II catalyst successfully cyclised diene 204 to form the guanacastepene 
AB ring system 205. Removal of the MOM protecting group and epoxidation lead to compound 
207 (Scheme 1.62). 
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(a) Grubbs II catalyst, 0CM, 45°C, (82%); (b) CI3CCO2H, DCM/H20, 0°C, (80%); (c) DCM, NaHCO3 (aq), 
mCPBA, 0°C to rt, (81%). 
Scheme 1.62. Hydroazulene synthesis. 
1.3.1.3 Chiu's Approach 
Chiu et al. have disclosed a rapid route to the hydroazulene core of guanacastepene A that 
involves a classical Nazarov cyclisation to create the A-ring cyclopentenone. 3° The dienone 211 
was identified as the required precursor for the Nazarov cyclisation, which was synthesised in 












(a) NaH, (MeO)2P(0)CI, THF; (b) Me2CuLi, (91% over two steps); (c) LiCH2P(0)(OMe)2, THE, -78°C to rt, 
(96%); (d) Me2CHCHO, LiCI, DIPEA, MeCN, rt, (88%). 
Scheme 1.63. Synthesis of dienone. 
With the synthesis of dienone 211 complete, a range of acid catalysts were screened for the key 
electrocyclisation and boron trifluoride diethyl etherate in DCM gave the best results, affording 
hydro-azulene 212 in an excellent 98% yield. In order to functionalise the hydroazulene core 
further, allylic oxidation under Corey's conditions furnished the enedione 213, which is an 









(a) BE3.Et20, DCM, (98%); (b) Pd(OH)2/C, tB uO2H, DCM, (65%). 
Scheme 1.64. Classical Nazarov cyclisation followed by functionalisation. 
Further studies on the Nazarov cyclisation indicated that the use of coordinating solvents such as 
methanol were essential for efficient deprotonation of the oxy-allylcation Nazarov intermediate 
to occur. Non-coordinating solvents such as DCM promoted the formation of the spirocycle 214 
as the major product, which forms due to a Wagner-Meerwein shift of the intermediate 







Scheme 1.65. By-product of the Nazarov cyclisation. 
1.3.1.4 Srikrishna's Approach 
Srikrishna and Dethe have reported an enantiospecific approach to the guanacastepenes and 
related terpenes starting from the readily available chiral pool material (R)-carvone. 3 ' They have 
presented both an A -p AB and a C - CB approach, in both cases the B-ring is derived from a 
ring closing metathesis reaction of a precursor derived from carvone. 
Their C - CB approach begins with two alkylations of carvone to give enone 217, which was 
subjected to sonochemical Barbier reaction with 4-lithio-1 -butene to afford the tertiary alcohol 
218. Oxidative allylic transposition with PCC gave the RCM precursor 219. Treatment of 219 
with Grubbs' I catalyst in DCM furnished the desired BC bicycle 220 in nearly quantitative 
yield. The extraneous isopropenyl group can in principle be oxidatively cleaved to a hydroxyl 






a 	 b 	 c 
215 	 216 	 217 	 218 
cI 0 
219 	 220 
(a) LDA, THF, -70 °C to it, CH2=CHCH2Br, (85%); (b) LDA, THF, -70 °C to rt, CH3I, (84%); (c) Li, 
CH2=CH(CH2)2Br, THF, ))), it; (d) PCC, Si02, DCM, rt, (70% for two steps); (e) Grubbs 1(10 mol %), 0CM, 
it, (>95%). 
Scheme 1.66. Formation of the RCM precursor. 
The same group have also demonstrated the synthesis of the AB ring fragment from the common 
intermediate 219, via ring contraction of the cyclohexyl ring to form the cyclopentanoid A ring. 
Enone 219 was transformed into the keto-epoxide 221 in three steps. Favorskii-type ring 
contraction was initiated upon treatment with sodium methoxide in refluxing methanol, to afford 
the cyclopentane ester 222 in 75% yield after esterification. RCM of 222 furnished the AB ring 











(a) (i) NaOMe, methanol, reflux, (ii) CH2N2, Et20, 0°C, (75%, 2 steps); (b) Grubbs I catalyst, DCM, it, 
(95%). 
Scheme 1.67. Synthesis of the AB ring system. 
Compound 223 represents the hydroazulene skeleton of the guanacastepene AB ring system with 
the correct cis stereochemistry at C6 and C7, but also features unwanted secondary methyl and 
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ester groups in the A-ring. A more versatile intermediate could be constructed from 221 using an 
alternative Lewis acid mediated ring contraction of the keto-epoxide. Treatment of 221 with 
boron trifluoride etherate in DCM gave the fl-diketone 222 in reasonable yield. This compound 
also underwent RCM to yield the required hydroazulene 223. Although this compound also 
features an extraneous acetyl appendage, the authors point out that removal through a retro-aldol 
process should be feasible (Scheme 1.68). 
 0 
a. 	iE1 b 12 
221 	 224 	 225 
(a) BF3.Et20, DCM, rt, (60%); (b) Grubbs I catalyst, DCM, rt, (97%). 
Scheme 1.68. Hydroazulene synthesis. 
1.3.2 Convergent and tandem approaches to the synthesis of 
guanacastepene A. 
1.3.2.1 Lee's Approach 
Lee's convergent approach to the synthesis of guanacastepene A involves the closure of the 
central 13-ring from a suitable precursor containing the fully-functionalised A and C rings. 32 The 
a,,8-unsaturated ketoaldehyde 227 was envisaged as a suitable precursor to the ring closure, 
which could be synthesised from the cyclopentene 228. Compound 228 could in turn be 
synthesised by combining the two readily available chiral starting materials, verbenone 230 and 
citronellyl bromide 231 (Scheme 1.69). 
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Scheme 1.69. Lee's retrosynthetic analysis. 
In order to test the feasibility of this strategy, Lee employed the cheaper (S')-citronellyl isomer, 
which initially creates the C8 stereocentre with the opposite stereochemistry to the natural 
product. Inversion of this stereocentre was envisaged to be straightforward, through 
manipulating the alkene functionality in compounds such as 229. 
The synthesis began with the copper catalysed addition of the Grignard reagent derived from (5)-
citronellyl bromide to (15)-verbenone to give the 1,4-adduct 233. This installed the correct 
stereochemistry at the C 1 quaternary carbon due to the facial bias present in the starting 
material. A stereoselective reduction of the ketone was achieved with LAH and the resulting 
secondary alcohol was protected as a TBS ether. Ozonolysis of the trisubstituted alkene afforded 
the unstable aldehyde 234, which was converted into the C-ring precursor using an efficient five-
step sequence of cyclopentene annulation, followed by oxidative ring-opening and 
intramolecular aldol cyclisation. Deprotection of the hindered OTBS group was achieved using 
PTSA in methanol, setting the stage for the fragmentation of the cyclobutane ring. This took 
place smoothly through the treatment of the derived xanthate 237 with tributyltin hydride, 
producing the bis-cyclohexene 238 in 68% yield (Scheme 1.70). 
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236 	 237 	 238 
(a) 232, Cul, (85%); (b) (i) LAH, THF, -78°C, (ii) TBSCI, imidazole, DMF, (95% for 2 steps); (c) 03, DCM, - 
78°C, Me2S, (60%); (d) (I) EtMgBr, THF, (85%), (ii) RuCl2(PPh3)3, NMO, acetone, 25°C; (e) Me 3SiCHN2, 
BuLl, THF, -78 to 25°C, (92%); (t) (i) 0504, NMO, THF/1-120, (ii) Na104, THF/1-120; (iii) KOH, methanol, rt, 
(76% for 3 steps). (g) TBAF, THF, 25°C, (98%); (h) NaH, THF, CS2; Mel, HMPA, (I) Bu3SnH, AIBN, 
toluene, 100°C, (45-50%, 2 steps). 
Scheme 1.70. Formation of the ring closing precursor. 
Selective cleavage of the more electron rich double bond via a standard two step protocol 
produced the bis-aldehyde 239, which upon treatment with excess pipendme led to the selective 
formation of the desired a43-unsaturated aldehyde 240. Several reactions to cyclise 240, whilst 
maintaining the unsaturation in the six membered ring were tried, for example an ene reaction, 
nitrile-oxide mediated cycloaddition and a thiazolium catalysed Stretter reaction, were 
unsuccessful. Reductive cyclisation conditions were more successful and when 240 was treated 
with samarium diiodide the tricycle 241 was formed in a moderate 45% yield as a mixture of 











(a) (i) 0SO4, NMO, THF/1-120, (ii) Na104; (b) pipendine, Et20, rt, (52%); (c) SmI2, THF, 
tBuOH,  (45%) 
Scheme 1.71. Formation of the tricyclic core. 
Having synthesised the tricycle 241, work began on installing the correct stereochemistry at the 
C8 position. This could be achieved by repositioning the double bond from C3-C4 to C6-C7 in 
compound 240 using a six step sequence to afford aldehyde 244. However, cyclisation attempts 
of substrate 244 gave disappointing results, of inseparable mixtures, with samarium diiodide. In 
light of this result, and the rather lengthy synthesis involved in the formation of 244, an 
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(a) 0SO4, NMO, THF/H20; (b) (i) Me2C(OMe)2, PPTS, (ii) LDA, Et02CCN; (c) (i) H2, Pd/C, (ii) NaH, PhSeBr, 
H202, (iii) PPTS, H20; (d) (I) Na104, THF/H20, (ii) piperidine, Et20. 
Scheme 1.72. Formation of the pseudosymmetric compound 
Lee advanced the hypothesis that compounds such as 247 might self differentiate the 
diastereotopic C3-C4 and C6-C7 double bonds during the cyclisation. This is not unreasonable, 
as a trans relationship between the two methyl groups is likely to be sterically more favoured 
over the cis. The cyclohexadienone 247 was synthesised without incident and the conjecture put 
to the test. Treatment of 247 with samarium diiodide produced the tricyclic core of 
guanacastepene A 248 as a single isomer in 70% yield. The trans C8-C11 relative 
stereochemistry was confirmed by X-ray crystallographic analysis, confirming Lee's hypothesis 

















(a) (I) TBSCI, DMF, (ii) LDA, PhSeBr, mCPBA, (iii) TBAF; (b) (i) Na104, THF/1-120, (ii) piperidine, Et20, 
25°C, (45% for 2 steps); (c) Sm12, THF, tBuOH,  25°C, (70%). 
Scheme 1.73. Formation of the tricyclic core. 
1.3.2.2 Kwon's Approach 
Kwon et al. have developed a convergent approach to the tricyclic core of guanacastepene A that 
uses a sequential conjugate addition/intramolecular Mukaiyama aldol reaction to form the 
central B ring (Scheme 1 •74)•33 
O OHC 	 o MeO2C 
OEt 	
MeO OMeCO2Me <1151115#0Et 
11 	8 
1 	 249 	 250 
0 	 OMeCO2Me 
OEt 
+ Me55_ 0Et 
BnO 
251 	 252 
	
253 
Scheme 1.74. Kwon's retrosynthetic analysis. 
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This synthetic strategy was successfully tested on a model compound, in which the C8 methyl 
group was absent .34  Compound 258 was identified as the key intermediate and was prepared in 
six steps from 1,1 ,4-trisubstituted diene 253, via a Diels-Alder reaction. A metal mediated 









253 	 254 
10 	 10 
e,f 	0 	CO21Vle g 	 2Me 
OEt 	 OEt 
,1 
HO  
256 	 257  
b-d 	
OHC CO2Me 
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258 
(a) maleic anhydride, hydroquinone, PhH, 253, pressure tube, 105°C, (70%); (b) H2, 10% Pt/C, EtOAc, 
(92%); (c) methanol, 80°C, (85%); (d) BH3-Me2S, ii to 40°C, Et 20-THF (5:1), then PCC, DCM, reflux, 
(72%); (e) Bu 4NBr, HOCH2CH20H, CH(OMe)3, (92%); (f) H2, Pd(OH)2, MeOH/pH7 buffer (3:1), (88%); (g) 
PPh3, 12, imidazole, Et20-CH3CN (3:1), 0°C to rt, (99%); (h) activated zinc, 40°C, CuCN.2L1CI, -10°C, then 
p-iodocyclopentenone, 0°C to rt, (82%). 
Scheme 1.75. Synthesis of the precursor 258. 
Michael addition of lithium dimethylcuprate, trapping of the resulting enolate with TMSC1 and 
subsequent TiC14-mediated Mukaiyama aldol reaction generated the two tricyclic products 259a 
and 259b in a 54% combined yield together with a small quantity of the eliminated products. 
Elimination of the C2 hydroxyethoxy group furnished the two compounds 260a and 260b, 
having opposite configurations at Cli. The cis:frans ratio of the reaction was approximately 1:1 
indicating that the addition of lithium dimethyl cuprate in the Michael addition was not 
stereoselective. The ratio was improved slightly to 1.2:1 with methyl magnesium bromide 
addition catalysed by copper bromide dimethyl sulphide complex. In order to overcome this 
problem in the synthesis of the natural product they stated that if the Michael addition can not be 
improved, asymmetric synthesis of the functionalised five and six membered rings could be used 
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259b 	 260b 
(a) (I) Me2CuLi, TMSCI, Et3N, HMPA, 0°C to rt, (77%); or MeMgBr, CuBr.Me2S, HMPA, TMSCI, (50%), (ii) 
T1CI4, 4 A MS, 0CM, 0°C, (54% with Me2CuLi, 64% from MeMgBr); (b) PTSA, H20, benzene, 80°C, (73% 
from 259a, 79% from 259b). 
Scheme 1.76. Synthesis of the tricyclic structure. 
1.3.2.3 Brummond's Approach 
Brummond et al. have developed a novel C - CBA strategy in which the guanacastepene A and 
B rings are constructed simultaneously via an intramolecular allenic Pauson-Khand reaction of a 














Scheme 1.77. Brummond's retro-synthetic analysis. 
The synthesis of the Pauson-Khand precursor started from the racemic enone 263. Alkylation 
with alkynyl iodide 264 was low yielding under a variety of enolisation conditions, producing 
265 in yields of 30-40%. Introduction of the requisite allene functionality began with the 
addition of lithium acetylide ethylenediamine complex to enone 265, followed by hydrolysis of 
the crude product to give enone 266. Protection of the hydroxy group, followed by Luche 
reduction gave the secondary alcohol, as an inseparable mixture of two diastereoisomers, which 
were protected as TBS ethers. Deprotonation of the terminal alkyne followed by addition of 
paraformaldehyde gave the propargylic alcohol 267. Mesylation followed by addition to 
(Me2PhSi)2Cu(CN)Li2 afforded the desired Pausen-Khand precursor, allene 268. When allenyne 
268 was treated with {Rh(CO) 2Cl2] the desired tricyclic Pauson-Khand product 269 was 















(a) LDA, Mel, (89%); (b) LDA, HMPA, 264, (30-40%); (c) (i) lithium acetylide ethylenediamine, (ii) 3N HCI, 
(65% for 2 steps); (d) imadazole, TBSCI, (95%); (e) NaBH4, CeCI3.71-120, (91%); (f) imadazole, TBSCI, 
(95%); (g) "BuLi, (CH20), (74%); (h) (i) Et3N, MsCI, (ii) (DMPS)2Cu(CN)Li2, -85°C, (90% for 2 steps); (i) 
[Rh(CO)2Cl]2 (lOmol%), toluene, 80°C, CO (1 atm), (65%). 
Scheme 1.78. Formation of the tricycle 269. 
The ftmctionalised tricyclic guanacastepene A core has been constructed in eleven steps from 
commercially available starting materials. It should, in principle, be possible to access the 
complete guanacastepene skeleton from 269 by introducing the Cli methyl group via a 1,4- 
addition to the cyclopentenone A ring. However, initial attempts at this transformation proved 
unsuccessful, exclusively forming the 1,2-addition product. Molecular mechanics calculations 
indicated that the Cli position is extremely hindered towards addition as the C2 
dimethyiphenylsilyl group is blocking the lower face, while the cyclohexene C-ring is twisting 
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round to block the upper face, indicating that the desired 1,4-addition is not favoured leading to 
the preferential formation of the 1,2-addition product. 
1.3.2.4 Yang's Approach 
Yang et al. have developed an A + C -+ AC -+ ABC strategy that included an intramolecular 
Diels-Alder (J1MIDA) reaction as the key reaction to form the tricyclic core. 36 Their first synthetic 
study towards the guanacastepene structure was based on IIV1DA reactions of furans such as 270 
to yield the tetracycle 271. It was hoped that the oxa-bridge could be ring opened upon treatment 
with a Lewis acid to set the C8 and C5 stereocentres. Ring opening was achieved upon treatment 
with trimethyl aluminium, but X-ray analysis revealed that the product did not have the correct 










(a) toluene, 110°C, (80%); (b) AIMe3, 0CM, -25°C, (62%). 
Scheme 1.79. Initial IMDA studies towards the tricyclic structure. 
More recently Yang reported the synthesis of C8-epi-guanacastepene 0 based on these initial 
studies  .37  The key diene intermediate was identified as either 273 or 275, because it was difficult 
to predict which isomer would lead to the desired stereochemistry. When these two dienes were 
refluxed in toluene cyclisation occurred, however analysis showed that the two products were 
identical and that the stereochemistry was incorrect for the natural product. With no obvious way 
of reversing the stereochemical outcome of the reaction they decided to continue with the 
synthesis of C8-epi-guanacastepene 0 (Scheme 1.80). 
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Scheme 1.80. IMDA studies. 
In order to construct the guanacastepene structure they needed to prepare the fully functionalised 
cyclopentenone 278. This was achieved in four steps from furan 276. Treatment with ZnC1 2 in 
dioxane-H20 yielded a cyclopentenone, which underwent 1,2-addition of MeLi to afford 277. 
Protection of the secondary alcohol as the TBS ether followed by PCC-mediated oxidative 
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(a) ZnCl2 , dioxane-H20, reflux, (80%); (b) MeLi, THF, -78°C, (85%); (c) TBSOTf, 2,6-lutidine, DCM, 0°C, 
(95%); (d) PCC, 4A MS. 0CM rt, (82%). 
Scheme 1.81. Synthesis of the A ring fragment. 
With the desired A ring fragment in hand they turned their attention to synthesising the tricycle 
284 via an IMDA reaction. The synthesis began with a lithium-halogen exchange of iodide 279 
followed by conjugate addition to 278 in the presence of copper cyanide, to yield the desired 
diene. Addition of aldehyde 281 to the lithium enolate of 280 formed the corresponding alcohol 
as a diastereomeric mixture. Chemoselective reduction with BH 3 .THF afforded the propargyl 
alcohol, which underwent selective oxidation to yield the ketone 283. Refluxing a toluene 




















283 	 284 
(a) tB uLi, CuCN, Et20, BF3.Et20, 278, (88%); (b) LDA, -78°C, then 281, -100 °C, (70%); (c) BH 3 .THF, -40°C, 
(72%); (d) TEMPO, BAIB, 0CM, it, (75%); (e) toluene, reflux, (75%); 
Scheme 1.82. Formation of tricycle 284. 
Elaboration to unnatural guanacastepene 0 began with oxidation of alcohol 284 followed by 
cyclisation with a catalytic amount of t-BuOK. Oxidation with PDC installed the oxygen 
functionality at C5 to give lactone 285. Hydrogenation of the C6-C7 double bond with Lindlar's 
catalyst followed by sequential desilylation and acetylation afforded 286, which underwent 













286 	 287 
(a) DMP, 0CM, 4A MS, rt, (85%); (b) tB uOK, THF, II, (62%); (c) POC, 0CM, 4A MS, it, (69%); (d) Lindlar 
cat., H2, EtOAc, it, (90%); (e) HF.py , CH3CN, 40°C; (f) Ac20, py, DMAP, 0CM, ii, (75%, two steps); (g) 
DIBALH, DCM, -95°C, (58%). 
Scheme 1.83. Formation of C8-epi-guanacastepene 0. 
1.4 Conclusions 
In 2000, Clardy et al. reported the isolation and characterisation of guanacastepene A, a 
diterpene natural product possessing a novel [5-7-6] tricyclic structure with a highly oxidised 
upper face. Screening for biological activity revealed antibiotic activity towards the drug 
resistant bacterium MIRSA and VREF. Approximately a year later the same group published the 
structures of a further fourteen natural products isolated from the same source, all possessing the 
same tricyclic structure. Unfortunately, further tests revealed homolytic activity towards human 
red blood cells, rendering it unsuitable as a drug candidate. This interesting activity and novel 
structure has, however, enticed several organic research groups to develop synthetic strategies 
towards this family of natural products. 
To date there have been five examples of total syntheses of guanacastepene A, and one example 
of the synthesis of guanacastepene 0. The first synthesis of guanacastepene A was achieved by 
the Danishefsky group just two years after the initial publication of its structure. The racemic 
approach is based on a linear synthesis in which the hydroazulene core 22 was identified as a 
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key intermediate. A tandem epoxide opening -eliniinationIKnovenagel cyclisation afforded the 
tricycle which was advanced to the natural product. Shortly afterwards the Snider group 
published their synthetic efforts as a formal synthesis, based on a modified Stork-Jung 
vinylsilane Robinson annulation. The Hanna group have published an elegant convergent formal 
synthesis based on a tandem RCM approach to synthesise the B and C rings. The Sorensen 
group published the first asymmetric formal synthesis of guanacastepene A based on a [2+2] 
cycloaddition/fragmentation strategy to form the central ring of the tricycle. More recently the 
Overman group have published the asymmetric synthesis of Guanacastepene N based on a 7-
endo Heck cyclisation to construct the central seven membered ring. Mehta has reported the 
synthesis of guanacastepene C and Trauner the synthesis of guanacastepene N 
Besides these total syntheses there have been a further nine synthetic strategies published 
towards the synthesis of these natural products, representing a wide variety of approaches and 
development of new reaction methodologies. 
The small structure and complex stereochemistry of guanacastepene A makes it an attractive 
target for synthetic chemists, allowing for a wide diversity of methodologies to be developed and 
tested. It can be seen, from the vast array of literature published in the last seven years, that the 
guanacastepenes have presented some interesting challenges which have been overcome to yield 




The interesting biological activity and novel structure of guanacastepene A encouraged us to 
devise a novel and efficient synthetic strategy towards the natural product. Many of the 
challenges encountered by the groups discussed above can be attributed to the synthesis of the 
fused five and seven membered rings. These difficulties prompted us to develop a novel route to 
the hydroazulene core of the guanacastepenes based on the rearrangement of a hydro-
naphthalene intermediate, as we reasoned that the ease of formation of fused six membered rings 
would give rise to a more efficient synthesis. 
With this in mind we set about devising a retrosynthesis of the guanacastepenes based on the 
rearrangement of a suitably functionalised hydro-naphthalene intermediate. Our strategy, like 
that of the Danishefsky group, is based on a linear AB-ABC synthesis in which a suitably 
functionalised hydroazulene 288 was identified as a key intermediate. There are several reports 
in the literature based on the rearrangement of a,-epoxy ketone hydro-naphthalenes, which will 
be looked at in more detail in subsequent chapters. Compounds such as 290, were identified as 
suitable substrates for the rearrangement. 
The retrosynthesis is therefore based on the synthesis and rearrangement of a suitable a4 -epoxy 
ketone to yield a suitably functionalised hydroazulene. Removal of the C ring of guanacastepene 
A yields the hydroazulene core 288 as the key intermediate, containing a ketal group in the B 
ring. Removal of the ketal group unmasks a ketone at C3 allowing for the stereocontrolled 
installation of the C ring, which has been demonstrated by both the Damshefsky and Snider 
groups, giving rise to the C8 stereocentre. The 5-7 bicycle 288 arises from the reduction of enol 
289, the photochemical rearrangement product. The oxygen functionality at C2 will be reduced 
to yield the corresponding enone required for the construction of guanacastepene A. Incidentally 
this enol fUnctionality will be useful for the synthesis of other members of the guanacastepene 
family, which contain additional levels of oxidation at this position. The precursor to the key 
rearrangement step, a, -epoxy ketone 290, is derived from epoxidation of the corresponding 
bicyclic enone 291. The second key step, a Robinson annulation between ketal protected 3-
methyl-1,2-cyclo-hexanedione 293 and 5-methythex-3-en-2-one 292, will yield this bicyclic 
enone 291, setting the C1  and C12 stereocentres in a single transformation (Scheme 1.84). 
73 
Introduction 
o OHC OH 
	
0 	 0 OH0 
AcO 12 11 




> AcO_ 0 
1 	 288 	 289 
O' ) 
O 
01P P -> 	 + 0: 
290 	 291 	 292 	 293 
Scheme 1.84 Retrosynthesis. 
The retro-synthetic route outlined above represents an efficient synthesis of the hydroazulene 
288, a key intermediate in the synthesis of several of the guanacastepenes. The efficiency of this 
route arises from the rearrangement of a 6-6 bicycle to yield the 5-7 ring system, from a 




The retro-synthetic analysis highlighted two challenging transformations in our approach 
towards guanacastepene A. The first of which is the rearrangement of a suitably functionalised 
hydro-naphthalene intermediate to the hydro-azulene core, via a photochemically induced ring 
transposition. The second challenge arises from the stereochemistry present at Cli and Cl 2 of 
the natural product, which we intend to achieve via a stencally hindered conjugate addition. 
Once these key transformations have been demonstrated in a racemic sense work will begin on 
developing an asymmetric variant of the conjugate addition reaction to complete the asymmetric 
synthesis of the hydroazulene core of guanacastepene A. 
The synthesis can be divided into three objectives: the first of which is to demonstrate the 
feasibility of a ring transposition strategy towards the synthesis of the hydroazulene core, based 
on the rearrangement of a suitable a,-epoxy ketone precursor. Initial studies into this reaction 
will be conducted on a model system 294, in which the C 12 isopropyl group is absent, allowing 
for a rapid conclusion to be made (Scheme 1.85). 






Scheme 1.85 Rearrangement of a model compound. 
The second key step involves a conjugate addition, setting the relative stereochemistry between 
Cli and C12, to yield the hydronaphthalene 291. It is anticipated that the n-substituted 
electrophile will be sterically hindered, requiring activation of either the nucleophile or the 
electrophile. With the key steps successfully demonstrated, combination of the two will allow 
for a racemic synthesis of a fully functionalised hydroazulene core 296 (Scheme 1.86). 
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Scheme 1.86 Racemic synthesis of the core. 
With a suitable racemic strategy in place the development of an asymmetric variant for the 
synthesis of the hydroazulene core will prove a major challenge. In order to accomplish this, an 
asymmetric conjugate addition is required to set the absolute stereocentres at Cli and Cl 2. With 
a suitable asymmetric intermediate 297 in hand, the final task will be to merge the asymmetric 
route with the racemic studies to complete the development of an efficient strategy towards the 
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Scheme 1.87 Asymmetric synthesis. 
The following discussion will be divided into two chapters. The first highlights the synthetic 
studies towards the two key transformations required for the natural products by synthesising a 
racernic version of the fully functionalised hydroazulene core. The second half will focus on the 
synthetic efforts undertaken to develop a suitable asymmetric variant of the conjugate addition 
and conversion of the resulting product to a common intermediate in the racemic synthesis on 
route to the total synthesis of guanacastepene A. 
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2 Racemic Synthesis 
21 Hydroazulene synthesis 
As outlined in the previous chapter, the first objective of this PhD was to develop a synthetic 
strategy of the hydroazulene core structure 300 en route to the total synthesis of guanacastepene 
A (Scheme 2.1). The key transformation of the synthesis would be the formation of the 
hydroazulene via the rearrangement of a suitably functionalised hydronaphthalene substrate 301. 
Demonstrating the feasibility of this rearrangement strategy, as an efficient synthetic route 
towards the natural product, was the first objective. With a successful synthesis of the 
hydroazulene in hand the substrate will be advanced further towards a racemic synthesis of the 
functionalised core of guanacastepene A. 
299 	 300 	 301 
Scheme 2.1 Synthetic strategy to the tricyclic structure 
A literature search revealed there were several possible transformations capable of such a 
rearrangement, the first of which was a photo-chemically induced ring transposition. 
2.1.1 Photochemical ring transposition 
Over the past forty years or so the use of ultraviolet radiation to initiate chemical 
transformations, for the synthesis of complex natural products, has been widely utilised. The 
frequent use of photochemistry arises from the ability to perform a variety of novel 
transformations with a high degree of chemo-, regio- and stereo-selectivity, facilitating the 
synthesis of complex molecules, which would be otherwise difficult, if not impossible to achieve 
by other means. The widespread use of photochemical transformations has led to the 
development of a diverse array of reactions. We became interested in one particular synthetic 
transformation for the synthesis of the hydroazulene core of the guanacastepenes. This 
transformation first appeared in the literature as early as 1918 when Bodforss et al. described the 
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photochemical rearrangement of benzalacetophenone epoxide (chalcone oxide) 302 to yield 1,3-
diphenylpropane-1 ,3-dione 303 (Scheme 2.2). 38  This photo-isomerisation can be provisionally 
described by two consecutive steps: fission of the Ca-0 bond of the epoxide, followed by a 1,2-
hydrogen shift of the 3H. Migration of the phenyl group would result in the formation of the 
aldehyde 304. Further studies carried out by Reusch 39 and Zimmerman4° have shown that 3-alkyl 
groups undergo the same 1,2 shift to the a position in the order: methylene>methyl>phenyl. 
0 	 00 	
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Scheme 2.2. Early photoisomerisation of a,-epoxy ketones. 
In the 1960s Jeger et al. successfully applied this photochemical rearrangement in steroidal 
systems such as the 3-oxo-4,5-oxido steroids 305 and 307, which resulted in a simultaneous 
expansion and contraction of the AB fused rings .41 Their work included the independent 
rearrangement of both the a and P epoxides, which formed the same 1,3 -diketones 306 and 308, 
demonstrating that irradiation of either of the two possible epoxides gave the same 
rearrangement product, irrespective of the relative configuration of the epoxide used. Also of 
note was the retention of stereochemistry observed at the C10 stereocentre, indicating that the 
reaction proceeded with complete stereocontrol (Scheme 2.3). 
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(a) ho, ethanol or dioxane. 
Scheme 2.3. Photochemical rearrangements of steriods 
In the 1980s Paquette et al. extended and applied this photochemical rearrangement to the 
synthesis of non-steroidal natural products, by synthesising the iso-mgenane and dollabellane 
skeletons  .42  They published their synthetic studies towards the diterpene natural product, 
ingenol, based on the photoisomerisation of the advanced a,-epoxy ketone intermediate 309 to 
form the tricyclic ingenene core in a single transformation. Irradiation of 309, as a mixture of 
epoxides, yielded the desired tricycle 310 in an excellent 80% yield (Scheme 2.4). 
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(a) ho, quartz, ethanol, 18 hr, (80%) 
Scheme 2.4. Paquette's synthesis of the ingenane core 
Paquette et al. also used the same rearrangement in their synthesis of the dollabellane 
framework, which is structurally related to the guanacastepenes, as demonstrated by their 
synthesis of (±)4a,100-doladiol acetate 313. Their synthetic strategy was based on the 
photoisomerisation of a suitable anthracene precursor 311 to yield the tricyclic dolabellane core. 
Like Jeger's work on steroidal systems, irradiation of a mixture of epoxides resulted in the 
formation of a single diastereoisomer with retention of the stereochemistry at the C4a position. 
The low yield of this reaction is the result of the photo-degradation of the UV active 1,3-
diketone product, so irradiation is terminated prematurely to allow for recovery of the starting 










(a) (I) ho, pyrex, THF; (ii) Ac20, DMAP, pyridine, DCM, rt, (33% over two steps, with 52% recovered SM) 
Scheme 2.5. Paquette's synthesis of the dolabellane skelton 
Other than these reports, this potentially powerful synthetic transformation has seen little 
application in the synthesis of other complex molecules. 
The mechanism of the rearrangement is believed to proceed as follows: excitation of the 
carbonyl group of the a,-epoxy ketone results in the formation of the diyl radical, resulting in 
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heterocyclopropmyl radical ring opening of the epoxide to give the oxygen radical 316. - 
scission of the C4a-C8a bond, followed by rearrangement, simultaneously -forms the five and 
seven membered rings, which after radical termination yields the hydroazulene 319. It is 
believed that the 4a-8a bond shift is concerted with the carbonyl formation at C8a, preventing 
the C8a radical centre from assuming a planar configuration accounting for the stereospeciflcity 
of the reaction. In order for this to occur an interaction between the radical position on C8a and 
the it-system in the transition state 317 has to be assumed (Scheme 2.6). 
O(f1 6 	 6 ...m 	ho  
314 	 315 	 316 
0 	 ° a,> 
IN 
0i: 
317 	 318 	 319 
Scheme 2.6 Proposed mechanism of the photochemical rearrangement 
These examples suggest that a rearrangement of a suitably functionalised hydronaphthalene 
intermediate to form the hydroazulene core of the guanacastepenes is at least feasible by means 
of a photo isomerisation reaction. Our initial studies focused on the synthesis and rearrangement 
of a model compound in an effort to validate this methodology before continuing towards the 
synthesis of the core of guanacastepene A. 
2.1.2 Model studies 
Our initial efforts focused on the synthesis of a model system lacking the C12 isopropyl group 
and C3 oxidation state required for the C ring annulation. The known aj -epoxy ketone 322 was 
identified as a suitable substrate and the synthesis began with an acid catalysed Robinson 
annulation of 2-methyl cyclohexan-1-one with but-3-en-2-one, to yield the enone 321 in 44% 
yield. Epoxidation under basic/hydrogen peroxide conditions yielded the desired substrate in a 
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moderate 56% yield as a 1:3 mixture of a and 0 epoxides (based on the integration of two sets of 
singlets corresponding to the epoxide CH at 8.j = 2.99 ppm and 8.,i n = 2.31 ppm and the methyl 
group at 6 = 1.25 ppm and S j,, = 1.15 ppm in the 'H NMR) . 45 The yield of this epoxidation 
was significantly increased when a three step reduction/epoxidation/oxidation strategy was 
employed, which required only one column purification: reduction of the enone under Luche 
conditions afforded the allylic alcohol, 46 in quantitative yield, which was then epoxidised with 
m-CPBA to yield the epoxy alcohol in 96% after column chromatography. A PCC oxidation 
cleanly afforded the desired a,3-epoxy ketone 322, after filtration through a silica pad, in 70% 
yield over three steps. Further analysis revealed that the compound had been formed as a single 
diastereoisomer (shown by the presence of one singlet corresponding to the epoxide CH at ö = 
2.99 ppm in the 1 H NMR), which based on literature precedent, indicated that the epoxidation 
had occurred on the less hindered convex face of the allylic alcohol. 47 






(a) MVK, H2SO4, toluene, \, (44%); (b) (i) CeCI3.7H20, NaBH4, methanol, 0°C; (ii) m-CPBA, 0CM, 
NaHCO3, 0°C, (96% over 2 steps); (c) PCC, 0CM, rt, (72%). 
Scheme 2.7 Synthesis of a,-epoxy ketone 322 
With the required substrate in hand attention turned towards the photochemical ring 
transposition. Irradiation of an ethanol solution of 322 through a Pyrex filter for four hours, 
yielded the desired hydroazulene 323 after column chromatography in a moderate 50% yield, 
although 25% of starting material was recovered. A solvent screen revealed that polar solvents, 
such as ethanol or dioxane, were required for the reaction, whilst non-polar solvents, such as 
hexane, gave poor yields. The use of a triplet photosensitiser, such as acetone, resulted in the 
degradation of starting material, and led to complex reaction mixtures from which no identifiable 
compounds could be isolated. This finding is in agreement with the mechanistic studies carried 
39 
out by Reusch et al. who concluded that the mechanism proceeded via an excited singlet state. 
Further optimisation studies revealed that prolonged irradiation times resulted in a decrease in 
yield, which is presumably due to further deleterious excited-state side reactions of the 
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chromophore containing 1,3-diketone product. A compromise between conversion and isolated 
yield was therefore made, an observation in line with previous studies on this reaction. 43 A 
longer wavelength of radiation (up to 365 rim with a Quartz filter compared to 254 rim with the 
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(a) ho, filter, solvent, 4hr. 
Scheme 2.2.8 Optimisation studies 
Table 2-1 Optimisation studies of the photochemical rearrangement 
Solvent Yield (%) Recovered (%) Filter! X (nm) 
Hexane 22 6 Pyrex 
Acetonitrile 28 7 Pyrex 
Ethanol 50 25 Pyrex 
Dioxane 49 16 Pyrex 
Acetone/Acetonitrile 
(9:1)  
0 0 Pyrex 
Ethanol 0 0 Quartz 
These initial model studies confirmed that the photochemical ring transposition strategy was an 
efficient synthetic strategy for preparing the hydroazulene core required for the total synthesis. 
Having optimised the reaction conditions we turned our attention towards the synthesis of 
substrate 294, containing additional functionality at C3 which would be required for the C ring 
annulation of the tricyclic core of the natural product (Scheme 2.9). 
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Scheme 2.9 C3 functionalised photo substrate 
The synthesis of 294 started with 3-methyl-1 ,2-cyclo-hexanedione 324, which is itself readily 
available from 2-methyl cyclohexan-1 -one via a literature procedure. 48 Acetal protection of the 
1,2-diketone occurred in low yield and several reactions were attempted to increase it, by 
changing the acid catalyst and varying the reaction temperature, but resulted in lower isolated 
yields. The optimised conditions (catalytic PTSA in toluene with azeotropic removal of water) 
resulted in the formation of the mono protected product, which after tautomerisation revealed the 
previously enolised ketone, in a moderate 45% yield. Base catalysed Robinson annulation with 
but-3-en-2-one (methyl vinyl ketone, MVK) formed the desired cyclic enone 294 in 60% yield. 
Our previous experience with peroxide/base epoxidations of bicyclic ring systems suggested that 
this more sterically hindered substrate would be problematic, so a similar three step epoxidation 
procedure was employed to produce the desired photo substrate 325, as an 8:1 mixture of a and 
3 epoxides (based on the intergration of two singlets at 8. j 3.34 ppm and 6,,,, 3.42 ppm in the 
111 NMR). The relative stereochemistry of this compound was determined by X-ray 
crystallography, which showed that epoxidation had occurred on the top face of the molecule to 
form the a epoxide as the major isomer (Scheme 2.10). 
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(a) (i) Br2, diethyl ether, -10°C (ii) NaOH, THF, 0°C, (75%); (b) ethylene glycol, PTSA, toluene, A, -H20, 
(45%); (c) MVK, methanol, NaOMe, A (60%); (d) (i) CeCI3.71 ­120, NaBH4, methanol, 0°C; (ii) m-CPBA, 
DCM, 0°C, (75% over 2 steps); (e) PCC, DCM, rt, (87%) 
Scheme 2.10 Synthesis of 325, with X-ray structure 
Irradiation of 325 under the previously optimised conditions (ethanol solution through a Pyrex 
filter) was anticipated to lead to the hydroazulene 295, however in this case a complex mixture 
was formed, from which the desired product could not be isolated. Changing the solvent to either 
dioxane or uhF also failed to form the desired product; whilst increasing the wavelength of 
irradiation, by removal of the Pyrex filter, only resulted in degradation of 325. It is believed that 
the high level of strain combined with the high level of oxidation in this photo-substrate made it 
unstable to the photochemical conditions (Scheme 2.11). 





(a) ho, pyrex filter, ethanol or THF. 
Scheme 2.11. Attempted rearrangement of 325 
Having successfully demonstrated the use of a photochemically induced rearrangement in a 
hydronaphthalene model system, we turned our attention towards preparing substrate 325, which 
was oxidised at C3, to allow for the construction of the C ring of the natural product. 
85 
Results and Discussion I 
Unfortunately under a variety of reaction conditions this substrate did not undergo the desired 
rearrangement. It is documented in the literature that treatment of a,3-epoxy ketones with Lewis 
acids or bases results in the cleavage of the C-O bond of the epoxide, causing a 1,2-carbonyl 
migration (as opposed to the desired C-O bond cleavage required for rearrangement). 49 With no 
alternative strategy for the rearrangement of a,3-epoxy ketones to hand we then turned our 
attention towards using a Pinacol rearrangement to achieve the same objective. 
2.1.3 Pinacol type rearrangement. 
The pinacol rearrangement occurs when a substituted vicinal diol is treated with a strong acid, 
resulting in a 1,2 alkyl shift. 5°  When the diol system is part of a fused ring system the product 
formed arises from a ring expansion/ring contraction. An analogous reaction can occur with the 
base induced rearrangement of mono-mesylated diols. This pinacol type rearrangement dates 
back as far as the 1960s and there are several known examples where complex molecules have 
been prepared by using this reaction as a key step. 
Mukherjee et al. used a pinacol type rearrangement as the key step in their synthesis of the 
norsesquiterpene (±)-norzizanone 328.51  A series of straightforward synthetic transformations 
furnished the rearrangement precursor 327 in thirteen steps from readily available 1,1 -dimethyl-
6-methoxyindane 326. Treatment of the mesylate 327 with one equivalent of potassium tert-
butoxide initiated a pinacol rearrangement to form ketone 328, in 88% yield, and thereby 
completed a racemic formal synthesis of (±)-zizaene (Scheme 2.12). 
MsO 	 0
OH 	 H 
MeO 	 ref. 51 
326 
	
327 	 328 
(a) tBu OK, tbutanol, 20°C, (88%) 
Scheme 2.12. Mukherjee's synthesis of (±)-norzizanone 
Intermediate enone 294 was identified as a suitable starting point as the desired pinacol substrate 
can be synthesised in two reactions; dihydroxylation of the enone followed by mesylation of the 
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secondary alcohol. Treatment with a strong base was anticipated to induce the rearrangement to 
yield the hydroazulene 295 (Scheme 2.13). 
MsO HO_ OOFb) 
Oc< _ O*Tc. 
294 	 329 	 295 
Scheme 2.13. Proposed Pinacol rearrangement. 
Attempts to carry out a catalytic dihydroxylation of enone 294 with osmium tetroxide and NMO, 
as the co-oxidant, proved unsuccessful and only resulted in the recovery of starting material. The 
use of a stoichiometric amount of osmium tetroxide in pyridine furnished the desired diol 330 in 
good yield. Based on our earlier observations, it was assumed that dihydroxylation occurred on 
the top face of the concave molecule resulting in the desired anti-periplanar relationship between 
the secondary alcohol and the internal bond required for the pinacol rearrangement. Treatment of 
330 with methanesulfonyl chloride in pyridine selectively mesylated the secondary alcohol to 
yield the desired substrate in 91% yield. Treatment of 329 with strong bases such as potassium 
tert-butoxide and sodium hydride only resulted in the formation of complex mixtures from 
which the desired product could not be isolated. The apparent instability of the substrate could 
be due to competing kinetic deprotonation of the protons adjacent to the ketone (Scheme 2.14). 
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(a) 0SO4, pyridine, (65%); (b) MsCI, pyridine, (91 %), (c) tBuOK, tbutanol or NaH, THE. 
Scheme 2.14. Attempts at the pinacol type rearrangement 
In order to increase the stability of the substrate the acidity of the a protons was reduced by 
protecting the enone. It has been reported in the literature that treating 331 with potassium tert-
butoxide in tert-butanol deprotonates the tertiary alcohol to initiate a pinacol-type rearrangement 
to initially form ketone 332, which was unstable to the highly basic reaction conditions and 
fragmented to give the hydroazulene 334 after loss of the ethylene glycol ether (Scheme 2.15).
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333 	 334 
(a) tBu OK, tbutano l (40%) 
Scheme 2.15. Protected pinacol rearrangement. 
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Several attempts to form the di-acetal failed to yield the desired pinacol substrate, resulting in 
the isolation of starting material. The enone 294 was therefore reduced, under Luche conditions, 
to afford the allylic alcohol which was subsequently protected as the TBDMS ether 335. It was 
assumed that the reduction had come from the top convex face of the molecule to give the 
stereochemistry shown in Scheme 2.16. Treatment with osmium tetroxide in pyridine led to diol 
337, however, attempts to mesylate the secondary alcohol were again unsuccessful. It was 
postulated that the steric bulk of the protecting group was hindering mesylation. Protection of 
the allylic alcohol as a linear EOM ether was then undertaken. However, frustratingly, all 
attempts to dihydroxylate the enone failed to yield the diol (Scheme 2.16). 
/_\ 	 I_\ 	 H,- HOiO 
1 
ao*II:JCr b TBDMSO,, O 
 IN 	 0. 	 D 
294 	 335 R = TBDMS 	 337 
336 R= EOM 
(a) (I) CeCI3.71-120, NaBH4, methanol, 0°C; (ii) (1) TBDMSCI, TEA, DMAP, 0CM, it, (66% over 2 steps); (2) 
EOMCI, DIPEA, 0CM, it, (95% for 2 steps); (b) 0SO4, pyridine, it, (64%); 
Scheme 2.16. Synthesis of protected pinacol substrates. 
These results suggested that the pinacol-type rearrangement of the mesylate was hindered by the 
steric enviroment surrounding the hydroxyl group. The additional steps needed to protect the 
enone, combined with the need for stoichiometric quantities of osmium tetroxide renders this 
route unattractive. 
All attempts to rearrange the C3 oxidised substrate 294 failed to yield the desired hydroazulene 
295, which led us to devise an alternative strategy based on our initial success with the 
photochemical rearrangement. It was believed that oxidation of the B ring could be conducted 
after a successful transposition. Shortly after starting our synthetic efforts the Chiu group 
reported the successful oxidation of the hydroazulene 212, in their synthetic efforts towards 
guanacastepene A. 30 
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(a) BF3.Et20, 0CM, (98%); (b) Pd(OH)2/C, tB uO2H, DCM, (65%). 
Scheme 2.17. Chiu's hydroazulene oxidation 
2.1.4 Conclusion 
The first objective of the project was to develop suitable methodology for the ring transposition 
of a hydronaphthalene intermediate into the hydroazulene core of the guanacastepenes. There 
have been very few successful reactions of this type reported in the literature to date, however, 
one that stands out is the photo-chemically induced isomerisation reaction developed in the 
1960s by Jeger and Paquette. This methodology was applied to a model system and shown to be 
an effective route to hydroazulenes. A more advanced intermediate, containing additional 
functionality at C3, for the annulation of the C ring, was synthesised, however several attempts 
at the rearrangement failed to yield the desired intermediate. 
An alternative strategy, based on a pinacol-type rearrangement, was investigated as a route 
towards the functionalised intermediate. Unfortunately the need to protect the ketone and 
difficulties encountered with the synthesis of the substrates, led us to devise an alternative retro-
synthesis based on the successful photochemistry conducted on the model system. The required 
oxidation of the enone in the seven membered ring was to be conducted post rearrangement to 
yield the desired hydroazulene 213. 
With a suitable ring transposition in place our next goal was the synthesis of a substrate 
possessing the C12 isopropyl group with the correct stereochemistry. Work towards this 
intermediate was centred on a sterically hindered conjugate addition. 
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2.2 Conjugate addition. 
With a successful rearrangement strategy in place we turned our attention towards the inclusion 
of the C12 isopropyl group of the A ring. As outlined in our retro synthesis we intended to 
achieve this via a Robinson armulation between 2-methyl cyclohexanone 320 and 5-methyl hex-
3-en-2-one 292 or their synthetic equivalents (Scheme 2.18). 
0 OH O'T 	0, 0 
338 	 339 	 292 	320 
Scheme 2.18. Retrosynthesis of hydroazulene core. 
Since the introduction of the Robinson annulation, in the 1930s, it has been widely used for the 
construction of six membered rings and there are numerous examples of its use in the synthesis 
of complex molecules. The annulation mechanism consists of two stages; nucleophilic attack of 
an enolate (or ketoester enolate), in a Michael addition, onto a vinyl ketone acceptor to produce 
the intermediate 3-oxobutyl adduct 341. It should be noted that conjugate addition in this case 
results in the formation of a quaternary centre next to tertiary substituted branched centre. In the 
second stage an intramolecular aldol reaction closes the ring to afford an intermediate keto 
alcohol, which undergoes dehydration to yield the annulation product. 
53 
For the synthesis of guanacastepene A, a Robinson annulation between the enolate of 2-methyl 
cyclohexanone and 5-methyl hex-3-en-2-one 292 was required to install the Cli and C12 
stereocentres of the A ring (Scheme 2.19). 
8 	 OJ 
+ ::0 0 	
------- Y- 
292 	 340 	 341 	 339 
Scheme 2.19. Robinson annulation 
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Attempts to carry out a direct annulation between 2-methyl cyclohexanone and 5-methylhex-3-
en-2-one proved unsuccessful. This was not entirely unexpected as the steric hindrance of the 
isopropyl group would seriously hinder the nucleophilic attack of the enone. There are very few 
examples in the literature of successful Robinson annulations with sterically hindered I-
substituted enones. Those that have been reported typically have low yields and poor selectivity. 
For example, the reaction of trans-3 -penten-2-one with methyl cyclohexanone proceeds poorly, 
unless the nucleophile is activated.M 
It was clear from these initial reactions that the electrophile was too sterically hindered for 
riucleophilic attack in the initial conjugate addition. Activation of either the nucleophile or the 
electrophile would be required to increase the rate of the initial conjugate addition. Direct 
installation of the isopropyl group was desirable, so initial efforts focused on activation of the 
nucleophile, in such a way as to allow for it to be converted into the C 1 methyl group of the 
natural product. Replacing the methyl group with a strongly electron withdrawing group (EWG) 
was expected to aid formation of the enolate, making the nucleophile more reactive. Compounds 
342, 343 and 344 were all identified as suitable candidates, as methods for reducing the 
activating group to the corresponding methyl group are known. These three compounds are all 
either commercially available or synthesised by known procedures (Figure 2.1 
).55, 56 
0 	 0 	 0 
NC IIII' HOXIIIJ Me02C: 
342 	 343 	 344 
Figure 2.1. Activated nucleophiles 
All attempts to perform a Michael addition between 5-methyl-hex-3-en-2-one 292 and the 
activated nucleophiles 342, 343 and 344 failed to give any Michael adduct. These results 
suggests that the steric hindrance imparted by the isopropyl group has a much greater effect and 
that activation of the nucleophile is simply not enough to overcome this energy barrier. 
Activation or reduction of the steric bulk of the electrophile in such a way as to allow conversion 
to the C12 isopropyl group was required. 
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The electrophiles 345 and 346 were identified as suitably activated synthetic equivalents to 5- 
17 
methylhex-3 -en-2 -one, and were synthesised using known procedures (Figure 2.2).' 
58 
0 	 N 0 
MeO2C 
345 	 346 
Figure 2.2. Activated electrophiles. 
Keto-esters such as 345 are known to undergo Michael additions and were first applied in an 
annulation sequence by Peak and Robinson 59 and later by Wieland and Miescher. 6° The a-
substituted vinyl ketone reduces the energy barrier of the addition by stabilising the initial 
Michael adduct, and can then be easily removed, via decarboxylation, to yield the desired 
compound. Unfortunately this substrate failed to react with the enolate of 2-methyl 
cyclohexanone to give any Michael adduct. This result further reinforces the theory that the 
steric bulk of the isopropyl group has a strong influence on the outcome of this reaction. 
Activation of electrophiles for sterically hindered Michael additions have been reported by 
Langlois et al.61  The reaction involves activation of the electrophile by formation of the 
trifluoroacyloxazolinium ion 347, which then reacts with the silyl enol ether of 2-
methylcyclohexanone 340 to yield the Michael adduct 348. Acid hydrolysis of the oxazoline 
reveals the protected acid, which can then be converted to the desired methyl ketone. Although 
there have been no examples reported in the literature to date of this type of reaction being 
carried out with isopropyl substituted enones, it was hoped that activation of both the 
nucleophile and the electrophile would be sufficient to overcome the steric hindrance (Scheme 
2.20). 
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346a-c 	 347a-c 	 340 
R = H, Me, Ph 	R = H, Me, Ph 
b 	
HOyIIIIJ Do 
348a-c 	 349a-c 
R=H, Me, Ph 	 R=H, Me, Ph 
(a) 720, CaCO3, 0CM, -55°C, then 340; (b) HCI(a q) (3N), 100°C, (51-93% two steps) 
Scheme 2.20. Nuclophilic and electrophilic activation. 
Treatment of oxazolines 346a-c with triflic anhydride followed by addition of the silyl enol ether 
340, resulted in no reaction. Several attempts at repeating this reaction, under different 
conditions, also met with failure. 
With all attempts to install the isopropyl group directly resulting in isolation of the starting 
materials, an alternative strategy was explored, in which synthetic equivalents to the isopropyl 
group were employed. The aim of this strategy was to use less bulky 3-substituted electrophiles 
in the initial Michael addition. Conversion to the desired isopropyl group could then be 
achieved, after cyclisation, in a straightforward sequence of transformations. 
Use of the methyl ester 350 allows for a reduction of the stenc hindrance as well as activating 
the nucleophile. This literature reaction was originally reported in 1974 by McMurray et al 
.62 
Refluxing a benzene solution of methyl 4-oxopent-2-enoate, 2-methyl cyclohexanone and PTSA 
(20 mol%), with azeotropic removal of water, yielded the desired Robinson product in a modest 
20% yield, as reported. Attempts to increase this yield, by changing the solvent to toluene, had 
little effect on the yield and changing the acid catalyst to triflic acid or sulphuric acid resulted in 
lower yields. Further analysis indicated that the product is formed as a single diastereomer (as 
shown by the presence of a singlet corresponding to the enone CH at 5.70 ppm in the 1H NMR), 
94 
Results and Discussion I 
the relative stereochemistry of which was determined by X-ray crystallography and shown to be 
cis with respect to Cl 1-C 12. Acid catalysed epimerisation placed the ester group in the 
thermodynamically favoured pseudo-equatorial position (Scheme 2.21). 
o 	
+ °X2J a 01YO 
CO2Me 	 CO2Me 
350 	 320 	 351 
(a) PTSA (cat.), toluene, i, -HO, (20%). 
Scheme 2.21 Robinson annulation 
It has been reported by Yoshikoshi et al.,63 that this compound can be synthesised via a 
Mukaiyama Michael addition, followed by intramolecular aldol cyclisation in an increased yield 
of 73%. Repeating these reaction conditions failed to yield the desired product and the major 
component was isolated and identified as the 1,2-adduct. It was discovered that by increasing the 
temperature of the reaction to 25°C the desired 1,4-addition product was formed preferentially in 
72% yield. Analysis of the product showed the presence of two diastereoisomers in a ratio of 
2:1. Treatment with PTSA (20 mol%) in refiuxing toluene, with azeotropic removal of water, 
yielded the desired decalin as a mixture of diastereomers. The crude material was protected as 
the acetal to afford the desired product in 47% yield over two steps, as a single diastereomer. 
The overall yield for the three steps to synthesis 351 was 34% compared to a yield of just 13% 
for the synthesis of the same compound via the classical Robinson annulation (Scheme 2.22). 
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(a) T04, DCM, 0°C, (72%, 2:1 dr); (b) PTSA, toluene, A, -1-120; (c) PTSA, ethylene glycol, toluene, A, -1-120, 
(47% over two steps). 
Scheme 2.22. Mukaiyama Michael addition. 
Despite obtaining a lower than expected yield, the inconsistency in yield and lengthier 
preparation of the required starting materials, it was concluded that the classic Robinson 
annulation would be more amenable to scale up due to the operational simplicity of the reaction. 
The modest yield of 20% was not considered to be an issue at such an early stage of the 
synthesis. 
With a successful annulation strategy in place we turned our attention towards converting the 
methyl ester into the desired isopropyl group. The first step was to protect enone 351 as a 1,3-
dioxolane, which caused a strain driven migration of the double bond into the second ring. 
Treatment with excess methyl lithium afforded the tertiary alcohol 355 in 53% yield, along with 
22% of the intermediate ketone, which was isolated and re-cycled through the reaction.' 
Attempts to drive this reaction to completion by increasing the equivalents of methyl lithium 
present, resulted in a lower isolated yield. Reduction of the hydroxyl group would result in 
formation of the isopropyl group, however several attempts at the radical removal of the 
corresponding triflate resulted in isolation of the El elimination product 356.65  It was anticipated 
that the isopropenyl group could be formed in higher yield upon treatment with phosphorous 
oxychloride. Selective hydrogenation the resulting atkene would afford the isopropyl group. 
Cleavage of the 1,3 -dioxolane was achieved under acidic conditions, and also regenerated the 
enone system, as compound 357 (Scheme 2.23). 
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(a) ethylene glycol, PTSA (cat.), toluene, -H2O, A, (65%); (b) MeL1, THF, 0°C to it, (53%); (c) POd3, 
pyridine, it, (75%); (d) PTSA (cat.), acetone/water (15:1), A, (61%). 
Scheme 2.23. Introduction of the isopropyl group 
It was at this juncture that we turned our attention towards the ring transposition. Epoxidation 
under basic peroxide conditions yielded the photo-substrate 358 in a moderate 51% yield as a 
single isomer. Irradiation under the previously optimised conditions, afforded the desired 1,3-
diketone 359 in an improved 57% yield with 18% recovery of starting material. This compound 
represents the complete carbon skeleton of the hydroazulene core of the guanacastepenes 
(Scheme 2.24). 
0 OH 
°iIIiiJ a 	O:IS:J 	b  _3 
357 	 358 	 359 
(a) H202, NaOH( aq), methanol, 0 °C to it, (51%); (b) ethanol, pyrex filter, hv, 0 °C, (57 %). 
Scheme 2.24. Photochemical rearrangement 
Having successfully demonstrated the feasibility of the photo-chemical rearrangement we turned 
our attention towards further converting the molecule into the desired hydroazulene core 338. 
Our first aim was to selectively hydrogenate the isopropenyl group at the C12 position. Enone 
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357 was identified as a suitable substrate for hydrogenation due to the different electronic 
properties of the two double bonds. 
Initial efforts using either 10% palladium on charcoal or platinum oxide (Adam's catalyst) in 
methanol or ethyl acetate under atmospheric hydrogen all resulted in reduction of the enone 
system. Switching to the homogeneous Wilkinson's catalyst, 66 which is known to selectively 
hydrogenate the least hindered alkenes, did give the desired product albeit in low yield (15%) 
when carried out in methanol at room temperature using hydrogen at 1 atm. This could be 
increased slightly (30%) when the methanol solution was refluxed, however catalyst degradation 
occurred, resulting in higher catalyst loadings. Increasing the pressure of hydrogen dramatically 
increased the yield with a selective hydrogenation occurring after twelve hours at fifteen bar of 
hydrogen to yield 339 in quantitative yield after filtration. Lower catalyst loadings led to longer 
reaction times, which caused competing hydrogenation of the enone. Employing a three-step 
reductionlepoxidationloxidation strategy yielded the desired photo substrate 360 in 81% yield, 
over the three steps, with a diastereoselectivity of 20:1 by NlvliR (Scheme 2.25). 
04T a 	 b
No 
357 	 339 	 360 
(a) H2 (15 bar), Wilkinson's catalyst (20 mol%), methanol, rt, (99%); (b) (i) CeCI3.71­120, NaBH4, methanol, 
0°C; (ii) m-CPBA, 0CM, NaHCO3, 0°C, (95% over 2 steps); (c) PDC, 0CM, rt, (86%). 
Scheme 2.25. Isopropyl group 
Irradiation of 360 in ethanol with a Pyrex filter afforded the desired product 338 in 56% yield 
after purification, along with 23% recovered starting material. In order to increase the yield the 
optimum reaction time was found by in process monitoring of the reaction by NIMR. Aliquots of 
two millilitres were taken every two hours and concentrated under reduced pressure prior to 'H 
NMIR analysis. The progress of the reaction was followed by integration of the methyl groups in 
the starting material and product (occurring at 1.18 ppm and 1.08 ppm respectively). After three 
hours the reaction had undergone approximately 50% conversion, with the highest conversion 
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being observed after eleven hours, however photo-degradation of the material became significant 
after nine hours (Table 2-2). 
Table 2-2 In process data for photochemical rearrangement reaction. 
0 OH 
360 	 338 






The epoxy ketone 360 was therefore irradiated for nine hours before being concentrated under 
reduced pressure and purified by column chromatography to afford the hydroazulene 338 in 56% 
yield, with 23% recovery of starting material. The hydroazulene was isolated as a single 
diastereomer, the relative stereochemistry of which was determined by X-ray crystallography. It 
can be clearly seen that the isopropyl and methyl groups in the C12 and C 1 position were on 
the same face, which was correct for the natural product. This confirms that the stereochemistry 
of the bridgehead methyl group had not racemised during the photochemistry, which was 
consistent with the work of Jeger and Paquette who also observed retention of stereochemistry at 
this position (Scheme 2.26). 
(a) ho, Pyrex, ethanol, 9 h (56% with 23% recovered SM) 
Scheme 2.26. Photochemical rearrangement. 
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2.2.1 Conclusions 
Having successfully identified a suitable method for the rearrangement our attention turned 
towards the introduction of the C12 isopropyl group via a hindered Robinson annulation. This 
was not a trivial feat due to the steric hindrance imparted by the isopropyl group in the 3 position 
of the electrophile. Several nucleophiles and electrophiles were identified as activated 
alternatives to under go the conjugate addition reaction. Of the ones investigated 350 proved to 
have the required balance between activation and steric bulk and underwent the desired 
Robinson annulation to yield the product in 20% yield as a single diastereomer, as shown by the 
crystal structure. Attempts to improve the yield via a Mukiayama Michael addition were 
successful, isolating 351 in an improved 34% yield. It was decided that the classical Robinson 
annulation was more amenable to scale up, and was therefore used for the synthesis of 351. 
A series of efficient reactions were developed to afford the rearrangement substrate 360 in good 
yield, which smoothly underwent the photochemical rearrangement to yield the hydroazulene 
338. In process monitoring of the photochemical reaction identified nine hours as the optimum 
irradiation time, allowing for the formation and isolation of 338 in 56% yield, which represents 
the complete carbon skeleton of the hydroazulene core of the guanacastepenes. 67 
2.3 Towards the core 
Having successfully rearranged the hydronaphthalene 359 to the corresponding hydroazulene 
338 we turned our attention to elaborating it further towards the functionalised core 288. 
Oxidation at C2 is found in the majority of the guanacastepenes, such as guanacastepenes N and 
E, and may prove to be a useful handle in the synthesis of other members of the family. 
However, it proved more convenient to progress the material towards hydroazulene 288, which 
is the key intermediate in the synthesis of guanacastepene A. Oxidation at the C3 position is also 
required for the eventual introduction of the C ring and is a reaction which has been reported in 
the literature . 30  Further oxidation at the C13 position was also desirable as it represents the 
complete AB ring system of guanacastepene A (Scheme 2.27). 
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0 	 0 OH 
AcO 0 > Ac 
: 0 
— C) —t)  
288 	 361 	 212 	 338 
Scheme 2.27. Retrosynthesis of the fully functionalised guanacastepene core. 
Reduction of the C2 enol functionality was achieved by hydrogenolysis of the derived enol 
triflate, to give the hydroazulene 212 in 65% over two steps. 
Due to the unsuccessful rearrangement of the decaim 294 via either the photochemical or 
Pmacol type reactions, oxidation at the C3 position is required for the construction of the C ring 
of the tricyclic core. This oxidation has been previously carried out by Chiu et al. in their 
synthesis of the hydroazulene 213. 






 ref. 30 
338 	 212 
	
213 
(a) Tf20, DIPEA, DCM, 0°C, (86%), (b) Pd(OAc)2, TEA, PPh3, HCO2H, DMF, 60°C, (76%). 
Scheme 2.28. Enol reduction 
At this stage we examined methods for achieving oxidation of the A ring. The insertion of an 
acetoxy group at C13 is well documented in the later stages of Danishefsky's synthesis of 
guanacastepene A. 68  A three step Rubottom protocol, on the advanced intermediate 22, afforded 
23, which after diol deprotection and oxidation of the primary alcohol, yielded guanacastepene 
A (Scheme 2.29). 
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22 	 23 
(a) (I) Et3SIOTf, Et3N, DCM; (ii) DMDO/acetone, DCM, -78CC, then Me2S, (82-90% for 2 steps) (iii) Ac20, 
pyridine, DMAP, DCM, (96%). 
Scheme 2.29. Danishefsky's Rubottom oxidation. 
It would be more desirable to achieve this transformation in a single step and it has been 
reported in the literature that manganese tetra-acetate is capable of doing just this . 69 Treatment of 
hydroazulene 212 under these conditions afforded a new compound and preliminary assignment 
of its structure suggested that it was the desired product 362, which was formed in a low 34% 
yield as a 2:1 mixture of diastereoisomers (based on the intergration of two peaks corresponding 
to the acetate CH 3 at 8.aj  = 2.16 and ö,, = 2.14 ppm in the 'H NMR). Attempts to increase this 
yield proved unsuccessful and analysis of the mixture by NMR did not assist in determining the 
favoured isomer. It was hoped that by repeating the reaction on an earlier intermediate in the 
synthesis both an increase in yield and selectivity might be achieved. The decalin 339 was 
identified as a suitable substrate and when the reaction was repeated the product was isolated in 
87% yield as a 6:1 mixture of diastereoisomers (based on the intergration of two peaks 
corresponding to the acetate CH 3 at 8nj = 2.03 and 6,,,,, = 2.18 ppm in the 1 H NMR). Analysis of 
the intermediate identified a coupling constant of 6.1 Hz in the major diastereoisomer, indicating 
an axial-axial relationship between H12 and H13, placing the acetoxy group on the lower face. 
Irradiation of 363, under the predetermined conditions, afforded a UV active product consistent 
with earlier reactions, however, attempts to isolate the material were unsuccessful. Insufficient 
material prevented any further attempts at performing the rearrangement (Scheme 2.30). 
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0 	 0 
a Ac0 	 k ACO:cJ 	b10 
212 	 362 	 363 	 339 
(a) Mn(OAc)4, benzene/acetic acid (10:1), A, -H20,(34%, 2:1 dr), (b) Mn(OAc)4, benzene/acetic acid (10:1), 
A, -H20, (96%, 6:1 dr), (c) ho, pyrex, ethanol. 
Scheme 2.30. Acetoxylation studies. 
2.3.1 Conclusions 
The first aim of the project was to investigate and develop a suitable racemic synthesis of the 
hydroazulene core of guanacastepene family of natural products. A photo isomerisation strategy 
was successfully applied to a model system and the hydroazulene 323 was isolated in a moderate 
50% yield. Synthesis of a more oxygenated substrate 325 was achieved, however, this failed to 
undergo the rearrangement. Based on these results an alternative strategy, based on a pinacol 
type rearrangement, was investigated. The first substrate proved to be unstable to the reaction 
conditions, due to the presence of acidic protons, and failed to rearrange. Synthesis of a series of 
protected substrates proved difficult due to the steric bulk of the compounds. The increased 
number of steps and use of toxic reagents forced us to develop an alternative strategy based on 
the successful earlier photochemical studies. 
With a suitable rearrangement strategy in place we turned our attention towards the second key 
step of the synthesis, a sterically hindered Robinson annulation to fix the Cli and C12 
stereocentres. Several attempts to insert the isopropyl group with activated nucleophiles and 
electrophiles proved unsuccessful, indicating the need to reduce the steric hindrance imparted by 
the isopropyl group. This was achieved with 350 to yield the hydronaphthalene 351 as a single 
diastereoisomer. With the correct stereochemistry in place an efficient series of reactions were 
developed for converting the methyl ester to the desired isopropyl group. Rearrangement of the 
resulting hydronaphthalene yielded the complete carbon skeleton of the core of natural product 
in 56% yield. 
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The hydroazulene 338 was advanced further towards the functionalised desired core, by 
deoxygenation in the C2 position via the intermediate triflate. In order to construct the third ring 
of the natural product oxidation at the C3 position was required. Previous attempts to achieve 
this prior to the rearrangement had all met with failure. There was literature precedent for the 
oxidation of similar enones, which had been demonstrated by Chiu et al. in their synthesis of the 
core. 30  Acetoxylation at the Cl 3 position was achieved in one step, prior to the rearrangement, to 
afford the desired substrate, as a 6:1 mixture of diastereoisomers, unfortunately favouring of the 
undesired isomer. Repeating this reaction post rearrangement yielded the substrate as 2:1 
mixture of diastereoisomers in a poor 35% yield. A Rubottom oxidation has been successfully 
applied on more advanced intermediates for the synthesis of guanacastepene A. 
With a successful route to the core in hand the remainder of our efforts focused upon the 
synthesis of the key intermediate 339 in an enantiopure form via an asymmetric conjugate 
addition reaction. 
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3 Asymmetric synthesis 
3.1 Enantioselective 1,4-conjugate addition 
With a suitable strategy to the core in place our attention turned towards an asymmetric 
synthesis of hydroazulene 212, en route to completing the total synthesis of guanacastepene A. 
Previous asymmetric approaches towards the natural products have focused on synthesising the 
key building blocks from the chiral pool, 8 leading to lengthy synthetic routes, or involve chiral 
resolutions,' °  resulting in loss of material. A more elegant strategy would involve the use of a 
catalytic asymmetric reaction to set the absolute stereochemistry with complete control. The use 
of metallic complexes as catalysts for use in asymmetric reactions has been extensively 
investigated and has led to the introduction of a number of highly efficient and enantioselective 
reactions. 70 
Hydronaphthalene 297 was identified as a suitable key intermediate, which was synthesised via a 
1,4-conjugate addition, in the racemic approach. For an asymmetric synthesis it was necessary to 
incorporate an enantioselective variant of the Michael addition, setting the absolute 
stereochemistry of the Cli and C12 stereocentres (Scheme 3.1). 
OT 0 OH OHC 15 H O 
- - - 	ACO)3)5 _j 
16 
297 	 364 	 1 
Scheme 3.1 Enantioselective intermediate. 
3.1.1 Background 
Our previous work highlighted that a 1,4-conjugate addition, for the synthesis of 
hydronaphthalene 339, was complicated by the presence of the isopropyl group. There are very 
few reported examples in the literature of enantioselective catalytic Michael additions of a-
substituted ketones with sterically hindered Michael acceptors, however recent methodology 
from the Jacobsen group is exceptional in this regard. Their initial publication focused on the 
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enantioselective conjugate addition of a,3-unsaturated imides with activated nucleophiles, 
catalysed by a dimeric salen-aluminium complex 369. The steric congestion of the addition 
reaction is apparent from the need to activate the nucleophile with two electron withdrawing 
groups (EWG), in the form of either methyl cyanoacetate 365 or malononitrile 366. Several 
successful examples utilising a-substituted imides were reported, which included the sterically 
hindered 3-iso-propyl and tert-butyl compounds, which gave rise to the desired products with 
high enantio- and diastereo-selectivity, as well as excellent yields (Scheme 3.2).' 
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(a) (R,R)-[(salen)AI]20 369 (5 mol%), tB UOH cyclohexane, it, (87-99%, 86-97% ee) 
Scheme 3.2. Jacobsen's asymmetric conjugate addition onto imides. 
Further investigations by the group revealed that the use of imides was not essential and that the 
reaction also worked well with a4-unsaturated ketones, and these reaction were carried out 
using a five fold reduction in catalyst loading (Scheme 3•3)•72 
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NCCO2 Me 	+ 	 R' 	
a 	
NC R,go 
R 	 EWG 
365 	370 R = Ph, Pr 	 371 
R'= Me, Bu, Or 
(a) (R,R)-[(salen)A]]2 369 (1 mol%), cyclohexane, rt, (86-91%, 75-93% ee) 
Scheme 3.3. Jacobsen's asymmetric conjugate addition of enones. 
The excellent selectivity achieved with sterically hindered nucleophiles encouraged us to adopt 
Jacobsen's enantioselective 1,4 conjugate addition methodology in the synthesis of 
guanacastepene A. 
3.1.2 Initial studies 
Our preliminary reactions used cyclic nucleophiles and although there were no examples 
reported by Jacobsen et al. it was hoped that cyclohexanones 342 and 344 would be activated 
enough to undergo a conjugate addition with 5-methylhex-3-en-2-one 292. An intramolecular 
aldol condensation could then be used to construct the A ring affording the Robinson adducts 
372 or 373. The EWGs (R = CN or CO 2Me) could then be reduced to give the corresponding 
methyl group, which would then complete the synthesis of hydronaphthalene 297 (Scheme 3.4). 
OT: - - - .-OT 
292 	342 R=CN, 	 372 R=CN, 	 297 
344 R = CO2Me 	373 R = CO2Me 
Scheme 3.4. Proposed cyclic nucleophiles for asymmetric conjugate addition. 
Work started with the synthesis of 2-oxocyclohexanecarbonitrile 342, via a Thorpe-Ziegler 
condensation73  of commercially available pimelonitrile. 55 Treatment with Jacobsen's catalyst in 
the presence of 5-methylhex-3-en-2-one 292, resulted in no reaction, even at elevated 
temperatures. A similar result was observed using methyl 2-oxocyclohexanecarboxylate 344. 
Even more discouraging was the discovery that the activated electrophile 350, which was 
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previously employed in the racemic synthesis, also resulted in no reaction. These results 
suggested that the cyclic nucleophiles were too hindered for use with this catalytic system. 
Based on these results we devised a route incorporating an acyclic nucleophile in the asymmetric 
conjugate addition. The absolute stereochemistry would be set using Jacobsen's methodology 
with alkyl substituted methyl cyanoacetates, which could then be cyclised onto the methyl 
cyanoacetate to construct the B ring. This approach required a high level of diastereoselectivity 
in the addition reaction and Jacobsen et al. have reported one example of a substituted 
nucleophile, phenyl methyl cyanoacetate 375, to afford a fully substituted quaternary centre in 
high diastereoselectivity (Scheme 3 •5)•72 
n-Pr 0 
0 	 Ph 	a  





- 	 CO2Me 	 NIC 
CO2Me 
374 	 375 	 376 
(a) (S,S)-[(salen)Al]20 (2.5 mol%), methyl cyclohexane, 0°C, (88%, >30:1 dr, 89% ee). 
Scheme 3.5. Jacobsen's asymmetric conjugate addition of substituted electrophiles. 
Substituted methyl cyanoacetate 377 was identified as a suitable nucleophile as the ester group 
will undergo a Dieckmman cyclisation 74  onto the methyl ester, to form cyclohexanone 379. With 
no obvious way of incorporating the ester functionality into the synthesis of the natural product, 
it would have to be removed via decarboxylation. If successful an intramolecular Aldol 
condensation would then be used to construct the A ring, by forming the hydronaphthalene 380 
(Scheme 3.6). 
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Scheme 3.6. Acyclic substrate for asymmetric conjugate addition. 
The synthesis began with the formation of the substituted methyl cyanoacetate 377 via alkylation 
of methyl cyanoacetate with commercially available methyl 5-bromopentanoate and potassium 
carbonate in acetonitrile. Unfortunately, no reaction was observed when this substrate was 
subjected to Jacobsen's conditions in the presence of 5-methylhex-3-en-2-one 292, resulting in 
the isolation of the starting material. 
3.1.3 Malononitrile 
The earlier results carried out on the enantioselective conjugate addition indicated that the 
reaction was dependant on the steric environment of the nucleophile, which led us to investigate 
alkyl substituted malononitrile substrates. It was hoped that reducing the steric hindrance, by 
replacing the methyl ester with a second nitrile group, would facilitate a successful addition. The 
malonomtrile 382 would then be reduced to the corresponding bis-aldehyde 383, which should 
undergo an intramolecular aldol condensation. Hopefully the cyclisation would favour one 
aldehyde and give rise to enone 384 diastereoselectively. It was hoped that the stereochemical 
outcome of the cyclisation would favour that of the natural product. A second 1,4-conjugate 
addition of the functionalised alkyl chain onto the cyclic enone, with in situ trapping of the 
intermediate enolate would allow regeneration of the enone, and so generate the 
hydronaphthalene 385. Finally reduction of the aldehyde into a methyl group would afford the 
desired compound 297 (Scheme 3.7). 
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Scheme 3.7. Substituted malononitnle route to hydronaphthalene. 
A four carbon chain was required for the construction of the B ring from aldehyde 383 and 
model studies were conducted on butene substituted malonomtrile 387. The terminal alkene 
should not affect the asymmetric addition and could be later oxidised. 2-(But-3-
enyl)malononitrile 387 was synthesised via alkylation of malonomtrile with commercially 
available 4-bromobut-1 -ene 386. Treatment of 387 with Jacobsen's catalyst, (RR)-[(salenAl) 20] 
369, in the presence of 5-methyl hex-3-en-2-one 292 afforded the desired conjugate addition 
product 388 in quantitative yield after eighteen hours (Scheme 3.8). The enantiomeric excess of 
this reaction was inferred and only determined by chiral HPLC analysis after conversion to the 
advanced intermediate 391 (Scheme 3.10). 
0 
CN 	 a 	CN 
I 
Br 	 NC 	
b 	
CN 
I +  
366 	 386 	 387 	 388 
(a) acetonitrile, K2CO3, rt, (62%); (b) (R,R)-[(salen-AI)20] 369 (5 mol%), cyclohexane, rt, (99%) 
Scheme 3.8. Successful asymmetric conjugate addition. 
After successfully demonstrating the asymmetric conjugate addition, we next turned our 
attention towards the reduction of the nitrile groups to the corresponding bis-aldehyde, in order 
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to investigate the possibility of performing a diastereoselective cyclisation. DIBALH was chosen 
as the reducing agent as it is known to form an intermediate aluminium complex, preventing 
further reduction of the aldehyde to the alcohol . 75 Formation of the acetal 389 was 
straightforward, which was then treated with two equivalents of DIBALH in THF at -78°C, but 
the only result observed was recovery of starting material. The reaction was repeated in diethyl 
ether and the starting material was completely consumed by t.l.c after eighteen hours. Isolation 
and characterisation of the product revealed that the product was aldehyde 390, which resulted 
from the selective reduction of only one nitrile group, which was formed as a 10:1 mixture of 
diastereoisomers (determined from the integration of the two aldehyde peaks at E = 9.33 ppm 
and 8n1jj = 9.25 ppm in the 1H NMR). The aldehyde was isolated in 42% yield after purification 
by column chromatography, however washing the silica column lead to the isolation of more 
material. The column was washed with methanol before being concentrated under reduced 
pressure and the resulting yellow oil was then re-columned to give the aldehyde in a combined 
yield of 72%. This observation suggested that the intermediate aluminium complex was stable 
and that quenching the reaction, with saturated Rochelle salts, did not fully hydrolyse the 









(a) PTSA, toluene, ethylene glycol, A , (86%); (b) DIBALH, diethyl ether, rt, (72%, 10:1 dr). 
Scheme 3.9. Diastereoselective nitrile reduction. 
Acid hydrolysis of the acetal group afforded the ketone, which upon treatment with catalytic 
CSA, cyclised to give enone 391. Two dimensional NMR studies revealed the cis relationship 
between the isopropyl and nitrile groups, which is correct for the natural products. Chiral HPLC 
analysis revealed that the initial 1,4-conjugate addition had proceeded in a moderate 57% e.e. 
(Scheme 3.10). 
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(a) (i) PTSA, THF, H20, ,; (ii) CSA, PhMe, A, (68% over two steps). 
Scheme 3.10. Formation of enone 391 and confirmation of stereochemistry. 
The diastereoselectively of the DIBALH reduction has been attributed to the formation of a 
complex arising from coordination of the aluminium to the oxygen atom of the acetal group, thus 
delivering the hydride from one face. Reduction of the second nitrile group is thought to be 
hindered by the presence of the neighbouring isopropyl group and the intermediate aluminium 
complex, which remains stable until the work up (Figure 3.1). 
ri  
Figure 3.1. Proposed structure of aluminium complex. 
3.2 Alkylation 
Having successfully demonstrated the desired 1,4-conjugate addition strategy we then sought to 
apply this methodology in an asymmetric synthesis of the core of the natural products. A 
literature search revealed very few examples of successful 1,4-conjugate additions onto cyclic 
enones for the construction of hydronaphthalenes. Given this finding and our previously 
discussed experience of Robinson annulations, it seemed more prudent to construct the B ring 
first. Hydronaphthalene 380 could be synthesised via an intramolecular Aldol condensation to 
construct the A ring from cyclohexanone 372. It was envisaged that construction of the B ring 
could be achieved via an intramolecular Barbier cyclisation and the organometallic species 393 
was identified as a key intermediate. Iodide 394 was identified as a suitable precursor to the 
Barbier reaction, arising from the diastereoselective reduction of the bis-nitrile 395 (Scheme 
3.11). 
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Scheme 3.11. Retrosynthesis of hydronaphthalene 380. 
The synthesis of iodide 395 began with oxidative hydroboration of alkene 389, to give the 
desired alcohol 396 in poor yield (9%). Several attempts at increasing this yield failed to produce 
the product in reasonable quantities. The material isolated was carried through to the next 
reaction without complete characterisation and converted to the corresponding iodide 395, under 
standard conditions. Insufficient material was isolated to allow for full analysis or study of the 













396 	 395 
(a) (i) 9-BBN, THF, OC to it; (ii) H202, NaOH, (9%); (b) PPh3, 2, imidazole, THF, it, (64%). 
Scheme 3.12. Alkene oxidation. 
Due to the yield of the hydroboration and the additional step required for conversion to iodide 
395, we searched for alternative ways of generating substituted malononitriles for the 
asymmetric 1,4-addition. Iodide 398 was identified as a suitable substrate, but attempts to 
synthesise it by direct alkylation of malononitrile with I ,4-diiodobutane 397, under a variety of 
conditions, resulted in the formation of complex mixtures of products (Scheme 3.13). 
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Scheme 3.13. Attempted synthesis of iodide 398. 
Intermediate alcohol 396 was identified as a suitable target and attempts to prepare it began with 
the formation of benzyl ether 400, from commercially available benzyl 4-bromobutyl ether 399 
and malononitrile. The asymmetric conjugate addition with 5-methyl hex-3-en-2-one 292 
proceeded smoothly under standard conditions to yield the desired product in 96% yield. 
Determination of the e.e. of 401 by chiral HPLC, was complicated by the absence of a strong 
chromophore. Acetalisation yielded 405, however attempts to deprotect the benzyl group under 
mild hydrogenation conditions, were unsuccessful. Increasing either the pressure or temperature 
resulted in the formation of complex mixtures, presumably arising from competing reduction of 
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(a) acetonitnle, K2CO3, rt, (67%); (b) 5-methylhex-3-en-2-one 292, (R,R)-[(salen-A1)20] (1 mol%), 
cyclohexane, rt (96%); (c) PTSA, toluene, ethylene glycol, ,, -HO, (74%). 
Scheme 3.14. Formation of benzyl ether 402. 
The complications in the synthesis of an alkyl substituted nucleophile led us to consider an 
alternative approach, in which the C 1 methyl group was inserted directly, avoiding the final 
nitrile reduction. An asymmetric conjugate addition between 5-methyl hex-3-en-2-one 292 and 
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malononitrile 388 was expected to proceed in high yield and e.e. using the Jacobsen conditions. 72 
Alkylation with methyl iodide would construct the desired quaternary centre, ready for a 
diastereoselective nitrile reduction to afford aldehyde 404. Wittig olefination could then be used 
to introduce the side chain in preparation for the cyclisation of the B ring. The geometry of the 
alkene was not important as hydrogenation was expected to afford intermediate 407, which 
could then undergo a second nitrile reduction in preparation for the construction of the B ring. 
An intramolecular Barbier cyclisation followed by oxidation and Aldol cyclisation should then 
afford the hydronaphthalene 297 (Scheme 3.15). 
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Scheme 3.15. Wittig approach. 
The asymmetric conjugate addition of 5 -methylhex-3 -en-2 -one with malononitrile, under 
Jacobsen's conditions, afforded ketone 403. The e.e. of the reaction was determined by chiral 
HPLC analysis after synthesis of compound 395 (Scheme 3.19). Protection as the acetal 
followed by alkylation with methyl iodide afforded 410. Treatment with excess DIBALH in 
diethyl ether yielded aldehyde 404 as a 3:1 mixture of diastereoisomers (determined by the 
integration of the two aldehyde peaks at 8. j = 9.35 ppm and ömjfl = 9.27 ppm in the 1 H NMR). It 
was found that the diastereoselectivity of this reaction was increased, to 8:1, by cooling the 
reaction to -78°C (Scheme 3.16). 
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(a) (R,R)-[(salen-Al)20] 369 (1 mol%), cyclohexane, rt (90%); (b) PTSA, toluene, ethylene glycol, A, -H20, 
(94%). (c) Mel, K2CO3, acetone, A, (86%); (d) DIBALH, diethyl ether, -78°C, (52%, 8:1 dr) 
Scheme 3.16. Synthesis of Wittig substrate. 
With aldehyde 404 in hand work began on the synthesis of a suitable Wittig reagent. A literature 
search revealed that phosphate salts such as 405 readily undergo intramolecular cyclisation to 
yield the corresponding cyclopropane. 76 Alcohol 412 was therefore chosen as an alternative 
substrate as iodination after olefination would afford intermediate 406. Formation of 412 was 
achieved by refluxing a toluene solution of commercially available 3-bromo-propan-1-ol with 
triphenyl phosphine. Treatment of 412 with two equivalents of tert-butyl lithium at -78°C 
formed the desired ylid which was slowly added to aldehyde 404. The result was the formation 
of a complex mixture, from which the product could not be isolated. It was assumed that 
formation of the lithium alkoxide was hindering the reaction. It has been reported in the 
literature that this can be avoided by an in situ protection of the alcohol as a silyl ether. 77 
Treatment of the phosphonium salt 412 with two equivalents of tert-butyl lithium, followed by 
the dropwise addition of TMSC1, should have generated the intermediate TMS protected ylid 
413. The crude solution was then added dropwise to aldehyde 404, however no reaction was 
detected after eighteen hours (Scheme 3.17). 
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(a) PPh3, toluene, A, (66%); (b) THF, -78°C, "BuLi, then TMSCI, then 404, -78°C to rt. 
Scheme 3.17. In situ Wittig reaction. 
It was unclear whether the in situ protection had worked, so instead we opted for a two step 
synthesis in which the TBS protected alcohol 416, was first formed. Treatment of 3-bromo 
propan-1-ol 415 under standard conditions afforded silyl ether 416, which was then treated with 
triphenyl phosphene in toluene to afford the phosphonium salt 417 after filtration. Unfortunately 
using standard Wittig conditions the desired olefination did not occur and only starting materials 
were recovered (Scheme 3.18). 
Br 
a 	 b 	e 
Br"---'OH 	 Br'OTBS 	
Ph3P'OTBS 
415 	 416 	 417 
(a) TBSCI, DMAP, TEA, DCM, ii, (92%); (b) PPh3, toluene, A, (20%). 
Scheme 3.18. Synthesis of phosphate 417. 
The poor results combined with the additional steps required to synthesise the Wittig substrates, 
led us to reconsider the earlier strategy (section 3.1) based on the reduction of the nitrile to the 
Cli methyl group. Direct alkylation of 409 with 1 ,4-diiodobutane proceeded smoothly to afford 
the key intermediate, iodide 395, in 77% yield. Chiral HPLC analysis of 395 implied that the 
initial conjugate addition had occurred in an excellent 97% e.e. The e.e. was then increased, by 
re-crystallisation from propan-2-ol, to afford the product in >99% e.e. Treatment of 395 with 
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excess DIBALH afforded aldehyde 394 in 63% yield as a 10:1 ratio of diastereoisomers 
(determined by the integration of the two aldehyde peaks at 6 = 9.35 ppm and 6mm = 9.28 ppm 
in the 'H NMR) (Scheme 3.19). 





409 	 395 
b C PCHH 
394 
(a) 1,4-diiodobutane, K2CO3, acetone, A, (77%); (b) DIBALH, diethyl ether, ii, (63%, 10:1 dr). 
Scheme 3.19. Synthesis of aldehyde 418. 
3.3 Cyclisation studies 
With intermediate 394 in hand our attention now focused upon the intermolecular Barbier 
reaction for the construction of the B ring. Treatment of iodide 394 with magnesium metal in 
TIIF was unsuccessful in forming the Grignard reagent, resulting in the recovery of starting 
material. A lithium/halogen exchange was carried out with tert-butyl lithium, yielding the 
desired cyclohexanol 392 in a moderate 56% yield. Scale-up of this reaction resulted in the 
isolation of 392 in lower yields, questioning the reliability of these conditions. Several attempts 
to reproduce or improve this yield were unsuccessful. In an attempt to find a more reliable set of 
conditions we investigated a radical approach in which iodide 418 was treated with tributyltin 
hydride, however several attempts at this reaction resulted in the formation of complex mixtures, 
from which the desired product was not isolated. 
There are reports in the literature of samarium diiodide being utilised in Barbier reactions .78  It is 
also known that certain functional groups, such as esters, amides and nitriles are inert under 
standard conditions (TI{F, with or without HIvIPA, at room temperature) . 79 Treatment of iodide 
418 with Sm12 in THF failed to yield the desired product, however when HMPA, a known 
promoter of samarium diiodide reactions '80  was used as a co-solvent, the cyclohexanol 392 was 
isolated in a reproducible 83% yield. Oxidation with TPAP/NMO afforded ketone 372, which 
was subsequently deprotected to reveal the second cyclisation precursor. A successful 
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intramolecular Aldol condensation was achieved, under acidic conditions, to afford 380 in 91% 
















(a) Sm12, THE, HMPA, -78°C, (83%); (b) TPAP, NMO, DCM, 4A MS, (82%); (c) (i) PPTS, THE, H20, i; (ii) 
PTSA, toluene, A, (90% over two steps). 
Scheme 3.20. Synthesis of hydronaphthalene 380. 
3.4 Towards the core 
With a suitable route to the bicycle in place we concentrated on elaborating it further towards 
intermediate 297. It was envisaged that reduction of the nitrile group to the corresponding 
aldehyde could be achieved, followed by formation of thioacetal 418. Reduction with Raney 
nickel should then afford hydroazulene 297 to complete the asymmetric synthesis of the core of 
the guanacastepenes (Scheme 3.21). 
119 
Results and Discussion II 
0 - 	 0 	 0 
380 	 385 
	
418 
---- 0- T 
297 
Scheme 3.21. Proposed synthesis of 297. 
Protection of the enone as an acetal, in preparation for the nitnle reduction, proved problematic 
with the product being isolated in low yield. The enone 380 was therefore reduced, under Luche 
conditions, to afford the allylic alcohol 419 in quantitative yield, with no requirement for 
purification. Reduction of the nitrile group with DIBALH afforded aldehyde 420 in 78% yield 
over the two steps. Treatment of 420 with 1 ,2-dithioethane under standard conditions (BF 3.OEt2 , 
DCM, rt) resulted in the formation of a complex mixture, from which the product could not be 
isolated. This result was presumably due to the presence of the secondary alcohol. The alcohol 
was then protected as silyl ether 421 in good yield. Unfortunately all attempts at the 
thioacetalisation of 421 failed under standard conditions (Scheme 3.22). 
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0 	 HO,, CN 
CN 	 TCC N 	 CHO 
380 
	
419 	 420 
C 
10 	 3 CHO 
421 
(a) CeCI3.7H20, NaBH4, methanol, 0°C, (83%); (b) DIBALH, diethyl ether, -40°C, (94%); (c) TBSCI, 
imidazole, DMAP, DCM, rt, (77%). 
Scheme 3.22. Nitrile reduction. 
Corey et al. recently reported the deoxygenation of aldehyde 422 in their enantioselective Diels-
Alder approach towards palominol 424.81 Their attempts at reducing the aldehyde all met with 
failure, which included thioacetalisation under standard conditions. They then developed a mild 
novel method for the synthesis of the thioacetal in which aldehyde 422 was treated with 
Me2A1SCH2CH2SA1Me2, in DCM at 60°C. Reduction with Raney nickel, after cleavage of the 











(a) (i) (Me2AISCH2)2, DCE, 60°C; (ii) TBAF, THF; (b) Raney Ni, THF, rt, (65% from aldehyde 422) 
Scheme 3.23. Corey's non-acidic thioacetalisation. 
Unfortunately treatment of aldehyde 421 with Me 2A1SCH2CH2SA1Me2, under Corey's 
conditions, did not lead to the desired thioacetal. 
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3.5 Conclusions 
Work towards developing an asymmetric synthesis of guanacastepene A started with an 
investigation into enantioselective 1,4-conjugate additions, to set the C 1 and C 12 stereocentres, 
utilising the recent methodology of the Jacobsen group. Initial efforts focused on the use of 
cyclic nucleophiles, however, it became evident that they were too sterically hindered, even for 
this doubly activated catalyst system. We opted for an acyclic route based on methyl 
cyanoacetate 377 and envisaged a Dieckmann cyclisation for the synthesis of the B ring. 
Unfortunately all attempts at the Michael addition met with failure resulting in the recovery of 
starting materials. 
In order to reduce the stenc hindrance of the nucleophile we explored the use of malononitrile 
derivatives, with the intention of reducing to the bis-aldehyde, before cylising to afford the A 
ring. An asymmetric conjugate addition with butene substituted malononitrile 387 afforded 388 
in quantitative yield. Treatment with DIBALH selectively reduced one of the nitrile groups to 
afford aldehyde 390, as a 10:1 mixture of diastereoisomers, which were readily converted into 
enone 391. Chiral HPLC analysis revealed that the conjugate addition had occurred in a 
moderate 57% e.e. NMIR analysis showed that the stereochemistry was correct for the family of 









Scheme 3.24. Synthesis of en one 391. 
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Further investigations revealed that by changing the order of the alkylation and the Michael 
addition it was possible to synthesise iodide 395 in both high yield and enantioselectivity. The 
serendipitous diastereoselective DIBALH reduction discovered previously afforded aldehyde 
394, as a 10:1 mixture of diastereoisomers, in preparation for the construction of the B ring. 
Barbier cylisation studies revealed that samarium diiodide was suitable for cyclising iodide 394 
onto the aldehyde to afford the cyclic alcohol in 83% yield. Oxidation and deprotection followed 
by Aldol cyclisation yielded the desired compound, hydronaphthalene 380, in good yield 
(Scheme 3.25). 
OY 	Co 




















Scheme 3.25. Synthesis of hydronaphthalene 380. 
With a suitable route to the hydronaphthalene in place we examined the reduction of the Cli 
nitrile into the corresponding methyl group. Protection of the enone was problematic, so 
reduction to the allylic alcohol was performed in good yield. Reduction of the nitrile to the 
aldehyde proceeded smoothly to afford the product in 94% yield. Unfortunately all attempts to 
form the thioacetal proved unsuccessful even after protection of the allylic alcohol. 
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4 Conclusions and Future Work 
The overall aim of the PhD project was to lay the foundations for the synthesis of the natural 
product guanacastepene A. Our restrosynthetic analysis was based on the rearrangement of a 
suitably functionalised hydronaphthalene intermediate to afford the hydroazulene core. Six 
membered rings are synthetically easier to construct then five and seven membered ones, 
allowing us to develop an efficient route to the core. 
4.1 Racemic approach 
Our initial studies focused on the photochemically promoted rearrangement of epoxy ketones to 
yield the core and work began with known substrate 322, allowing for optimisation studies to be 
conducted on this literature reaction. Irradiation of an ethanolic solution of 322, through a Pyrex 
filter for five hours, afforded the desired hydroazulene 323. These encouraging results led us to 
synthesise the advanced photo substrate 325, which contains additional functionality in the B 
ring, required for the annulation of the third ring. Unfortunately, under a variety of 
photochemical conditions this substrate failed to yield the desired product. A base promoted 
Pinacol type rearrangement was explored, as an alternative, however several ketal containing 
derivatives failed to yield the desired hydroazulene 295. 
0 OH 
O4 a °i5 
322 	 323 	 325 
Scheme 4.1. Photochemical studies. 
The success of the initial photochemical rearrangements enticed us to alter our strategy, with the 
oxidation of the B ring being carried out at a later stage in the synthesis. 
The second key step, a sterically hindered 1,4-conjugate addition reaction, for the installation of 
the C 11-Cl 2 stereocentres was investigated. Stencally hindered Michael additions are difficult, 
a fact which is supported by very few examples in the literature. Our efforts started with a series 
of activated nucleophiles and electrophiles, allowing us to explore this synthetically challenging 
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reaction for the installation of the isopropyl group. A literature Robinson annulation, first 
reported by McMurray, allowed for the synthesis of hydro-naphthalone 351, which has the 
correct relative stereochemistry between Cli methyl and the C12 methyl ester groups, as 
confirmed by its X-ray structure. A short sequence of functional group manipulations converted 
the methyl ester into the desired isopropyl group to afford the key intermediate, hydro-
naphthalone 339. Epoxidation afforded the photo-substrate, which after irradiation under the pre-
determined rearrangement conditions, yielded the complete carbon skeleton of the core of the 
guanacastepenes, 337. 
0 	 0 	
0 OH 
CO2Me 
351 	 339 	 359 	 337 
Scheme 4.2. Synthesis of the carbon skeleton of the guanacastepenes. 
Functionalisation towards the complete hydroazulene core was achieved by reduction of the enol 
functionality, arising from the rearrangement, to afford the known enone 212. This intermediate 
is known to undergo oxidation at the C3 position, allowing for the annulation of the C ring. 
4.2 Asymmetric approach 
With a suitable route to the hydroazulene core developed, we concentrated on an asymmetric 
synthesis of the key intermediate, hydronaphthalene 297. Our previous attempts at 1,4-conjugate 
additions highlighted the difficulties associated with the steric hindrance imparted by the 
isopropyl group, to set the Cli -C 12 stereocentres. However, a recent report from the Jacobsen 
group describes the asymmetric conjugate addition of activated nucleophiles to sterically 
hindered electrophiles. These results encouraged us to adopt this methodology towards the 
synthesis of guanacastepene A. Several attempts at this reaction with cyclic nucleophiles such as 
342 and 344 with 5-methyl hex-3-en-2-one 292 resulted in no reaction, further highlighting the 
importance of the steric hindrance imparted by the isopropyl group on these addition reactions. 
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A strategy based on acyclic substrates was developed with the intention of forming the bicycle 
after the conjugate addition. The use of malononitrile derivatives proved very successful, with 
the synthesis of enone 391 taking place in high yield. The e.e. of the addition reaction was 
shown to be 57% by chiral HPLC. The serendipitous discovery of a diastereoselective DIBALH 
reduction in the synthesis of 391 enhanced this synthetic route further. 
An alternative route, in which a Barbier cyclisation constructs the B ring was devised based on 
these DIBALU reductions. Iodide 395 was identified as a key intermediate and was synthesised 
in high yield from 1 ,4-diiodobutane. Chiral HPLC showed that the initial conjugate addition had 
proceeded in an impressive 97% e.e. The optical purity of this substrate was increased further by 
recrystallisation, from propan-2-ol, to >99%. A diastereoselective DIBALH reduction yielded 
the Barbier substrate 394, and samarium diiodide promoted its cyclisation to afford the B ring. 
Oxidation afforded 372, which after ketal hydrolysis under went an intramolecular Aldol 
cyclisation to furnish the A ring, forming the hydronaphthalene 380. 









Scheme 4.3. Synthesis of hydronaphthalene 380. 
With the formation of the required carbon-carbon bonds in place, all that remained was the 
reduction of the nitrite group to the corresponding methyl group to afford hydronaphthalene 297. 
This apparently straightforward reduction proved problematic at such a late stage in the 
synthesis, with all attempts proving unsuccessful. 
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4.3 Future work 
The work earned out during this PhD has outlined a photo-chemical ring transposition strategy, 
of a suitably functionalised hydro-naphthalone intermediate, for the construction of the hydro-
azulone core of guanacastepene A. An asymmetric variant, based on the 1,4-conjugate addition 
methodology reported by the Jacobsen group has also been devised, leading to the construction 
of enone 380. Several attempts to reduce the nitrite group to the corresponding C 1 methyl 
group were unsuccessful. 
Future work should therefore concentrate on the reduction of the nitrite group, completing the 
asymmetric synthesis of the hydroazulene core. Work can then be carried out of the annulation 
of the third ring, which is well documented, allowing for an efficient asymmetric synthesis of 
guanacastepene A. 
The versatility of this route can then be demonstrated with the synthesis of several of the other 
members of the guanacastepene family, allowing for further biological testing to be carried out 




5.1 General procedures 
'H nuclear magnetic resonance (NMR) spectra were recorded using an internal deuterium lock 
for the indicated reference at ambient probe temperatures on either a Bruker AC250 (250 MHz) 
or a BrUker DPX360 (360 MHz) Fourier transform instrument. The data is presented as follows: 
chemical shift (in ppm on the ö scale), integration, multiplicity, coupling constant (J in Hz) and 
the assignment. ' 3C NTvIIR spectra were recorded at ambient probe temperatures on either a 
Bruker AC250 (63 MHz) or a Bruker DPX360 (91 MHz) instrument and are reported in ppm on 
the 8 scale. Distortion Enhancement Polarisation Transfer (DEPT) spectra were recorded to 
assign the carbon signals as methyl (CH 3), methylene (CH2), methine (CH) or quaternary 
carbons (C). 
Infra Red spectra were recorded on a JASCO FTIIR-460 plus instrument using 4mm sodium 
chloride plates. The wavelengths of the maximum absorbance (v) are quoted in cm'. Samples 
were sent to the EPSRC National Mass Spectrometry Service Centre, Swansea for MS analysis. 
Accurate mass measurements were obtained on a Finnigan MAT 900 XLT double focusing mass 
spectrometer. The data is recorded as the ionisation method followed by the calculated and 
measured masses. Optical rotations were measured on an AA-1000 polarimeter with a path 
length of 0.5 dm at the sodium D line (589 rim) and reported as follows: [a]D concentration (c in 
g/100 mL) and solvent. Melting points were determined on a Gallenkamp Electrothermal 
melting point apparatus and are uncorrected. 
TLC was performed on Merck 60F 254 silica plates and visualised by UV light and/or 
anisaldehyd& or potassium permanganate 11 stains. Compounds were purified by wet flash 
'Anisaldehyde stain was prepared as follows: Concentrated sulphuric acid (10 ml-) was added 
carefully to a stirring solution of ethanol (200 ml-) and p-methoxybenxaldehyde (10 mL). 
"Potassium Permanganate stain was prepared as follows: potassium permanganate (3g) and 
potassium carbonate (20g) were dissolved in 5% sodium hydroxide (5 mL) and water (300 ml-). 
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chromatography using Merck Kieselgel 60 (particle size 35-70A) silica under a positive pressure 
and the eluent compositions are quoted as a percentage. Chiral IIPLC was performed using a 
Waters instrument with an OD-H column equipped with a UV detector. A standard flow rate of 
0.8 mL/min of a propan-2-ollhexanes mixture as the eluent was used. 
Anhydrous toluene, dichloromethane, tetrahydrofuran, diethyl ether, methanol and acetomtrile 
were obtained from an Innovative Technologies solvent purification system unless otherwise 
stated. Diisopropylamine and pyridine were distilled and stored over potassium hydroxide. n-
Butyl lithium (BuLi) and tert-butyl lithium (BuLi) solutions were titrated against diphenyl 
acetic acid in THF at 0°C in triplicate immediately prior to use. All other chemicals were used as 
supplied except where otherwise stated in the text. 
All experiments were performed under an inert atmosphere of nitrogen under anhydrous 
conditions using oven dried apparatus cooled in a dessicator prior to use. Standard techniques for 
handling air-sensitive materials were employed. 
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5.2 Experimental Procedures for Chapter 2 
4a-Methyl-hexahydro-naphthalen-2(3H)-one (321) 






2-Methy1cyclohexanone (320) (6.5 mL, 0.054 mol) and methyl vinyl ketone (8.8 mL, 0.106 mol) 
were dissolved in toluene (50 mL) and sulfuric acid (0.3 mL, conc.) was added dropwise over 
approximately 10 mm. The resulting solution was heated at 85°C for 18 h before being allowed 
to cool to RT and quenched with water (20 mL). The layers were separated and the aqueous 
phase was extracted with diethyl ether (3 x 20 mL). The combined organics were washed with 
aqueous NaHCO 3 (20 mL, sat.), brine (20 mL), dried (MgSO4) and concentrated in vacuo to 
yield a yellow oil. Column chromatography (Si0 2, 10 % ethyl acetate in hexanes) afforded the 
title compound (3.17 g, 44 %) as a yellow oil: IR (neat)/cm - 1 u a,, 1675 (C=O); 'H NMR 8 (250 
MIHz, CDC13) 5.65 (11-1, s, C=CII), 2.42-2.16 (4H, m, CH2), 1.79-1.57 (6H, m, CH2), 1.39-1.26 
(21-1, m, CH2), 1.17 (31-1, s, Cl!3); ' 3C NMR 6 (63 MHz, CDC13) 199.7 (C), 170.5 (C), 124.1 
(CH), 41.5 (CH 2), 38.0 (CH2), 35.9 (C), 33.9 (CH2), 32.7 (CH2), 27.1 (CH2), 22.0 (CH3), and 
21.7 (CH2); HRMS (EI+) m/z calcd. for C 11H 160 [M] 164.1201, found, 164.1202. 
'H NIN'IIR data in agreement with the literature. 
4a-Methyl-laH-octahydro-naphth011-b] oxiren-2-oJ (321b) 
Orp 	




	 321 b 
4a-Methyl-hexahydro-naphthalen-2(3H)-One (321) (520 mg, 3.17 mmol) and CeC1 3 .71120 (1.70 
g, 4.57 mmol) were dissolved in methanol (30 mL) and cooled to 0°C before NaBI{4 (127 mg, 
3.36 mmol) was added portionwise over approximately 10 mm. The resulting solution was 
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allowed to warm to RT and stirred for a further 10 min before being quenched with acetone (20 
mL). Ammonium chloride (ca. 1 g) was added and the solvent removed in vacuo. The resulting 
slurry was partitioned between water (15 mL) and DCM (15 mL) and the aqueous phase was 
extracted with DCM (3 x 10 mL). The combined organics were washed with brine (10 mL), 
dried (MgSO4) and concentrated in vacuo to afford the title compound (0.526 g, 100 %) as a 
colourless solid, which was taken onto the next step without further purification. 
4a-Methyl-octahydro-naphthalen-2-ol (321a) (526 mg, 3.16 mmol) and NaHCO 3 (535 mg, 6.37 
mmol) were suspended in DCM (30 mL) and cooled to 0°C before addition of mCPBA (1.17 g, 
4.75 mmol, 70 %). The resulting solution was allowed to warm to RT and stirred for 3 h. The 
reaction was quenched with water (10 mL) and the aqueous phase was extracted with DCM (3 x 
10 mL). The combined organics were washed with aqueous NaHCO, (15 mL, sat.), brine (15 
mL), dried (MgSO4) and concentrated in vacuo to afford a yellow oil. Column chromatography 
(Si02, 30 % ethyl acetate in hexanes) afforded the title compound (519 mg, 9:1 d.r, 90 % over 
two steps) as a colourless solid; m.p. = 56-58°C (petroleum ether), lit. 
82  58-60 °C; IR (neat)/cm 
'o 3384 (OH); 'H NMR ö (360 MHz, CDC1 3) 4.07 (1H, d, J= 4.6 Hz, CHOH), 3.15 (1H, d, J 
= 4.6 Hz, CHOC), 2.76 (1H, s, 01]), 2.03 (1H, td, J = 13.5, 4.4 Hz, CH2CHOH), 1.82 (1H, m, 
CH2CHOH), 1.59-1.44 (6H, m, 3 x CH2), 1.36-1.23 (4H, m, 2 x CH2), 1.07 (311, s, CH3); 13C 
NMR 6 (91 MHz, CDC13) 67.6 (C), 64.3 (CH), 63.5 (CH), 36.1 (CH 2), 33.2 (C), 31.4 (Cl 2), 
30.6 (CH2), 26.3 (CH2), 25.6 (CH2), 22.8 (CH3) and 21.3 (CH2). 
'H NMR data in agreement with the literature. 82 
4a-Methyl-laH-hexahydro-naphtholl-bI oxiran-2(311)-one (322) 
HOIcJ ON 	 tIIIIIIIIIJ 
321b 	 322 
4a-Methyl- laH-octahydro-naphtho[ 1 -b]oxiran-2-ol (321b) (463 mg, 2.54 mmol) and PCC (1.10 
g, 5.09 mmol) were dissolved in DCM (30 mL) and stirred for 18 h. The solution was filtered 
through silica and washed with DCM (2 x 50 mL) and the resulting filtrate concentrated in vacuo 
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to give a yellow oil. Column chromatography (Si02, 20 % ethyl acetate in hexanes) afforded the 
title compound (329 mg, 72 %) as a colourless solid; m.p. = 55-58°C (petroleum ether), lit. 83 58-
60 °C; IR (neat)/cm' u n. 1708 (C=O); 'H NMR ö (250 MIHz, CDC1 3) major diastereoisomer: 
2.99 (1H, s, Cl?'), 2.32-2.05 (4H, m, 2 x CH 2), 1.93-1.85 (2H, m, CH2), 1.58-1.46 (611, m, 3 x 
CH2), 1.25 (311, s, CH,); 13C NMR 8 (63 MHz, CDC13) 206.9 (C), 69.5 (C), 62.6 (CH), 35.2 
(CH2), 34.6 (C), 33.4 (CH2), 31.5 (CH2), 30.6 (CH2), 26.3 (CH2), 22.6 (CH3) and 21.4 (CH2); 
minor diastereoisomer diagnostic peaks: 'H NMR 6 (2 50 MiHz, CDC1 3) 2.31 (1H, s, CH), 1.15 
(3H, s, C?'!,); "C NMR 6 (63 MHz, CDC1 3) 207.5 (C), 69.3 (C), 63.1 (CH), 37.9 (CH 2), 34.3 
(C), 33.6 (CH2), 31.8 (CH2), 30.1 (CH,), 24.2 (CH2), 21.7 (CH2) and 20.6 (CR 3) HRMS (ES+) 
m/z calcd. for C,,H 1702 [M+Hj 181.1223, found, 181.1224; Elemental analysis calcd. for 
C 11H1602,C, 73.30; H, 8.95, found: C, 73.39; H, 9.06. 






4a-Methyl- 1 aH-hexahydro-naphtho[ 1 -b]oxiran-2(3H)-one (322) (49 mg, 0.27 mmol) was 
dissolved in ethanol (200 mL) and the solution deoxygenated with nitrogen for 1 h. The solution 
was immersed in an ice bath and exposed to UV radiation through a Pyrex filter for 6 h before 
being concentrated in vacuo. Column chromatography (Si0 2, 10 % ethyl acetate in hexanes) 
afforded the title compound (25 mg, 50 %) as a colourless oil, along with recovered starting 
material (12 mg, 25 % recovery). IR (neat)/cm' 3398 (OH'), 1645 (C0), 1604 (C=O); 'H 
NMR 6 (360 MHz, CDC13) 14.24 (1H, s, OR), 2.61-2.51 (211, m, CH2), 2.39-2.32 (211, m, CH2), 
1.82-1.63 (6H, m, 3 x CH2), 1.47-1.41 (2H, m, CH2), 1.14 (3H, s, CR'3); "C NMR 6 (91 MHz, 
CDC13) 206.3 (C), 183.0 (C), 119.8 (C), 43.6 (CH 2), 43.0 (C), 39.0 (CH 2), 37.6 (CH,), 36.0 
(CH2), 26.6 (CH2), 26.4 (CH2) and 24.7 (CH3); FIRMS (El) m/z calcd. for C,,H 1602 [M] 











Bromine (5.5 mL, 0.11 mol) was added dropwise to a solution of 2-methyl-cyclohexanone (6.01 
g, 0.054 mol) in diethyl ether (30 mL) at -10°C. The resulting solution was stirred for 30 mm 
before aqueous sodium thiosulfate (30 mL, sat.) was added. The aqueous phase was extracted 
with diethyl ether (2 x 20 mL) and the combined organics were washed with aqueous NaHCO 3 
(20 mL, sat.), brine (20 mL), dried (MgSO 4) and concentrated in vacuo to afford 2,6-dibromo-2-
methylcyclohexanone (320a) (14.45 g, 100 %) as a brown oil. The compound was taken onto the 
next step without further purification. 
Sodium hydroxide (32.89 g, 0.82 mol) dissolved in ice-cold water (300 mL) was added slowly to 
a solution of 2,6-dibromo-2-methylcyclohexanone (320a) (14.45 g, 0.054 mol) in THF (50 mL) 
at 0°C. The resulting solution was stirred for 2 h before being warmed to RT. The THF was 
removed in vacuo and the resulting brown solution was adjusted to pH 7 with conc. HC1 and 
extracted with ethyl acetate (6 x 50 mL). The combined organics were dried (M9SO 4) and 
concentrated in vacuo to yield a yellow oil. Column chromatography (Si0 2, 10 % ethyl acetate 
in hexanes) afforded the title compound (5.79 g, 86 %) as a colourless crystalline solid; m.p. = 
60-62 °C (ethyl acetate/hexanes), lit.' 58-60 °C; 'H NMR 8 (360 MHz, CDC1 3) 6.15 (1H, s, 
OR), 2.46 (2H, t, J = 6.4 Hz, COCH2CH2), 2.32 (2H, t, J = 6.4 Hz, CCH3CH2CH2), 1.92 (2H, 
quin, J = 6.4 Hz, CH2CH2CH2), 1.87 (3H, s, CH3); '3C NMIR 6 (91 MHz, CDC1 3) 194.1 (C), 
143.7 (C), 130.8 (C), 35.1 (CH 200.3 (CH2), 22.1 (CH2) and 16.8 (CH3). 
'H NAM data in agreement with the literature. 84 
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7-Methyl-1,4-dioxa-spiro [4.5] decan-6-one (293) 
H0j O 
	
324 	 293 
2-Hydroxy-3-methylcyclohex-2-enone (324) (5.08 g, 40.27 mmol), ethylene glycol (2.7 mL, 
48.41 mmol) and PTSA (cat.) were dissolved in benzene (50 mL) and the solution was heated at 
reflux with a Dean-Stark trap for 16 h. The reaction was quenched with aqueous NaHCO 3 (20 
mL, sat.) and the aqueous phase was extracted with diethyl ether (3 x 20 ML). The combined 
organics were washed with brine (30 mL), dried (MgSO 4) and concentrated in vacuo to yield a 
yellow oil. Column chromatography (Si0 2, 100 % DCM) afforded the title compound (2.91 g, 
43 %) as a yellow solid; m.p. = 83-85°C (DCM); IR (neat)/cm' v,, 1729 (C=0), 1026 (C-0); 
'H NMR 6 (250 MIHz, CDCI3) 4.06-3.74 (4H, m, OCH2CH20), 3.02 (1H, sept., J = 6.5 Hz 
CH3CII), 2.09-1.73 (4H, m, 2 x CH2), 1.30 (211, m, CH2), 1.02 (311, d, J= 6.5 Hz, CH3); 13C 
NMR ö (63 MHz, CDC13) 207.8 (C), 107.1 (C), 65.8 (CH 2), 64.4 (CH2), 42.8 (CH), 37.2 (CH2), 
35.1 (CH2), 22.0 (CH2) and 14.0 (CH3); fiRMS (EI+) m/z calcd. for C9H1403 [M] 170.0943, 
found 170.0942. 
8-(1,3-Dioxolane)4a-methyl-hexahydro-311-naphthalen-2-Ofle (294) 
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Methyl vinyl ketone (0.13 mL, 1.53 mmol) was added dropwise to a solution of 7-methyl-1,4-  
dioxa-spiro[4.5]decan-6-one (293) (254 mg, 1.49 mmol) and sodium methoxide (18 mg, 0.33 
mmol) in methanol (10 mL) and the solution was heated at reflux for 18 h. Ammonium chloride 
(ca. 0.5 g) was added and the solvent removed in vacuo. The resulting slurry was partitioned 
between water (10 mL) and DCM (10 mL) and the aqueous phase was extracted with DCM (3 x 
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20 niL). The combined organics were washed with brine (10 mL), dried (MgSO4) and 
concentrated in vacuo. Column chromatography (Si0 2, 15 % ethyl acetate in hexanes) afforded 
the title compound (199 mg, 60 %) as a yellow crystalline solid; m.p. = 112-113 °C (ethyl 
acetate/hexanes); IR (neat)/cm -1 v 1668 (CO), 1028 (C-O); 'H NMR ö (250 MIHz CDC13) 
6.06 (1H, s, COCH=C), 4.03-3.72 (4H, m, OCH2CH20), 2.33-2.30 (2H, m, CH2CO), 1.99-1.63 
(811, m, 4 x CH2), 1.32 (3H, s, CH3); ' 3C N1'IR 8 (63 MHz, CDC1 3) 200.7 (C), 164.6 (C), 122.7 
(CH), 107.1 (C), 65.5 (CH2), 63.7 (CH 2), 40.8 (CH2), 39.4 (CH2), 37.0 (CH2), 37.0 (C), 34.1 
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8(1,3-Dioxolane)-4a-methyl-hexahydro-3H-naphthalefl-2-one (294) (1.01 g, 4.53 mmol) and 
CeC13.7H20 (2.52 g, 6.76 mmol) were dissolved in methanol (30 niL). The solution was cooled 
to O'C and NaBH4  (183 mg, 4.84 mmol) was added portionwise over approximately 10 min and 
the resulting mixture stirred for a further 30 mm. Acetone (20 mL) and ammonium chloride (ca. 
0.5 g) were added and the solvent was removed in vacuo. The resulting slurry was partitioned 
between water (10 mL) and diethyl ether (10 niL) and the aqueous phase was extracted with 
diethyl ether (4 x 20 mL). The combined organics were washed with brine (20 mL), dried 
(MgSO4) and concentrated in vacuo to afford the title compound (1.01 g, 100 %) as a yellow oil. 
Analysis showed the product to be pure so it was taken onto the next step without further 
purification. IR (neat)/cm' u 3398 (OH); 'H NMIR 6 (250 MIHz, CDC1 3) 5.75 (111, d, J= 1.8 
Hz, C'CHCH), 4.20 (1H, m, 01]), 4.01-3.78 (411, m, OCH2CH20), 3.47 (lH, td, J= 7.0, 1.8 Hz, 
CHOH), 1.99-1.80 (4H, m, 2 x CH2), 1.64-1.46 (6H, m, 3 x CH2), 1.15 (3H, s, CH3); 13C NMR ö 
(63 MHz, CDC13) 142.7 (C), 125.3 (CH), 107.7 (C), 68.2 (CH), 64.9 (CH 2), 63.3 (CH2), 41.4 
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(CH2), 39.0 (CH2), 37.6 (CH2), 35.9 (C), 28.5 (CH2), 24.6 (CH 3) and 19.3 (CH 2); HRMS (EI+) 
m/z calcd for C 13112003  [M4] 224.1412, found, 224.1414. 
8-(1 ,3-Dioxolane)-4a-methyl-hexahydro-3H-naphthalefl-2-Ol (294a) (966 mg, 4.31 mmol) was 
dissolved in DCM (30 mL) and cooled to 0C and NaHCO 3 (723 mg, 8.61 mmol) was added. 
mCPBA (1.37 g, 7.96 mmol) was then added portionwise over approximately 15 mm. The 
resulting solution was allowed to warm to RT and stirred for 5 h. Aqueous NaHCO3 (10 mL, 
sat.) was added and the aqueous phase was extracted with DCM (3 x 10 mL). The combined 
organics were washed with brine (20 mL), dried (MgSO 4) and concentrated in vacuo to give a 
pale yellow oil. Column chromatography (Si0 2, 30 % ethyl acetate in hexanes) afforded the title 
compound (774 mg, 75 %) as a colourless oil. IR (neat)/cm' u,,..,, 3443 (OH); 'H NMR ö (360 
MHz, CDC13) 4.13-4.04 (211, m, O(CH2)20), 3.95-3.82 (311, m, O(CH2)20, Cl]), 3.62 (1H, d, J= 
4.4 Hz, CHO), 1.89-1.65 (2H, m, CH2), 1.65-1.37 (811, m, 4 x CH2), 1.20 (311, s, CH3); 13C 
NMR 8 (91 IVlIHz, CDC1 3) 107.6 (C), 68.8 (C), 65.9 (CH 2), 65.5 (CH2), 64.3 (C), 59.3 (CH), 36.3 
(CH2), 36.2 (CH2), 34.6 (C), 32.0 (CH 2), 26.3 (CH2), 23.8 (CH,) and 18.9 (CH 2); HRMS (EI+) 
m/z calcd. for C 13H2004  [M] 240.1362, found, 240.1356. 
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8-( 1 ,3-Dioxolane)-4a-methyl-hexahydro-1 -oxa-cyclopropa[d]naphthalen-2-ol (294b) (774 mg, 
3.22 mmol) was dissolved in DCM (50 mL) and cooled to 0°C. PCC (1.74 g, 8.06 mmol) was 
added portionwise over approximately 1 h and the solution was stirred for a further 18 h. The 
reaction was filtered through silica and washed with DCM (2 x 50 mL). The combined organics 
were dried (MgSO 4) and concentrated in vacuo to afford the title compound (666 mg, 87 %) as a 
colourless solid. Crystallisation from diethyl ether yielded the target compound as colourless 
needles; m.p. = 97-99 °C (diethyl ether); IR (neat)/cm' vna.,  1712 (C=O); 'H NMR 6 (360 IvIIHz, 
CDC1 3) major diastereoisomer: 4.08-3.81 (41-1, in, O(CH2)20), 3.40 (in, s, C=OCHO), 2.43-2.16 
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(2H, m, C=OCH2), 1.99-1.82 (21-1, m, CH2), 1.72-1.56 (4H, m, 2 x CH2), 1.51-1.29 (211, m, 
CH2), 1.34 (311, s, CH3); ' 3C NMR 6 (91 MHz, CDC1 3) 206.1 (C), 107.0 (C), 69.5 (C), 65.7 
(CR2), 65.5 (CR2), 58.2 (CH), 36.5 (CR2), 35.5 (C), 34.7 (CH2), 33.3 (CH2), 32.6 (CH2), 23.4 
(CH3) and 18.9 (CH2); minor diastereisomer diagnostic peaks: 'H NAM 6 (360 MIHz, CDC1 3) 
3.42 (11-1, s, C=OCHO), 1.18 (311, s, CH3); BERMS (EI+) mlz calcd. for C 13111804 [M] 238.1200, 
found, 238.1200. 
8(1,3DioxoIane)1,8adihydroxy_4a-methy1-OCtahYdrO-flaPhtha 1en-2-0fle (330) 
	







Osmium tetroxide (308 mg, 1.21 mmol) was dissolved in pyridine (5 mL) and added dropwise to 
a solution of 8-( 1 ,3dioxolane)-4a-methyl-4,4a,5,6,7,8-hexahydrO-3H-naPhtha1en-2-0ne (294) 
(257 mg, 1.16 mmol) dissolved in pyridine (5 mL) and the resulting solution was stirred for 7 h. 
Sodium dithiomte solution (10 mL, sat.) was added and the reaction mixture stirred for 18 h. 
Ethyl acetate (10 mL) was added and the aqueous phase was extracted with ethyl acetate (3 x 10 
mL). The combined organics were washed with brine (20 ML), dried (MgSO4) and concentrated 
in vacuo to give a brown oil. Column chromatography (SiO 2, 50 % ethyl acetate in hexanes) 
afforded the title compound (192 mg, 65 %) as a colourless crystalline solid; m.p. 63-65°C 
(ethyl acetate/hexanes); IR (neat)/cm 1 o 3452 (OH), 1714 (CO); 'H NMR 6 (360 MHz, 
CDC1 3) 4.44 (11-1, s, CH), 4.17-3.81 (411, m, O(CH2)20), 3.08 (111, bs, OR), 2.61-2.53 (2H, m, 
CH2), 2.16-1.76 (211, m, CH2), 1.73-1.71 (2H, m, CH2), 1.56-1.52 (2H m, CH2), 1.43-1.24 (211, 
m, CH2), 1.36 (311, s, CH3); ' 3C NMIR 6 (91 MHz, CDC13) 212.5 (C), 112.0 (C), 81.0 (C), 75.9 
(CH), 67.5 (CH2), 64.2 (CH2), 40.0 (C), 36.4 (CR 2), 35.4 (CH2), 32.9 (CH2), 21.7 (CH3) and 19.5 












8-( 1 ,3-dioxolane)- 1 ,8a-Dihydroxy-4a-methyl-octahydro-naphthalefl-2-Ofle (330) (38 mg, 0.15 
mmol) was dissolved in pyridine (2 mL) and methane sulfonyl chloride (0.15 mL, 1.94 mmol) 
was added dropwise. The reaction was left to stir for 1 h at RT and the pyridine was removed in 
vacuo. The residue was partitioned between water (5 mL) and DCM (5 mL) and the aqueous 
phase was extracted with DCM (3 x 5 mL). The combined organics were washed with brine (10 
mL), dried (MgSO4) and concentrated in vacuo to give a yellow oil. Column chromatography 
(Si02, 20 % ethyl acetate in hexanes) afforded the title compound (46 mg, 92 %) as a colourless 
crystalline solid; m.p. 52-54°C (ethyl acetate/hexanes); IR (neat)/cm' Umax  3398 (OH), 1738 
(C0), 1342 (S=O), 1173 (S=O); 1 H NMR 8 (360 MiIlz, CDC13) 5.52 (11-1, s, CH), 4.27-3.83 
(4H, m, O(CH2)20), 3.34 (3H, s, S0 2CH3), 3.02 (1H, bs, 011), 2.68-2.47 (211, m, Cl!2), 2.14 (21-1, 
m, CH2), 1.82-1.65 (4H, m, 2 x CH2), 1.55-1.43 (2H, m, CH2), 1.39 (3H, s, CH3); '3C NMR 
(91 MHz, CDC1 3) 205.7 (C), 111.0 (C), 85.8 (CH), 82.0 (C), 67.5 (CH2), 63.6 (CH2), 41.4 (C), 
41.2 (CH3), 37.9 (CH), 35.5 (CH2), 35.2 (CH2), 32.0 (C112), 21.4 (CH3) and 19.0 (CH2); HRMS 
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8-(1 ,3-Dioxolane)-4a-methyl-hexahydro-3H-naphthalefl-2-Ol (294a) (191 mg, 0.85 mmol) was 
dissolved in DCM (20 mL) and cooled to 0°C. TBSC1 (0.193 g, 1.28 mmol), DMAP (cat.) and 
TEA (0.24 mL, 1.72 mmol) were added and the solution was stirred at RT for 18 h. The reaction 
was quenched by the addition of water (10 mL) and the aqueous phase was extracted with DCM 
(3 x 10 mL). The combined organic layers were washed with brine (20 mL), dried (M9SO 4) and 
concentrated in vacuo to yield a yellow oil. Column chromatography (Si0 2, 10 % ethyl acetate 
in hexanes) afforded the title compound (212 mg, 74 %) as a colourless oil; IR (neat)/cm' u,, 
1084 (C-O); 'H NMR 8 (360 MHz, CDC13) 5.70 (11-1, s, C=CH), 4.25 (1H, m, CH), 3.97-3.84 
(411, m, O(Cf12)20), 1.91-1.73 (2H, m, CH2), 1.64-1.49 (414, m, 2 x CH2), 1.47-1.26 (411, m, 2 x 
CH2), 1.21 (31-1, s, CH3), 0.90 (9H, s, OSiC(CH3)3), 0.09 (3H, s, OSiCH3), 0.08 (3H, s, OSiCH3); 
' 3C NMR 8 (91 MHz, CDC13) 142.3 (C), 127.7 (CH), 109.0 (C), 70.2 (CH), 66.0 (CH 2), 64.4 
(CH2), 42.8 (CH2), 40.4 (Cl2), 38.8 (CH2), 36.9 (C), 29.8 (CH 2), 27.0 (3 x CH,), 25.6 (CH3), 
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Osmium tetroxide (173 mg, 0.68 mmol) was dissolved in pyridine (5 mL) and added dropwise to 
a solution of tert-Butyl-dimethyl-(8-( 1,3 dioxo1ane)4amethyloctahydro-naphthalen-2-ylOXy)-
silane (335) (214 mg, 0.63 mmol) in pyridine (5 mL) and the reaction was stirred for 4 d. 
Sodium dithionite solution (20 mL, sat.) was added and the resulting solution was stirred for 18 
h. Ethyl acetate (20 mL) was added and the aqueous phase was extracted with ethyl acetate (3 x 
20 mL). The combined organics were washed with brine (20 mL), dried (MgSO 4) and 
concentrated in vacuo to afford a yellow oil. Column chromatography (SiO 2, 10 % ethyl acetate 
in hexanes) afforded the title compound (151 mg, 64 %) as a colourless crystalline solid; m.p. = 
72-75°C (ethyl acetate/hexanes); IR (neat)/cm' O ( 3476 (OH), 1094 (C-O); 'H NMR 6 (360 
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MHz, CDC13) 4.11-3.83 (4H, m, O(CH2)20), 3.21 (1H, bs, OR), 2.91 (1H, bs, 011), 2.06-1.84 
(211, m, 2 x Cu), 1.73-1.66 (4H, m, 2 x CH2), 1.58-1.47 (611, m, 3 x CH2), 1.13 (311, s, CH,), 
0.91 (911, s, OSiC(CH3)3), 0.11 (311, s, OSiCH3), 0.09 (3H, s, OSiCH3); 13C NMR 8 (91 MHz, 
CDC1 3) 113.7 (C), 77.8 (C), 75.7 (CH), 74.7 (CH), 66.9 (CH 2), 63.5 (CH2), 40.1 (C), 35.0 (CH2), 
34.9 (CH), 31.4 (CH2), 30.0 (CH2), 27.0 (3 x CH,), 21.2 (CH 3), 19.6 (CH2), 19.2 (C), -3.3 (CII,) 
and -3.5 (CH,); HRMS (ES+) m/z calcd. for C 1911,N05Si [M+NH4] 390.2670, found 390.2672. 
1(1,3Dioxo1ane)_7-ethoxymethoxy-4a-methy1-oCtahydrO-flaPhtha1efle (336) 
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8(1,3Dioxolane)-4a-methy1-hexahydro-3H-naphtha1en-2-Ol (294a) (322 mg, 1.44 mmol) was 
dissolved in DCM (20 mL) and cooled to 0°C. DIPEA (0.50 mL, 2.87 mmol) was added and 
EOMC1, (0.30 mL, 3.23 mmol) was added dropwise over 10 mm. The resulting solution was 
stirred for 1 h at 0°C and then at RT for 16 h. The reaction was quenched with NaHCO, solution 
(10 mL, sat.) and the aqueous phase was extracted with DCM (3 x 10 mL). The combined 
organics were washed with brine (20 mL), dried (MgSO 4) and concentrated in vacuo to afford 
the title compound (402 mg, 99 %) as a yellow oil. Analysis showed the compound to be pure so 
it was taken onto the next step without further purification; IR (neat)/cm' u a. 1065 (C-O); 'H 
NMR(360 MIHz, CDC1 3) 5.80 (111, s, C=CH), 4.81 (211, q,J= 7.3 Hz, OCH20), 4.19 (1H, m, 
CH), 4.00-3.82 (411, m, O(CH2)20), 3.66-3.60 (211, m, OCH2CH3), 2.05-1.85 (211, m, CH2), 
1.62-1.43 (8H, m, 4 x Cl!,), 1.22 (311, t, J= 7.0 Hz, OCH2CH3), 1.21 (3H, s, CH,); "C NMR 
(91 MIHz, CDC1 3) 144.1(C), 124.7 (CH), 108.9 (C), 94.7 (CH,), 74.4 (CH), 66.0 (CH 2), 64.4 
(CH2), 64.1 (CH2), 42.6 (CH,), 40.1 (CH2), 38.9 (CH,), 37.0 (C), 26.6 (CH,), 25.7 (CH,), 20.5 




Methyl 4-oxo-2-pentenoate (350) 
CO2Me 	 CO2Me 
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Methyl levulmate (68.0 mL, 0.54 mol) was dissolved in chloroform (400 mL) and a solution of 
bromine (33.0 mL, 0.60 mol) in chloroform (70 mL) was added dropwise over 2 h. The reaction 
mixture was cooled to 0°C before TEA (240 mL) was added over 1 h. After stirring for 1 h at 
0°C the solution was quenched with sodium thiosulfate (50 mL, sat.) and water (100 mL) was 
added. The aqueous phase was extracted with diethyl ether (4 x 50 mL) and the combined 
organics were washed with HC1 (100 mL, 1M), brine (100 mL), dried (MgSO 4) and concentrated 
in vacuo. Column chromatography (Si0 2, 20 % ethyl acetate in hexanes) yielded a yellow solid, 
which was re-crystallised from hexanes to afford the title compound (33.99 g, 50 %) as a 
colourless solid; m.p. 57-59 °C (ethanol); lit. 85 58-60 °C; IR (neat)/cm' v 1721 (C=O), 1677 
(C=C); 'H NMR 8 (360 MIHz, CDC13) 7.02 (114, d, J = 16.0 Hz, CH3COCH=CH-), 6.65 (1H, d, 
J = 16.0 Hz, CH,COCH=CH-), 3.81 (3H, s, -0O2CH3), 2.35 (3H, s, -CH,); '3C NMR 8 (91 
MHz, CDC1 3) 197.4 (C), 165.9 (C), 140.1 (CH), 131.0 (CH), 52.4 (CH 3) and 28.1 (CH 3). 
'H NMR data in agreement with the literature. 85 
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Methyl 4-oxo-2-pentenoate (350) (30.18 g, 0.24 mol) and 2-methyl-cyclohexanone (28.7 mL, 
0.24 mol) were dissolved in toluene (460 mL) and a catalytic amount of PTSA (9.02 g, 0.05 mol, 
20 mol %) was added. The reaction mixture was heated at reflux with a Dean-Stark trap for 48 h 
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before being allowed to cool to RT and quenched with NaHCO 3 (100 mL, sat.). The aqueous 
phase was extracted with diethyl ether (4 x 50 mL) and the combined organics were washed with 
brine (100 mL), dried (MgSO 4) and concentrated in vacuo to yield a yellow oil. Column 
chromatography (Si0 2, 20 % ethyl acetate in hexanes) afforded the title compound (10.04 g, 20 
%) as a colourless solid: mp 58-61 °C (hexanes); IR (neat)/cm' 1731 (CO), 1672 (C0); 
'H NTffl 8 (360 MIHz, CDC1 3) 5.70 (1H, s, .-C=CH-), 3.70 (3H, s, -0O2CH3), 2.71-2.92 (2H, m, 
-CH2 -), 2.27-2.43 (3H, m, -CH2-, -CH-), 1.86-2.00 (2H, m, -CH2-), 1.56-1.68 (2H, m, -CH2-), 
1.32-1.48 (2H, m, -CH2 -), 1.22 (314, s, -CH3); '3C NMR ö (91 MHz, CDC13) 197.3 (C), 172.3 
(C), 168.9 (C), 124.2 (CH), 51.7 (CH,), 51.2 (CH), 39.6 (CH 2), 38.7 (C), 36.4 (CH 2), 32.7 (CH2), 
26.6 (CH2), 21.6 (CR2) and 18.2 (CH3); HUMS (El) m/z calcd. for C 13H 1803 [M+H] 223.1329, 
found, 223.1329. 
4'a-Methyl-hexahydro-1 'H-spirol I1,3ldioxolane-2,2'-naphthalenel-4'-carboxylic acid 
methyl ester (354) 
CO01:: D 10 01 
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8a-Methyl-3-oxo-octahydro-naphthalene-1 -carboxylic acid methyl ester (351) (8.19 g, 0.04 mol) 
and ethylene glycol (6.2 mL, 0.11 mol) were dissolved in toluene (150 mL). A catalytic amount 
of PTSA (1.41 g, 7.4 mmol, 20 mol %) was added and the resulting solution was heated at reflux 
with a Dean-Stark trap for 18 h. The reaction mixture was allowed to cool to RT and quenched 
with NaHCO, (50 niL, sat.). The aqueous phase was extracted with diethyl ether (4 x 50 mL) 
and the combined organics were washed with brine (50 mL), dried (M9SO4) and concentrated in 
vacuo to give a yellow oil. Column chromatography (Si0 2, 20 % ethyl acetate in hexanes) 
afforded the title compound (6.13 g, 65 %) as a colourless solid; m.p. 44-46 °C (ethyl 
acetate/hexanes); IR (neat)/cm' v, 1731 (C=O); 'H NMR 6 (360 M}Iz, CDC1 3) 5.45 (1H, m, 
=CH-), 3.92-3.99 (4H, m, -OCH2CH2-0), 3.67 (311, s, -0O2CH3), 2.51-2.58 (2H, m, -CH2-), 
2.09-2.17 (211, m, -CH2 -), 1.92-2.05 (2H, m, -CH2-), 1.78 (1H, ddd, J= 3.4, 3.4, 13.8 Hz, -CH-), 
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1.58-1.69 (4H, m, 2 x -Cl-I2 -), 1.13 (311, s, -CCH3); ' 3C N1'LR ö (91 MHz, CDC13) 173.8 (C), 
138.8 (C), 124.1 (CH), 108.3 (C), 64.6 (CH 2), 64.4 (CH2), 51.2 (CH3), 51.1 (CH), 41.7 (CH2), 
37.1 (CH2), 36.7 (C), 34.0 (CH2), 25.4 (CH2), 19.4 (CH3) and 18.8 (CH2); HRMS (ES+) m/z 
calcd. for C 15H2304 [M+H] 267.1591, found, 267.1590. 
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4'a-Methyl-hexahydro-1 'H-spiro[[ 1 ,3]dioxolane-2,2'-naphthalene]-4'-carboxylic acid methyl 
ester (354) (3.64 g, 0.014 mol) was dissolved in THF (50 mL) and cooled to 0°C before methyl 
lithium (21.9 mL, 0.035 mol, 1.6 M in THF) was added dropwise over 30 min. The reaction was 
allowed to warm to RT and stirred for 18 h. The solution was cooled to 0°C and quenched with 
aqueous N11 1C1 (30 mL, sat.). The aqueous phase was extracted with diethyl ether (4 x 30 mL) 
and the combined organics were washed with brine (30 mL), dried (MgSO 4) and concentrated in 
vacuo. Column chromatography (Si0 2, 30 % ethyl acetate in hexanes) afforded the title 
compound (2.87 g, 78 %) as a colourless solid; m.p. 39-41 °C (ethyl acetate/hexanes); IR 
(neat)/cm' v 1, 3398 (OH), 1643 (C=C), 1108 (C-O); 'II NMR ö (360 MHz, CDC1 3) 5.36 (111, 
m, CCF]), 3.92-3.97 (411, m, OCH2CH20), 2.47 (1H, dd, J = 2.9, 13.5 Hz, C112CII), 2.05-2.22 
(2H, m, CH2), 1.44-2.03 (911, m, 4 x CH2, 011), 1.28 (311, s, CHCCH3), 1.26 (311, s, CHCCH3), 
1.20 (3H, s, CCH3); 13C NMR (91 MHz, CDC1 3) 141.4 (C), 123.4 (CH), 108.9 (C), 75.1 (C), 
64.2 (CH2), 64.1 (CH2), 54.4 (CH), 42.6 (CH 2), 39.5 (C), 39.2 (CH 2), 34.8 (CH2), 32.0 (CH3), 
29.2 (CH3), 25.3 (CH2), 20.4 (CH3) and 19.3 (CH2); fiRMS (ES+) m/z calcd. for C 16H2703 
[M+H] 267.1955, found, 267.1956; 
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4'-Isopropenyl4'a-methyl-hexahydro-1'H-spirol 11,31 dioxolane-2,2'-naphthalenel (356) 
C0 





2-(4'a-Methyl-hexahydro- 1 'H-spiro[[ 1 ,3]dioxolane-2,2'-naphthalene]-4'-yl)-propan-2-Ol 	(355) 
(1.01 g, 3.8 mmol) was dissolved in pyridine (10 mL) and phosphorus oxychioride (1.1 mL, 
0.011 mol) was added dropwise over 10 mm. The resulting solution was stirred at RT for 18 h, 
cooled to 0°C and quenched with water (10 mL). The aqueous phase was extracted with diethyl 
ether (3 x 20 mL) and the combined organics were washed with HC1 (20 mL, 1M), NaHCO 3 (20 
mL, sat.), brine (20 mL), dried (MgSO 4) and concentrated in vacuo. Column chromatography 
(Si02, 10 % ethyl acetate in hexanes) afforded the title compound (705 mg, 75 %) as a 
colourless solid; m.p. 38-41 °C (ethyl acetate/hexanes); IR (neat)/cm' 1111 (C=C), 1092 
(C=C); 'H NMR 8 (360 MHz, CDC1 3) 5.38 (1H, m, C=CI1), 4.90 (1H, s, CCH3CH2), 4.70 (1H, 
s, CCH3CH2), 3.93-3.97 (411, m, OCH2CH20), 2.52 (1H, dtd, J= 3.2, 5.5, 13.5 Hz, CH), 2.01-
2.24 (2H, m, CH2), 2.00 (211, t, J = 13.5 Hz, CH2), 1.76 (31-1, s, CCH3CH2), 1.44-1.62 (6H, m, 3 
x CH2), 1.06 (3H, s, Cl!3); ' 3C NMR 6 (91 MHz, CDC1 3) 145.7 (C), 140.7 (C), 122.8 (CH), 
113.7 (CH2), 109.0 (C), 64.4 (CH 2), 64.2 (CH2), 51.6 (CH), 41.9 (CH2), 37.6 (C), 37.4 (CH2), 
37.0 (CH2), 25.7 (CH2), 24.1 (CH 3), 19.3 (CH3) and 18.9 (CH2); HRMS (ES+) m/z calcd. for 
C 1611250  [M+H] 249.1849, found 249.1851. 
4-Isopropenyl4a-methyl-hexahydro-3H-flaphthalefl-2-Ofle (357) 






4'-Isopropenyl-4'a-methyl-hexahydro-1 'H-spiro[[ 1 ,3]dioxolane-2,2'-naphthalene] (356) (45 mg, 
0.18 mmol) was dissolved in a mixture of acetone (3 mL) and water (0.2 mL). PTSA (7 mg; 
0.036 mmol, 20 mol %) was added and the solution was heated at reflux for 3 h. The reaction 
was allowed to cool to RT and quenched with aqueous NaHCO 3 (10 mL, sat.). The aqueous 
phase was extracted with DCM (4 x 15 mL) and the combined organics were washed with brine 
(20 mL), dried (MgSO4) and concentrated in vacuo to give a yellow oil. Column 
chromatography (Si0 2, 10 % ethyl acetate in hexanes) afforded the title compound (30 mg, 81 
%) as a colourless solid; m.p. 28-31°C (ethyl acetate/hexanes); JR (neat)/cm 1 v, 1672 (C=O); 
1 H NMR 5 (360 MHz, CDC13) 5.75 (111, s, C=CR), 5.01 (111, s, CCH 3CH2), 4.76 (111, s, 
CCH3CH2), 2.56-2.65 (211, m, CH2), 2.38-2.48 (111, m, CH), 2.24-2.33 (211, m, CH2), 1.87-1.91 
(211, m, CH2), 1.79 (311, s, CCH3CH2), 1.54-1.67 (211, m, CH2), 1.25-1.43 (211, m, CH2), 1.17 
(3H, s, CH3); 13C NMIR 6 (91 MHz, CDC1 3) 200.0 (C), 170.9 (C), 143.8 (C), 124.2 (CH), 115.4 
(CH2), 52.4 (CH), 40.0 (C), 39.7 (CH 2), 39.6 (CH2), 32.9 (Cl2), 26.7 (CH2), 23.7 (CH3), 21.8 
(CH2) and 18.1 (CH3); HRMS (ES+) m/z calcd. for C 141121 0 [M+H] 205.1587, found 205.1585. 
Hexahydro-4a-methyl-4-(prop-1-en-2-yl)-1 aH-naphtho I1-bloxiren-2(3H)-one (358) 




4Isopropenyl4a-methyl-4,4a,5,6,7,8-hexahydro-3H-naPhthalefl-2-ofle (357) (274 mg, 1.34 
mmol) was dissolved in methanol (10 mL) and hydrogen peroxide (1.0 mL, 13.4 mmol, 30% 
w/w in water) was added. The solution was cooled to 0°C and aqueous NaOH (0.7 mL, 1.0 M) 
was added dropwise over 10 min and the mixture was allowed to warm to RT and stirred for 18 
h. The reaction was quenched with water (5 mL), after which diethyl ether (15 mL) was added 
and the aqueous phase was extracted with diethyl ether (3 x 20 mL). The combined organics 
were washed with aqueous NaHCO 3 (20 mL, sat.), brine (20 mL), dried (MgSO4) and 
concentrated in vacuo to give a yellow oil. Column chromatography (Si0 2, 10 % ethyl acetate in 
hexanes) afforded the title compound (149 mg, 51 %) as a colourless solid; m.p. = 30-33 °C 
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(ethyl acetate/hexanes); Umax (neat)/cm' 1711 (C0), 889 (C=C); 'H NIMR 6 (360 MHz, CDC1 3) 
4.99 (1H, s, CCH 3CH2), 4.73 (111, s, CCH3CH2), 3.05 (1H, s, CH), 2.88 (1H, dd, J= 7.7, 11.2 
Hz, Cu), 2.39-2.35 (2H, m, CH2), 2.20-2.31 (214, m, CH2), 1.76 (3H, s, CCH3CH2), 1.50-1.71 
(6H, m, 3 x CH2), 1.05 (3H, s, CCH3); 13C NMR 8 (91 MIFIz, CDC13) 206.6 (C), 143.9 (C), 115.1 
(Cl2), 68.3 (C), 62.6 (CH), 48.8 (Cl), 39.6 (CH 2), 37.1 (C), 36.2 (CH 2), 30.1 (CH2), 24.5 
(CH3), 23.9 (CH2), 21.4 (CH2) and 15.9 (CH3); HRMS (ES+) m/z calcd. for C 14H24NO2 
[M+N114
]






358 	 359 
Hexahydro-4a-methyl-4-(prop-1 -en-2-yl)-1 aH-naphtho[ 1 -b]oxiren-2(3H)-one (358) (53 mg, 
0.24 nimol) was dissolved in ethanol (200 niL) and deoxygenated with nitrogen for 1 h. The 
solution was immersed in an ice bath and exposed to UV radiation through a Pyrex filter for 9 h 
before being concentrated in vacuo. Column chromatography (Si0 2, 10 % ethyl acetate in 
hexanes) afforded the title compound (31 mg, 58 %) as a colourless oil, along with recovered 
starting material (2 mg, 4 % recovery); JR (neat)/cm' u 3000 (0-H), 1635 (C0), 1627 
(C0), 890 (C=C); 'H NMR ö (360 MHz, CDC13) 14.36 (111, s, OR), 5.00 (1H, s, CCH 3CH2), 
4.81 (1H, s, CCH3CH2), 2.66-2.75 (1H, dd, J = 13.1, 17.0 Hz, CH), 2.53-2.62 (2H, m, CH2), 
2.34-2.42 (2H, m, CH2), 2.06-2.12 (2H, m, CH2), 1.82 (3H, s, CCH3CH2), 1.31-1.70 (411, m, 2 x 
CH2), 1.00 (3H, s, CH3); ' 3C NMR 6 (91 MIHz, CDC1 3) 203.6 (C), 182.1 (C), 142.5 (C), 119.1 
(C), 114.7 (CH2), 54.0 (Cl), 45.2 (C), 40.6 (CH2), 39.4 (CH2), 36.4 (CR2), 25.3 (CH2), 25.3 









Wilkinson's catalyst, (PPh 3)3RhC1, (34 mg; 0.037 mmol, 10 mol %) was added to a solution of 
4isopropeny14amethyl4,4a,5,6,7,8-heXahYdro-3H-flaPhthalen2one (357) (75 mg, 0.367 
mmol) in methanol (10 mL). The resulting solution was placed in a high pressure reaction vessel 
and subjected to hydrogen at 15 bar for 12 h. The solution was concentrated in vacuo and 
purified by column chromatography (Si0 2, 10 % ethyl acetate in hexanes) to afford the title 
compound (74 mg, 99 %) as a colourless solid; m.p. 40-43°C (ethyl acetate/hexanes); IR 
(neat)/cm' v 1670 (C=O); 'H NMR 6 (360 MHz, CDC13) 5.73 (1H, s, C=CR), 2.40 (1H, m, 
CH), 2.22-2.29 (2H, m, CH2), 1.98-2.12 (2H, m, CH2), 1.84-1.91 (1H, m, Cl!), 1.58-1.77 (4H, 
m, 2 x Cl!2), 1.29-1.42 (211, m, CH2), 1.16 (3H, s, CH3), 0.94 (311, d, J = 6.9 Hz, CH(CH3)2), 
0.88 (3H, d, J= 6.9 Hz, CH(CH3)2); 13C NMR 6 (91 MHz, CDC13) 200.8 (C), 171.3 (C), 124.4 
(CH), 50.7 (CH), 40.6 (C), 38.9 (CR 2), 34.6 (CH2), 32.8 (CR2), 26.9 (CH2), 24.9 (CH), 24.6 
(CH3), 21.8 (CH2), 18.6 (CH3) and 17.5 (CR3); HRMS (ES+) m/z calcd. for C 1411230 [M+H] 









339a 	 339b 
4Isopropy14amethy1-4,4a,5,6,7,8-heXahydrO-3H-flaP11tha1en20ne (339) (151 mg, 0.73 mmol) 
was dissolved in methanol (20 mL) and cooled to 0°C before CeC1 3 7H20 (411 mg, 1.67 mmol) 
and NaBH4  (29 mg, 0.75 mmol) were added. The resulting solution was stirred for 1 h at 0°C 
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and quenched with acetone (10 mL). NH 4C1 (ca. 0.5 g) was added and the solvent removed in 
vacuo. The resulting slurry was partitioned between water (15 mL) and diethyl ether (20 mL) 
and the aqueous phase was extracted with diethyl ether (5 x 20 mL). The combined organics 
were washed with brine (30 mL), dried (MgSO 4) and concentrated in vacuo to afford the title 
compound (149 mg, 98 %) as a colourless solid. The product was taken onto the next step 
without further purification. 
2,3 ,4,4a,5,6,7,8-Octahydro-4-isopropyl-4a-methylnaphthalen-2-ol (339a) (149 mg, 0.715 mmol) 
was dissolved in DCM (7 mL), cooled to 0°C and NaHCO 3 (120 mg, 0.143 mmol) was added. 
mCPBA (265 mg, 1.07 mmol) was added portionwise over 5 min and the mixture stirred for 2 h 
at 0°C. The reaction was quenched with aqueous sodium thiosulfate (10 mL, sat.) and the 
aqueous phase extracted with DCM (4 x 15 mL). The combined organics were washed with 
brine (20 mL), dried (MgSO4), and concentrated in vacuo to give a yellow oil. Column 
chromatography (Si0 2, 30 % ethyl acetate in hexanes) afforded the title compound (150 mg, 94 
%) as a colourless oil. IR (neat)/cm 1 3389 (OH); 'H NMR ö (360 MiHz, CDC13) 3.87 (1H, dd, J 
6.4, 10.6 Hz, C=CH), 3.12 (1H, s, CH), 2.59 (1H, s, OR), 1.92-2.01 (2H, m, CH2), 1.81 (1H, 
m, CH), 1.73 (1H, m, CH), 1.42-1.54 (2H, m, CH2), 1.24-1.41 (4H, m, 2 x CH2), 1.07-1.18 (2H, 
m, CH2), 1.01 (311, s, CH3), 0.85 (3H, d, J = 6.6 Hz, CH(CH3)2), 0.78 (3H, d, J = 6.6 Hz, 
CH(CH3)2); '3C NMR 6 (91 MHz, CDC1 3) 70.4 (CH), 67.5 (C), 66.7 (CH), 51.3 (CH), 39.7 
(CH2), 36.3 (C), 32.3 (CH 2), 25.8 (CH2), 25.4 (CH), 24.9 (CH 2), 24.4 (CH3), 21.1 (CH2), 18.5 
(CH3) and 16.3 (CH3). 





Octahydro-4-isopropyl4a-methyl-1 aH-naphtho[ 1 -b]oxiren-2-ol (339b) (150 mg, 0.67 mmol) 
was dissolved in DCM (10 mL), cooled to 0°C and PDC (572 mg, 1.47 mmol) was added 
portionwise over 10 mm. The resulting solution was allowed to warm to RT and stirred for 18 h 
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before being filtered through silica, washed with DCM (2 x 20 mL) and concentrated in vacuo to 
give a yellow oil. Column chromatography (Si0 2, 10 % ethyl acetate in hexanes) afforded the 
title compound (132 mg, 89 %, 25:1 d.r.) as a colourless oil; IR (neat)/cm' 1718 (CO); 
1 
NMR ö (360 MHz, CDC1 3) 3.05 (1H, s, CHCO), 2.74 (1H, dd, J = 7.2, 12.3 Hz, Cl]), 1.68-
2.07 (61-1, m, 3 x CH2), 1.21-1.62 (411, m, 2 x CH2), 1.18 (31-1, s, CH3), 0.86 (3H, d, J = 6.9 Hz, 
CH(CH3)2), 0.82 (311, d, J = 6.9 Hz, CH(CH3)2); 13C NMR (91 MHz, CDC13) 209.8 (C), 72.9 
(C), 65.3 (CH), 55.8 (CH), 39.5 (CH2), 37.8 (C), 33.6 (CH 2), 32.1 (CH2), 26.3 (CH), 24.6 (CH 2), 
24.0 (CH3), 20.9 (CH2), 18.3 (CH3) and 16.5 (CH3); HRMS (ES+) m/z calcd. for C 1417126NO2 
[M+NB4] 240.1958, found 240.1959. 
8Hydroxy_3isopropy1_3amethyI3,3a,4,5,6,7-heXahYdrO-2H-azUlene 40ne (338) 
0 OH 
O'~~ P 





4-Isopropyl-4a-methyl-hexahydro-1 -oxa-cyclopropa[d]naphthalen-2-one (360) (52 mg, 0.23 
mmol) was dissolved in ethanol (200 inL) and deoxygenated with nitrogen for 1 h. The solution 
was immersed in an ice bath and exposed to UV radiation through a Pyrex filter for 9 h before 
being concentrated in vacuo. Column chromatography (Si0 2, 10 % ethyl acetate in hexanes) 
afforded the title compound (29 mg, 56 %) as a colourless solid along with recovered starting 
material (12 mg, 23 %); m.p. 44-47 °C (ethyl acetate/hexanes); IR (neat)/cm' v,, 1613 (C=O); 
'H NMR ö (360 MHz, CDC13) 14.52 (111, s, OH), 2.59 (111, m, Cl]), 2.23-2.46 (211, m, CH2), 
2.10-2.40 (211, m, CH2), 1.85 (1H, m, Cl]), 1.20-1.80 (61-1, m, 3 x CH2), 1.09 (311, s, CH3), 1.02 
(31-1, d, J = 6.7 Hz, CH(CH3)2), 0.92 (311, d, J = 6.7 Hz, CH(CH3)2); '3C NMR 8 (91 MHz, 
CDC13) 202.5 (C), 183.2 (C), 120.5 (C), 53.5 (CH), 44.8 (C), 41.3 (CH 2), 39.7 (CH2), 36.8 
(CH2), 28.5 (CH), 25.3 (CH2), 25.2 (CH 2), 24.0 (CH3), 22.3 (CH3) and 17.9 (CH3); HRMS (El) 
m/z calcd. for C 141-12202 [M] 222.1614, found 222.1614. 
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Trifluoromethanesulfonic acid 1isopropyI-8a-methy1-3-oxo-octahydro-azuIefl-4-YI-eSter 
(338a) 





8-Hydroxy-3-isopropyl-3a-methyl-3 ,3a,4,5,6,7-hexahydro-2H-azulene- 1-one (338) (50 mg, 0.23 
mmol) was dissolved in DCM (5 mL), cooled to 0 °C and DIPEA (78 id, 0.45 mmol) was added. 
Trifluoromethansulfonic anhydride (56 p.1, 0.34 mmol) was added dropwise and the resulting 
solution was stirred for 1 h at 0°C. The reaction was quenched with water (5 ML) and the 
aqueous phase was extracted with DCM (4 x 5 mL). The combined organics were washed with 
brine (10 mL), dried (MgSO 4) and concentrated in vacuo. Column chromatography (Si0 2, 10 % 
ethyl acetate in hexanes) afforded the title compound (68 mg, 86 %) as a yellow oil; IR 
(neat)/cm' v ma,, 1687 (C=O), 1427 (S=O), 1208 (C-F), 1142 (S=O); 'H NMR 8 (360 MHz, 
CDC13) 2.43-2.66 (4H, m, 2 x CH2), 1.71-2.02 (611, m, 2 x CH2 , 2 x CH), 1.47-1.64 (2H, m, 
CH2), 1.22 (311, s, CH3), 1.00 (311, d, J = 6.4 Hz, CH(CH3)2), 0.91 (311, d, J = 6.4 Hz, 
CH(CH3)2); 13C NMR (91 MHz, CDCI,) 199.2 (C), 150.7 (C), 138.0 (C), 113.0-123.6 (CF 3), 
58.3 (CH), 47.6 (C), 44.0 (CH 2), 41.3 (CH2), 34.7 (CR2), 28.4 (CH), 24.6 (CH 2), 24.2 (CR2), 








To a solution of trifluoromethanesulfonic acid 1-isopropyl-8a-methyl-3-oxo-1,2,3,5,6,7,8,8a 
octahydro-azulen-4-yl-ester (338a) (65 mg, 0.18 mmol) in DMF (3 mL) was added palladium 
acetate (cat.), triphenyiphosphine (cat.), TEA (76 j.il, 0.55 mmol) and formic acid (14 tl, 0.37 
mmol) and the resulting solution was heated at 60°C for 16 h. The mixture was allowed to cool 
to RT, filtered through Si0 2, washed with ethyl acetate (2 x 20 mL) and concentrated in vacuo to 
give a yellow oil. Column chromatography (Si0 2, 10 % ethyl acetate in hexanes) afforded the 
title compound (29 mg, 76 %) as a colourless oil; IR (neat)/cm -1 v,.x 1671 (C=O); 'H NMR ö 
(360 MHz, CDC1 3) 6.78 (111, dd, J = 2.4, 3.3 Hz, CCH), 2.61 (1H, m, CH), 2.41-2.54(211, m, 
CH2), 2.04-2.13 (2H, m, CH2), 1.92 (1H, m, CH), 1.61-1.72 (411, m, 2 x CH2), 1.38-1.51 (211, m, 
CH2), 1.14 (311, s, CH3), 1.00 (311, d, J = 6.6 Hz, CH(CH3)2), 0.92 (3H, d, J = 6.6 Hz, 
CH(CH3)2); 13C NrwIR (91 M1Hz, CDC13) 200.7 (C), 152.6 (C), 141.0 (CH), 58.3 (CH), 47.9 
(C), 43.9 (CH2), 41.6 (CH2), 34.8 (CH2), 28.9 (CH), 25.4 (CH2), 25.0 (CH2), 23.4 (CH3), 22.5 
(CH3) and 17.7 (CH3). 
'H NMR data in agreement with literature. 30 
1-Isopropyl-8a-methyl-3-oxo-octahydro-flaPhthalefl-2-Yl acetate (363) 
ow ACO"92J 
339 	 363 
4Isopropyl-4a-methyl-hexahydro-3H-flaPhthalen-2-Ofle (339) (534 mg, 2.58 mmol) and 
Mn(OAc)3  (2.00 g, 7.05 mmol) in benzene/acetic acid (10:1) (55 mL) was heated at reflux with a 
Dean-Stark trap for 24 h. The reaction was filtered through silica, washed with DCM (2 x 30 
mL) and concentrated in vacuo to yield a yellow oil. Column chromatography (5i0 2, 5 % ethyl 
acetate in hexanes) afforded the title compound (563 mg, 87 %, 6:1 d.r.) as a colourless solid; 
m.p. 79-81 °C (ethyl acetate/hexanes); IR (neat)/cm' v,,, ax 1745 (C=O), 1643 (C=O); 'H NMR 
(360 MIHz, CDC1 3) major diastereoisomer 5.79 (111, s, C=CR), 5.76 (114, d, J = 1.9 Hz, 
CHCO2Me), 2.52-2.35 (3H, m, CH2, CH), 2.18 (3H, s, COCH3), 2.15-1.93 (2H, in, CH2), 1.99-
1.85 (311, m, CH2, CH), 1.71-1.62 (211, m, CH2), 1.41 (311, s, CH3), 1.06 (3H, d, J = 2.5 Hz, 
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CH(CH3)2), 1.02 (3H, d, J= 2.5 Hz, CH(CH3)2); ' 3C NMR 6 (91 MHz, CDC1 3) 195.3 (C), 173.6 
(C), 170.5 (C), 124.3 (C), 74.8 (CH), 54.6 (CH), 42.5 (CH2), 39.7 (CH), 34.4 (CH2), 30.6 (CH2), 
27.1 (CH2), 26.0 (CH3), 22.6 (CH3), 22.0 (CH), 20.7 (CH3) and 19.0 (CH3); minor 
diastereoisomer diagnostic peaks: 'H N1\'LR 6 (360 MHz, CDC1 3) 5.45 (1H, s, CCH), 5.40-5.38 
(1H, d, J= 6.1 Hz, CHCO2Me), 2.03 (3H, s, COCH3), 1.23 (3H, s, CH3), 0.97 (3H, d, J= 2.5 Hz, 
CH(CH3)2), 0.92 (3H, d, J= 2.5 Hz, CH(CH3)2); ' 3C NMR 6 (91 MHz, CDC1 3) 194.3 (C), 171.2 
(C), 169.4 (C), 122.8 (C), 72.6 (CH), 53.2 (CH), 43.2 (CH 2), 41.5 (CH), 39.7 (CH 2), 33.6 (CH2), 
29.0 (CH2), 26.6 (CH3), 22.2 (CH3), 22.0 (CH), 20.9 (CH 3) and 19.0 (CH3); HRMS (ES) m/z 
calcd. for C 16H28NO3 [M+N}L] 282.2064, found 282.2066. 
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Experimental Procedures for Chapter 3. 
Preparation of catalyst (369) 
Qs 
_ - 
BU_çOH HO1 )_tBu 	 BUt_(I 





In a flame-dried round-bottomed flask (R,R)-NN'-bis(3,5-di-t-butylsalicylidene)- 1,2-
cyclohexanediamine (1.71 g, 3.14 mmol) was suspended in a mixture of acetonitrile (10 mL) and 
toluene (3.3 mL). Trimethylaluminum (1.57 mL, 3.14 mmol, 2.0 M in toluene) was added 
dropwise and the mixture stirred at RT for 30 min and at reflux for 5 h. After cooling to RT 
water (57 tL, 3.16 mmol) was added dropwise and the resulting mixture heated at refiux for 15 
h. After cooling to RT acetonitrile (25 mL) was added and the mixture filtered through Celite 
and washed with acetonitnle (200 mL). The filtrate was discarded, and the Celite washed with 
DCM (125 mL) and concentrated in vacuo to yield aluminium complex 369 (1.21 g, 80 %) as a 
pale yellow solid; m.p. = >300°C (DCM); lit." >300°C; 'H NMR (360 MHz, d12-cyclohexane), 
7.99 (211, s, HC=N), 7.55 (2H, s, HC=N), 7.45 (2H, s, ArH), 7.21 (211, s, ArM), 6.97 (2H, s, 
ArH), 6.76 (2H, s, ArM), 3.34-3.29 (211, m, CHN=C), 2.68-2.64 (2H,m, CHN'C), 2.27-2.26 
(211, m, (CH2)4), 1.85-1.82 (211, m, (CH2)4), 1.56-1.12 (811, m, (CH2)4), 1.50 (811, s, C(CH3)3), 
1.31 (911, s, C(CH3)3), 1.24 (911, s, C(CH3)3), 1.12 (9H, s, C(CH3)3), 0.99-0.96 (211, m, (CH2)4), 
0.80-0.78 (211, m, (CH2)4). 
1 11 NMIR data in agreement with literature. 72 
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Dimethyl 2-cyanoheptanedioate (377) 
CO2Me 	 CO2Me 
	
NC 	
+ Br COM 	
NC CO2Me 
377 
Methyl-5-bromovalerate (1.6 mL, 11.3 mmol) was added dropwise to a solution of methyl-
cyanoacetate (1.0 mL, 11.3 mmol) and DBU (1.7 mL, 11.3 mmol) in benzene (20 mL) at 0°C. 
The mixture was allowed to warm to RT and stirred for 18 h. The reaction was filtered and the 
filtrate was partitioned between diethyl ether (10 mL) and aqueous N}Cl (10 mL, sat.). The 
aqueous phase was extracted with diethyl ether (3 x 10 ML) and the combined organics were 
washed with brine (30 mL), dried (MgSO 4) and concentrated in vacuo. Column chromatography 
(10 % ethyl acetate in hexanes) afforded the title compound (1.56 g, 65 %) as colourless oil; IR 
(neat)/cm - ' 2236 (CN), 1725 (C=O); 'H NMIR 6 (360 MHz, CDC1 3) 3.82 (311, s, CO2CH3), 
3.68 (3H, s, CO2CH3), 3.52 (1H, t, J= 6.9 Hz, CNCHCH2), 2.34 (2H, t, J= 7.3 Hz, CH2CO2Me), 
2.00-1.93 (211, m, CHCH2), 1.69-1.63 (2H, m, CH2CH2CO2Me), 1.58-1.52 (2H, m, CHCH 2CH2); 
' 3C NMR 6 (91 MHz, CDC13) 173.5 (C), 166.4 (C), 116.2 (C), 53.4 (CH 3), 51.6 (CR3), 37.1 











Potassium carbonate (3.13 g, 22.7 mmol) was added to a solution of 4-bromo- 1 -hexene (386) 
(2.3 mL, 22.7 mmol) and malononitrile (366) (3.00 g, 45.4 mmol) in acetonitrile (30 mL). The 
resulting suspension was stirred at RT for 16 h, after which it was partitioned between water (20 
mL) and diethyl ether (20 mL) and the aqueous phase extracted with diethyl ether (3 x 20 mL). 
The combined organics were washed with brine (20 mL), dried (MgSO 4) and concentrated in 
vacuo to give a yellow oil. Column chromatography (Si0 2, 10 % ethyl acetate in hexanes) 
afforded the title compound (1.69 g, 62 %) as a colourless oil: IR (neat)/cm' 2248 (CN), 
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1641 (C=C); 'H NMR S (360 MIHz, CDC1 3) 5.75 (111, tdd, J= 7.1, 10.2, 17.0 Hz, HC=CH 2), 
5.22 (111, ddd,J= 1.2, 2.5, 17.0 Hz, C=CH2), 5.19(1H, ddd,J= 1.2, 2.5, 10.2 Hz, C=CH2), 3.75 
(1H, t, J= 7.1 Hz, (CN) 2CH), 2.40 (2H, q, J = 7.1 Hz, (CN')2CHCH2), 2.15 (2H, q, J = 7.1 Hz, 
CH2CH=CH2); 13C NMR 5 (91 MHz, CDC13) 133.7 (CH), 118.8 (CH 2), 112.4 (C), 112.4 (C), 











292 	 387 
	
388 
R,R-Catalyst 369 (49 mg, 0.042 mmol, 1 mol %) was added to a solution of 5-methyl-hex-3-en-
2-one (292) (712 mg, 6.35 mmol) and 2-(but-3-enyl)malonomtrile (387) (503 mg, 4.19 mmol) in 
cyclohexane (10 mL) and the resulting solution was stirred at RT for 16 h. The solvent was 
removed in vacuo and the yellow residue was purified by column chromatography (Si0 2, 20 % 
hexanes in DCM) to afford the title compound (962 mg, 99 %, 57% e.e.") as a colourless oil; 
laiD = +10.3 0 (c 0.97, CHC13); IR (neat)/cm - ' u,., 2246 (CN), 1720 (C0), 1643 (C=C); 'H 
NMR 5 (360 MIHz, CDC1 3) 5.78 (111, tdd, J = 6.5, 10.2, 16.8 Hz, HC=CH 2), 5.16-5.07 (211, m, 
CCH2), 2.74 (211, ddd, J = 11.4, 5.1 Hz, COCH2CH-), 2.55-2.37 (3H, m, CHCH2CO-), 2.32 
(1H, dq, J = 6.8, 3.1 Hz, CH(CH3)2), 2.25 (3H, s, CH3CO), 2.00-1.81 (211, m, CH2CHCH2), 
1.04 (3H, d, J= 6.8 Hz, CH(CH3)2), 0.90 (311, d, J= 6.8 Hz, CH(CH3)2); '3C NMR 5 (91 MHz, 
CDC13) 204.5 (C), 134.5 (CH), 117.1 (CH 2), 115.4 (C), 114.9 (C), 43.0 (CH), 41.3 (C), 39.9 
(CH2), 36.2 (CH2), 29.9 (CH,), 29.7 (CH 2), 29.4 (CH), 21.7 (CR 3) and 16.4 (CH3); HUMS 
(ES+) m/z calcd. for C 14H24N30 [M+NH4] 250.1914, found 250.1915. 
enantiomeric excess was determined by chiral HPLC analysis of compound 391. 
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PTSA (cat.) was added to a solution of 2-(but-3-enyl)-2-((R)-2-methyl-5-oxoheXafl-3-
yl)malononitrile (388) (498 mg, 2.14 mmol) and ethylene glycol (0.3 mL, 5.34 mmol) in toluene 
(25 mL) and the resulting solution was heated at reflux with a Dean-Stark trap for 16 h. The 
solution was allowed to cool to RT, quenched with aqueous NaHCO 3 (10 mL, sat.) and the 
aqueous phase extracted with diethyl ether (3 x 10 mL). The combined organics were washed 
with brine (10 mL), dried (M9SO4) and concentrated in vacuo. Column chromatography (Si0 2, 
10 % ethyl acetate in hexanes) afforded the title compound (514 mg, 87 %) as a colourless oil; 
laiD = +16.2° (c 0.99, CHC1 3); IR (neat)/cm- ' uma,. 2242 (Ca-:N), 1642 (C=C), 1043 (C-O); 'H 
NMR 8 (360 MHz, CDC1 3) 5.84 (111, ddd, J = 6.4, 10.2, 17.0 Hz, HC=CH2), 5.15 (1H, dq, J 
17.0, 1.5 Hz, C=CH2), 5.09 (111, dq, J = 10.2, 1.5 Hz, C=CH2), 3.99-3.93 (4H, m, O(CH2)20), 
2.48-2.24 (411, m, CH2), 2.07-1.92 (311, m, CH, CH2), 1.83 (1H, m, Cl]), 1.34 (3H, s, CH3), 1.09 
(311, d, J = 6.9 Hz, CH(CH3)2), 1.05 (311, d, J = 6.9 Hz, CH(CH3)2); ' 3C NMR 8 (91 MHz, 
CDC13) 135.1 (CH), 116.6, (CH2), 116.0 (C), 115.8 (C), 108.3 (C), 64.5 (CH2), 64.3 (CH2), 43.8 
(CH), 41.8 (C), 36.5 (CH 2), 35.5 (CH2), 31.2 (CH), 29.7 (CH 2), 24.5 (CH3), 21.2 (CH3) and 17.6 
(CH3); HRMS (ES+) m/z calcd. for C 161125N202 [M+H] 277.1911, found 277.1910. 
(390) 
[ -0 
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2-(But-3-enyl)-2-((R)-3-methyl-1 -(2-methyl-i ,3-dioxolan-2-yl)butan-2-yl) malononitrile (389) 
(133 mg, 0.48 mmol) was dissolved in diethyl ether (10 mL) and cooled to -78°C before 
DIBAL-H (0.72 mL, 0.72 mmol, 1M toluene) was added dropwise over 10 mm. The reaction 
was stirred for 30 min at -78°C and then acetic acid (5 mL, 6 % aq. sol.) was added. The 
resulting solution was allowed to warm to RT and stirred for 20 mm. The aqueous phase was 
extracted with diethyl ether (3 x 10 mL) and the combined organics were washed with water (20 
mL), NaHCO3 (20 mL, sat.), brine (20 mL), dried (MgSO 4) and concentrated in vacuo to give a 
yellow oil. Column chromatography (Si0 2, 20 % ethyl acetate in hexanes) afforded the title 
compound (97 mg, 75 %, 10:1 d.r.) as a colourless oil; lai D = +12.0° (c 0.50, CHC13); IR 
(neat)/cm' u ma,, 2240 (CN), 1731 (C=O), 1643 (C=C), 1044 (C-O); 1 H NMR 8 (360 MHz, 
CDC13) major diastereoisomer: 9.33 (111, s, CHO), 5.76 (1H, ddd, J = 6.3, 10.3, 16.9 Hz, 
HC=CH2), 5.10-5.01 (2H, m, C=CH2), 4.00-3.88 (4H, m, O(CH2)20), 2.31-2.16 (211, m, CH2), 
2.07-1.82 (6H, m, 2 x CH2, 2 x CH), 1.32 (3H, s, CH3C), 0.97 (611, d, J = 6.9 Hz, 2 x 
CH(CH3)2); 13C NMR 5 (91 MHz, CDC13) 194.9 (CH), 136.2 (CH), 118.5 (C), 116.1 (CH 2), 
108.6 (C), 64.4 (CH 2), 64.4 (CH2), 58.7 (C), 42.5 (CH), 35.7 (CH 2), 32.2 (CH2), 31.2 (CH), 29.0 
(CH2), 24.6 (CR3), 21.5 (CH3) and 18.4 (CU3); minor diastereoisomer diagnostic peaks: 1 H 
NMR 6 (360 MHz, CDC13) 9.25 (111, s, CHO), 1.27 (3H, s, CH3C), 1.02 (31-1, d, J = 6.9 Hz, 
CH(CH3)2), 0.93 (311, d, J = 6.9 Hz, CH(CH3)2); 13C NMR 6 (91 MHz, CDC13), 194.7 (CH), 
136.1 (CH), 119.3 (C), 116.3 (CH 2), 109.1 (C), 64.0 (CH 2), 64.0 (CR2), 57.6 (C), 40.4 (CH), 
34.9 (CR2), 32.5 (CH2), 31.2 (CH), 29.1 (CR2), 24.2 (CR3), 21.9 (CH3) and 16.6 (CH3); HRMS 










PTSA (cat.) was added to a solution of(R)2formyl.2((R)3-methyl-1-(2-methyl-1,3-diOxOlan- 
2-yl)butan-2-yl)hex-5-enenitrile (390) (33 mg, 0.12 mmol) in a mixture of acetone (5 mL) and 
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water (0.2 mL). The resulting solution was heated at reflux for 2 h, allowed to cool to RT and 
concentrated in vacuo. The residue was partitioned between diethyl ether (10 mL) and NaHCO 3 
(10 mL, sat.) and the aqueous phase was extracted with diethyl ether (3 x 10 mL). The combined 
organics were washed with brine (20 mL), dried (MgSO 4) and concentrated in vacuo to afford 
the title compound (28 mg, 100 %) as a yellow oil. The product was taken on to the next step 
without further purification. 
CSA (cat.) was added to a solution of (R)-2-formyl-2-((R)-2-methyl-5-oxohexan-3-yl)heX-5-
enenitrile (390a) (28 mg, 0.12 mmol) in toluene (5 mL) and the resulting solution was heated at 
reflux with a Dean-Stark trap for 16 h. The reaction was allowed to cool to RT, quenched with 
NaHCO3 (5 mL, sat.) and the aqueous phase was extracted with diethyl ether (3 x 5 mL). The 
combined organics were washed with brine (10 mL), dried (M9SO 4) and concentrated in vacuo. 
Column chromatography (Si0 2, 10 % ethyl acetate in hexanes) afforded the title compound (18 
mg, 69 % over two steps, 10:1 d.r.) as a colourless oil; MD 25 = -32.00 (c 0.25, CHC13); IR 
(neat)/cm' u, 2236 (CN), 1686 (C=O); 'II NMR 5 (360 MHz, CDC13) major diastereoisomer: 
6.88 (1H, d, J= 10.2 Hz, COCH=CR), 6.10 (1H, d, J= 10.2 Hz, COCHCH), 5.82 (111, ddd,J 
= 6.5, 10.2, 16.8 Hz, HC=CH2), 5.15-5.05 (2H, m, C=CH2), 2.60-2.20 (5H, m, 2 x CH2, CH), 
2.13-1.99 (2H, m, CH2), 1.82 (11-1, m, CH), 1.13 (311, d, J= 6.9 Hz, CH(CH3)2), 0.96 (3H, d, J= 
6.7 Hz, CH(CH3)2); 13C NMR 5 (91 MHz, CDC13) 196.7 (C), 147.5 (CH), 136.2 (CH), 129.7 
(CH), 121.6 (C), 116.4 (CH 2), 47.0 (CH), 42.6 (C), 35.3 (CH2), 32.3 (CH2), 29.5 (CH2), 28.7 
(CH), 23.1 (CH3) and 19.5 (CH3); minor diastereoisomer diagnostic peaks: 1 H N1%'IR 5 (360 
MHz, CDC13) 6.73 (11-1, d, J = 10.0 Hz, COCHCH), 6.12 (111, d, J = 10.0 Hz, COCH=CH), 
1.04 (3H, d, J= 6.8 Hz, CH(CH3)2), 1.01 (3H, d, J= 7.0 Hz, CH(CH 3)2); ' 3C NMR 5 (91 MHz, 
CDC13) 197.4 (C), 146.6 (CH), 135.9 (CH), 130.7 (CH), 121.6 (C), 119.3 (CH 2), 45.5 (CH), 41.2 
(C), 35.9 (CH2), 35.3 (CH), 28.4 (CH2), 27.7 (CH), 22.8 (CH 3) and 17.0 (CH3); HRMS (El) m/z 
calcd. for C 14}118N0 [M-H] 216.1383, found 216.1380. Chiral HPLC Chiralpak AD-H 
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Potassium carbonate (570 mg, 4.12 mmol) was added to a solution of malonomtrile (366) (416 
mg, 6.30 mmol) in acetonitrile (30 mL). Benzyl 4-bromobutyl ether (399) (1.13 g, 4.18 mmol) in 
acetonitrile (5 mL) was added dropwise and the resulting solution was stirred for 16 h at RT. The 
reaction was quenched with water (30 mL) and the aqueous phase was extracted with DCM (3 x 
20 mL). The combined organics were washed with brine (30 mL), dried (MgSO 4) and 
concentrated in vacuo. Column chromatography (Si0 2, 10-20 % ethyl acetate in pentane) 
afforded the title compound (628 mg, 67 %) as a colourless oil; IR (neat)/cm' u na., 2253 (CN), 
1101 (C-O); 'H NMR 8 (360 MHz, CDC13) 7.39-7.28 (5H, m, C6115), 4.50 (2H, s, OCH2Ph), 
3.75 (1H, t, J = 7.0 Hz, CH(CN)2), 3.51 (2H, t, J = 5.7 Hz, CHCH2), 2.09-2.03 (211, m, CH2), 
1.79-1.66 (4H, m, 2 x CH2); 13C NMR 6 (91 MHz, CDC1 3) 138.1 (C), 128.5 (CH), 128.5 (CH), 
127.8 (CH), 127.7 (CH), 127.7 (CH), 112.5 (C), 112.5 (C), 73.2 (CH 2), 69.3 (CH2), 30.6 (CH2), 
28.3 (CH2), 23.8 (CH2) and 22.5 (CH); HRMS (ES+) m/z calcd. for C 14H16N2ONa [M±Na] 
251.1155, found 251.1162. 
2(4_(Benzyloxy)buty1)2((R)-2-methyl-5-OXOheXafl-3-Y1)ma1011011ifrile (401) 
0 
+ 	CN ('0Bn 
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R,R-catalyst 369 (33 mg, 0.028 mmol, 1 mol %) was added to a solution of 5-methyl-3-hexen-2-
one (292) (421 mg, 3.75 mmol) and 2-(4-(Benzyloxy)butyl)malononitrile (400) (628 mg, 2.75 
mmol) dissolved in cyclohexane (10 mL) and the resulting solution was stirred at RT for 16 h. 
The solvent was removed in vacuo and the yellow residue was purified by column 
chromatography (Si02, 20 % ethyl acetate in hexanes) to afford the title compound (904 mg, 96 
159 
Experimental 
%) as a yellow oil; laiD = 4•90 (c 0.81, CHC1 3); IR (neat)/cm' U )( 2246 (CN), 1717 (C0), 
1101 (C-O); 'H NMR ö (360 MFIz, CDC1 3) 7.39-7.28 (511, m, C 6H5), 4.51 (2H, s, OCH2Ph), 
3.51 (211, t, J= 6.1 Hz, CHCH2-), 2.76-2.69 (2H, m, CH2) 2.50 (111, dd, J= 5.8, 20.1 Hz, CH), 
2.30 (111, dsept,J= 6.8, 3.1 Hz, CH(CH3)2), 2.23 (311, s, CH3), 1.91-1.63 (6H, m, 3 x CH2), 1.05 
(3H, d, J = 6.8 Hz, CH(CH3)2), 0.90 (311, d, J = 6.8 Hz, CH(CH3)2); '3C NMR 8 (91 MHz, 
CDC13) 204.6 (C), 138.2 (C), 128.4 (CH), 128.4 (CH), 127.7 (CH), 127.7 (CH), 127.6 (CH), 
115.7 (C), 115.1 (C), 73.0 (CH 2), 69.4 (Cl2), 43.0 (CH), 41.8 (C), 40.0 (CH 2), 36.8 (CH2), 30.0 
(CH3), 29.4 (CH), 28.8 (CH2), 22.8 (CH2), 21.8 (CH3) and 16.5 (CH3); HRMS (ES+) m/z calcd. 
for C21 1128N202Na [M+Na] 363.2043, found 363.2021. 
2(4_(BenzJoxy)buty1)2((R)-3-methYl-1-(2-methYl-1,3-di0X01an-2Y1)bUtafl2 
yl)malononitnle (402) 
CN 	OBn 	 CN r-' OBn 
401 	 402 
PTSA (cat.) was added to a solution of 2-(4-(benzyloxy)butyl)-2-((R)-2-methyl-5-oxohexan-3-
yl)malononitrile (401) (872 mg, 2.56 mmol) and ethylene glycol (0.45 mL, 8.07 mmol) in 
toluene (30 mL) and the resulting solution was heated at reflux with a Dean-Stark trap for 16 h. 
The solution was allowed to cool to RT, quenched with NaHCO 3 (20 ML, sat.) and the aqueous 
phase was extracted with diethyl ether (3 x 20 mL). The combined organics were washed with 
brine (20 inL), dried (MgSO4) and concentrated in vacuo. Column chromatography (Si0 2, 20 % 
ethyl acetate in hexanes) afforded the title compound (732 mg, 74 %) as a yellow oil; [a]D25 = 
+10.90 (c 0.55, CHC13); IR (neat)/cm' u na., 2246 (CN), 1105 (C-O), 1043 (C-O); 'H NMIR 
(360 MHz, CDC13) 7.35-7.27 (5H, m, C6H5), 4.51 (2H, s, OCH2Ph), 3.94-3.85 (411, m, 
O(CH2)20), 3.51 (2H, dt, J = 1.9, 6.0 Hz, CH2), 2.33 (1H, dsept, J = 7.0, 2.7 Hz, CH(CH3)2), 
2.18 (111, m, CH), 2.04-1.70 (8H, m, 4 x CH2), 1.31 (3H, s, CH3), 1.08 (311, d, J = 7.0 Hz, 
CII(CH3)2), 1.04 (3H, d, J = 7.0 Hz, CII(CH3)2); 13C NMIR (91 MHz, CDC1 3) 138.4 (C), 128.4 
(CII), 128.4 (CH), 127.7 (CH), 127.7 (CH), 127.6 (CH), 116.2 (C), 116.0 (C), 108.3 (C), 73.1 
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(CH2), 69.6 (CH2), 64.5 (CH2), 64.3 (CH2), 43.5 (CH'), 42.2 (C), 37.2 (CH2), 35.6 (CH2), 31.2 
(CH), 29.1 (CH 2), 24.5 (CH3), 22.7 (CH2), 21.2 (CH3) and 17.7 (CH3); HRMS (ES+) m/z calcd. 









R,R-catalyst 369 (231 mg, 0.2 minol, 1 mol %) was added to a solution of 5-methyl-3-hexen-2-
one (292) (4.49 g, 0.04 mol) and malonomtrile (366) (1.32 g, 0.02 mol) dissolved in cyclohexane 
(100 mL). The resulting solution was stirred at RT for 16 h and concentrated in vacuo to afford a 
yellow oil. Column chromatography (Si0 2, 20 % ethyl acetate in hexanes) afforded the title 
compound (3.20 g, 90 %, 97% e.e.") as a yellow oil; MD 25 = +48.4° (c 0.99, CHC1 3); IR 
(neat)/cm' u,,, 2245 (CN), 1712 (C=O); 'H NMR (360 MHz, CDC13) 4.26 (1H, d, J= 5.2 Hz, 
CH(CN) 2), 2.78-2.61 (21-1, m, CH2), 2.52 (1H, dsept, J = 6.8, 1.2 Hz, CH(CH3)2), 2.25 (3H, s, 
CH3), 2.10 (1H, m, CH), 1.04 (3H, d, J = 6.8 Hz, CH(CH3)2), 1.01 (3H, d, J = 6.8 Hz, 
CH(CH3)2); '3C NMR ö (91 MHz, CDC13) 205.9 (C), 112.2 (C), 112.2 (C), 40.8 (CH 2), 40.0 
(CH), 30.3 (CH,), 29.7 (CH), 25.3 (CH), 20.8 (CR 3) and 18.1 (CH3); HRMS (ES-) m/z calcd. for 
C 10H130N2 [M-H] 177.1033, found 177.1032. 
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PTSA (cat.) was added to a solution of (R)-2-(2-methyl-5-oxohexan-3-yl)-malononitnle (403) 
(1.53 g, 8.57 mmol) and ethylene glycol (1.4 mL, 25.10 mmol) in toluene (30 mL) and the 
resulting solution was heated at reflux with a Dean-Stark trap for 16 h. The solution was allowed 
to cool to RT, quenched with aqueous NaHCO, (20 mL, sat.) and the aqueous phase was 
extracted with diethyl ether (3 x 20 mL). The combined organics were washed with brine (30 
rnL), dried (MgSO4) and concentrated in vacuo to give a yellow oil. Column chromatography 
(Si02, 20 % ethyl acetate in hexanes) afforded the title compound (1.79 g, 94 %) as a yellow oil; 
lala = +33.1° (c 1.03, CHC1 3); IR (neat)/cm' Umax 2245 (CN), 1043 (C0); 'H NMR 8 (360 
MIHz, CDC13) 4.56 (111, d, J = 3.8 Hz, CH(CN) 2), 3.98-3.96 (4H, m, O(CH2)20) 9  2.15-2.04 (2H, 
m, 2 x Cl]), 1.93-1.76 (2H, m, CH2), 1.32 (3H, s, CH3), 1.07 (3H, d, J= 6.6 Hz, CH(CH3)2), 1.03 
(3H, d, J = 6.6 Hz, CH(CH3)2); 13C NMRS (91 MHz, CDC13) 113.3 (C), 112.7 (C), 109.0 (C), 
64.7 (CH2), 64.2 (CH2), 40.8 (CH), 35.7 (CH2), 30.6 (CH), 25.8 (CH), 23.7 (CH3), 21.2 (CH3) 
and 17.8 (CH3); HRMS (ES+) m/z calcd. for C 12H19N202 [M+H] 223.1441, found 223.1438. 
2_Methyl_2_((R)_3 -methyl_1 -(2-methyl-1,3-dioxolafl-2-yl)bfltafl-2-Yl)malOfloflitrile (410) 
1 -0 
CN 	 CN 






Potassium carbonate (552 mg, 3.99 mmol) was added to a solution of 2#R)-3-methyl- l-(2- 
methyl-1 ,3-dioxolan-2-yl)butan-2-yl)malononitrile (409) (886 mg, 3.99 mmol) and methyl 
iodide (0.50 mL, 8.03 mmol) dissolved in acetomtrile (20 mL) and the resulting suspension was 
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heated at reflux for 18 h. The reaction was allowed to cool to RT, quenched with water (10 mL) 
and the aqueous phase was extracted with DCM (3 x 10 mL). The combined organics were 
washed with brine (20 mL), dried (MgSO4) and concentrated in vacuo. Column chromatography 
(Si02, 20 % ethyl acetate in hexanes) afforded the title compound (807 mg, 86 %) as a pale 
yellow solid; m.p. = 59-61 °C (ethyl acetate/hexanes); MD 25 = +11.5° (c 1.04, CHC13); IR 
(neat)/cm' u ma,, 2246 (CN), 1047 (C-O); 'H NM.R 6 (360 MHz, CDC13) 3.98-3.93 (4H, m, 
O(CH,),O), 2.32 (1H, dsept, J= 2.8, 6.9 Hz, CH(CH 3)2), 2.02 (1H, dd, J= 4.4, 15.7 Hz, CII,), 
1.92 (1H, m, CH), 1.86 (311, s, CH,), 1.79 (1H, dd, J = 4.0, 15.7 Hz, CH2), 1.33 (311, s, CH3), 
1.07 (3H, d, J= 6.9 Hz, CH(CH3)2), 1.04 (3H, d, J= 6.9 Hz, CH(CH3)2); ' 3C NMIR 6 (91 MHz, 
CDC13) 116.8 (C), 116.8 (C), 108.2 (C), 64.5 (CH2), 64.3 (CH,), 44.9 (CH), 36.0 (C), 35.3 
(CH2), 31.1 (CH), 25.7 (CH 3), 24.5 (CH3), 21.3 (CH,) and 17.5 (CH,); HRMS (FAB) m/z calcd. 
for C 13H21N202 [M+H] 237.1598, found 237.1602. 
(2R,3R)-2-Formyl-2,4-dimethyl-3-((2-methyl-1,3-dioxolafl-2-yl)IflethYl) pentanenitrile (404) 
C0 C 0  ON Y HO 
410 	 404 
2-Methyl-2-((R)-3-methyl- 1 -(2-methyl-i ,3-dioxolan-2-yl)butan-2-yl) malononitrile (410) (101 
mg, 0.43 mmol) was dissolved in diethyl ether (10 mL), cooled to -78°C and DIBAL-H (0.52 
mL, 0.5 mmol, 1M hexanes) was added dropwise over 10 mm. The resulting solution was stirred 
for 20 mm, quenched with aqueous Rochelle salts (10 mL, sat.) and stirred for a further 16 h. 
The aqueous phase was extracted with diethyl ether (3 x 10 mL) and the combined organics were 
washed with brine (20 mL), dried (MgSO 4) and concentrated in vacuo to give a yellow oil. 
Column chromatography (SiO,, 20 % ethyl acetate in hexanes) afforded the title compound (53 
mg, 52 %, 8:1 d.r.) as a colourless solid; m.p. = 76-78 °C (ethyl acetate hexanes); lab 25  = -3.70 
(c 0.54, CHC13); IR (neat)/cm' u, 2240 (CN), 1734 (C0), 1045 (C-O); 'H NMR ö (360 
MHz, CDC13) major diastereoisomer: 9.35 (1H, s, CHO), 3.94-3.87 (411, m, O(CH,),O), 2.03 
(1H, dt, J= 3.4,4.2 Hz, CH), 1.93 (2H, m, CH,), 1.72 (1H, m, Cl!), 1.47 (3H, s, CH3), 1.28 (3H, 
163 
Experimental 
s, CH3), 0.98 (311, d, J = 7.2 Hz, CH(CH3)2), 0.96 (3H, d, J = 7.2 Hz, CH(CH,),); ' 3C NI'LR 
(91 MHz, CDC13) 194.1 (CH), 119.5 (C), 108.6 (C), 64.3 (CR 2), 64.3 (CR2), 53.1 (C), 42.0 
(CH), 34.9 (CH2), 31.2 (CH), 24.4 (CR3), 21.8 (CH3), 18.9 (CH3) and 18.6 (CH,); minor 
diastereoisomer diagnostic peaks: 'H NMR 5 (360 MHz, CDC13) 9.27 (1R, s, CHO); ' 3C NMR 
(91 MHz, CDC13) 193.6 (CH), 120.3 (C), 109.1 (C), 63.8 (CH 2), 63.8 (CH2), 53.4 (C), 40.1 
(CH), 36.6 (CR2), 27.9 (CH), 24.1 (CH3), 23.2 (CH3), 19.4 (CH3) and 18.9 (CH3); HRMS (FAB) 
m/z calcd. for C 131122NO3 [M+H] 240.1594, found 240.1594. 
malononitrile 
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Potassium carbonate (100 mg, 0.72 mmol) was added to a solution of 2-((R)-3-methyl-1-(2-
methyl-1,3-dioxolan-2-yl)butan-2-yl)malonoflitflle (409) (144 mg, 0.65 mmol) and 1,4-
diiodobutane (0.25 mL, 1.90 mmol) dissolved in acetone (10 mL) and the resulting suspension 
was heated at reflux for 16 h. After cooling to RT the solution was concentrated in vacuo and the 
slurry partitioned between water (10 mL) and DCM (10 mL) and the aqueous phase was 
extracted with DCM (3 x 10 mL). The combined organics were washed with brine (20 mL), 
dried (MgSO4) and concentrated in vacuo. Column chromatography (Si0 2, 10 % ethyl acetate in 
hexanes) afforded a yellow oil, which was crystallised from propan-2-ol to yield the title 
compound (201 mg, 77 %, 99 % e.e.) as a colourless crystalline solid; m.p. = 42-44 °C (propan-
2-ol); MD 21 = +20.1° (c 1.00, CHC1 3); IR (neat)/cm' u 2245 (CN), 1043 (C-0); 'H NMIR 
(360 MHz, CDC1 3) 4.00-3.91 (41-1, m, 0(CH 2)20), 3.26-3.15 (21-1, m, CH2I), 2.34 (1H, dsept, J 
6.9, 2.7 Hz, CH(CH 3)2), 2.21 (1H, m, CH), 2.06-1.72 (811, m, 4 x CH2), 1.32 (31-1, s, CH3), 1.09 
(31-1, d, J = 6.9 Hz, CH(CH3)2), 1.05 (31-1, d, J = 6.9 Hz, CH(CH3)2); ' 3C NMR 8 (91 MHz, 
CDC13) 116.0 (C), 115.7 (C), 108.3 (C), 64.5 (CH2), 64.4 (CR2), 43.6 (CH), 42.0 (C), 36.3 
(CH2), 35.4 (CR2), 32.6 (CH2), 31.2 (CH), 26.7 (CH 2), 24.5 (CH3), 21.2 (CH3), 17.6 (CH3) and 
164 
Experimental 
4.8 (CH2); HRMS (ES+) m/z calcd. for C 16H261N202 [M±H] 405.1033, found 405.1036; 
elemental analysis for C 16H241N202 calcd. % C 47.53, % H 6.23, % N 6.93 found % C 48.03, % 
H 6.04, % N 6.87. Chiral HIPLC Chiralpak OD-H column, 1% IPA in hexanes, 0.8 ml, min 1 , 
254 nm, 	= 14.9 mm, RT(IJ) = 18.2 mm. 
(R)_2Formyl6_iodo2((R)_3-methyl-1-(2-methyl-1,3-diOXOlafl-2-Yl)bUtafl-2-Yl) 
hexanenitrile (394) 
f -0 	 '-0 
CH ( ~CNI ___ 
°fr CN 
395 	 394 
2-(4-Iodobutyl)-2-((R)-3-methyl- 1 -(2-methyl-i ,3-dioxolan-2-yl)butan-2-yi)malononitrile (395) 
(1.01 g, 2.49 mmol) was dissolved in diethyl ether (50 mL) and DIBALH (3.75 mL, 3.75 mmol, 
1M hexanes) was added dropwise over 20 mm. The resulting solution was stirred for a further 30 
min at RT, quenched with aqueous Rochelle salts (50 ML, sat.) and stirred for 18 h. The aqueous 
phase was extracted with diethyl ether (3 x 50 mL) and the combined organics were extracted 
with brine (50 mL), dried (MgSO4) and concentrated in vacuo to give a yellow oil. Column 
chromatography (Si0 2, 20 % ethyl acetate in hexanes) afforded the title compound (351 mg, 35 
%, d.r. 10:1) as a colourless solid. The column was washed with methanol (100 ML) and 
concentrated in vacuo to yield a yellow oil, which analysis showed contained product. This 
material was purified by column chromatography (Si0 2, 20 % ethyl acetate in hexanes) to afford 
the title compound (285 mg, 28 %, 10:1 d.r., 63 % combined yield) as a colourless solid; m.p. = 
66-68 °C (ethyl acetate/hexanes); [a]D 25 = 
 + 18.0, (c 1.0, CHC1 3); IR (neat)/cm' u,, 2250 (CN), 
1733 (C=O), 1042 (C-O); 'H NMR 6 (360 MM, CDC1 3) major diastereoisomer: 9.35 (11-1, s, 
CHO), 3.98-3.89 (41-1, m, OCH2CH20), 3.15 (21-1, dt,J = 7.0, 1.2 Hz, CH2I), 2.13-1.74(811, m, 4 
x Cl-I2), 1.32 (3H, s, CH3), 0.99 (611, d, J= 6.9 Hz, CH(CH3)2); 13C NAM ö (91 MIHz, CDC1 3) 
194.6 (CH), 118.5 (C), 108.6 (C), 64.4 (CH 2), 58.8 (C), 42.6 (CH), 35.7 (CH 2), 33.2 (CH2), 31.7 
(CH2), 31.2 (CH), 26.0 (CH2), 25.9 (CH2), 24.5 (CH3), 21.5 (CH 3), 18.4 (CH3) and 5.0 (CH2); 
minor diastereoisomer diagnostic peaks: 'H NMR 6 (360 MHz, CDC1 3) 9.28 (1H, s, CHO), 1.28 
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(3H, s, Cl-I3); '3C NMR 6 (91 MIHz, CDC1 3) 195.1 (CH), 120.3 (C), 109.1 (C), 64.0 (CH 2), 57.5 
(C), 40.4 (CH), 35.0 (CH2), 33.3 (CH2), 32.1 (CH2), 31.4 (CH), 27.3 (C}1 2), 24.3 (CH2), 24.1 
(CH3), 22.0 (CH3), 16.6 (CH3) and 4.9 (CH2); HRMS (ES+) m/z calcd. for C 1611301N203  







— 3 01' CN 
392 
(R)-2-Formyl-6-iodo-2-((R)-3-methyl-1 -(2-methyl-i ,3-dioxolan-2-yl)butan-2-yl) hexanenitrile 
(394) (438 mg, 1.08 mmol) and HMPA (1.87 mL, 10.74 mmol) were dissolved in TI-IF (10 mL) 
and cooled to -78°C before Sm1 2  (24.0 mL, 2.4 mmol, 0.1M THF") was added dropwise over 10 
mm. Aqueous NH4C1 (10 mL, sat.) was added and the solution allowed to warm to RT. The 
aqueous phase was extracted with diethyl ether (5 x 20 mL) and the combined organics were 
washed with brine (30 mL), dried (MgSO4) and concentrated in vacuo to give a yellow oil. 
Column chromatography (Si0 2, 20 % ethyl acetate in hexanes) afforded the title compound (251 
mg, 83 %) as a colourless oil; MD 25 = +24.0° (c 0.25, CHC13); IR (neat)/cm' u,. 3467 (OH), 
2229 (CN), 1046 (C-O); 'H NMR 6 (360 MHz, CDC1 3) 4.17 (1H, s, -011), 3.95-3.91 (411, m, - 
O(CH2)20-), 2.23 (11-1, dsept, J = 6.9, 2.7 Hz, -CH(CH3)2), 2.05-1.96 (311, m, -CH2-, -CH-), 
1.93-1.79 (311, m, -CH2-, -CH-), 1.76-1.52(6H, m, 3 x—CH2-), 1.31 (3H, s, -CH3), 1.02(3H, d,J 
= 6.9 Hz, -CH(CH3)2), 0.96 (3H, d, J = 6.9 Hz, -CH(CH3)2); ' 3C NMR 8 (91 MIHz, CDC13) 123.3 
(C), 109.3 (C), 67.8 (CH), 64.5 (CH 2), 64.4 (CH2), 46.3 (C), 41.5 (CH), 35.1 (CH 2), 30.9 (CH2), 
Sm12  was prepared immediately prior to use as follows: A suspension of iodine (0.259 g, 1.00 mmol) and 
samarium (207 mg, 1.40 mmol, -40 mesh) in dry THF (10 mL) was heated under reflux in the absence of 
light for one hour. The resulting deep blue solution of SrnI 2 (0. 1M in THF) was allowed to cool to room 
temperature and stored under nitrogen until required. 
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29.0 (Cl2), 27.7 (CH), 25.1 (CH 3), 22.4 (CR3), 22.4 (Cl2), 18.7 (CH2) and 17.5 (CH3); HRMS 
(ES+) m/z calcd. for C 16H31N203  [M+NIEL,] 299.2329, found 299.2330. 
carbonitrile (372) 
HO 




(1R)-2-Hydroxy- 1 -((R)-3 -methyl-i -(2-methyl-i ,3-dioxolan-2-yl)butan-2-yl)cyclohexafle 
carbonitrile (392) (220 mg, 0.78 mmol), TPAP (29 mg, 0.08 mmol) and NMO (185 mg, 1.58 
mmol) were dissolved in DCM (10 mL) and stirred at RT for 18 h. The reaction was filtered 
through silica, washed with DCM (2 x 20 mL) and concentrated in vacuo to give a yellow oil. 
Column chromatography (Si0 2, 20 % ethyl acetate in hexanes) afforded the title compound (180 
mg, 82 %) as a colourless solid; m.p. = 56-58°C (ethyl acetate/hexanes); laiD25  = +56.0° (c 0.25, 
CHC13); IR (neat)/cm' u ma, 2239 (CN), 1718 (C0), 1041 (C-O); 'H NMR 6 (360 MHz, 
CDC13) 3.99-3.84 (4H, m, O(CH2)20), 2.70-2.59 (2H, m, CH2), 2.37-2.20 (211, m, CH2), 2.15-
2.08 (2H, m, CH2), 1.94-1.82 (511, m, 2 x CL!2, CH), 1.80-1.69 (114, m, CH), 1.32 (311, s, CH3), 
1.03 (311, d, J= 6.9 Hz, CH(CH3)2), 0.98 (311, d, J= 6.9 Hz, CH(CH3)2); ' 3C NMR 6 (91 MHz, 
CDC13) 203.8 (C), 120.7 (C), 109.4 (C), 64.4 (CH 2), 64.0 (CH2), 57.8 (C), 38.5 (CH2), 38.2 
(CI), 36.3 (Cl 2), 35.4 (CH2), 28.2 (CH2), 27.1 (CH), 24.1 (CH 3), 22.2 (CH3), 21.1 (CR2) and 
16.8 (CH3); HRMS (ES+) m/z calcd. for C 161126NO3  [M+H] 280.1907, found 280.1908. 
(R)_5Isopropy17oxooctahydro-flaphtha1efle-(R)4a-Carb0flitfl1e (380) 
cjj2 	2 
372 	 372a 	 380 
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PPTS (cat.) was added to a solution of (R)-1-((R)-3-methyl-1-(2-methyl-1,3-dioxolan-2-
yl)butan-2-yl)-2-oxocyclohexane carbonitrile (372) (73 mg, 0.26 mmol) in a mixture of acetone 
(5 mL) and water (0.5 mL) and the resulting solution was heated at reflux for 16 h. The reaction 
was allowed to cool to RT and concentrated in vacuo. The residue was partitioned between 
diethyl ether (10 mL) and aqueous NaHCO 3 (5 mL, sat.) and the aqueous phase was extracted 
with diethyl ether (3 x 5 mL). The combined organics were washed with brine (10 mL), dried 
(MgSO4) and concentrated in vacuo to yield the title compound (61 mg, 100 %) as a yellow oil. 
The product was taken onto the next step without further purification. 
PTSA (cat.) was added to a solution of (R)-1 -((R)-2-methyl-5-oxohexan-3-yl)-2-
oxocyclohexanecarbomtrile (372a) (61 mg, 0.26 mmol) in toluene (10 mL) and the resulting 
solution was heated at reflux with a Dean-Stark trap for 16 h. The reaction was allowed to cool 
to RT, quenched with aqueous NaHCO 3 (5 mL, sat.) and the aqueous phase was extracted with 
diethyl ether (3 x 5 mL). The combined organics were washed with brine (10 mL), dried 
(MgSO4) and concentrated in vacuo. Column chromatography (Si0 2, 20 % ethyl acetate in 
hexanes) afforded the title compound (51 mg, 90 % over two steps) as a colourless oil; lain 25 = - 
44.4° (c 0.50, CHC1 3); IR (neat)/cm -1  u,,, 2231 (CN), 1679 (C=O), 1633 (C=C); 'H NMIR 
(360 MIHz, CDC1 3) 5.93 (1H, s, C=CH), 2.70 (1H, ddt, J = 1.5, 4.9, 13.1, Hz, CH), 2.46-2.31 
(4H, m, 2 x CH2), .2.22-2.07 (4H, m, 2 x CH2), 1.99-1.92 (211, m, CH2), 1.78-1.70 (111, m, CH), 
1.10 (3H, d, J= 6.8 Hz, CH(CH3)2), 0.92 (3H, d, J= 6.8 Hz, CH(CH3)2); '3C NMZR ö (91 MHz, 
CDC13) 197.3 (C), 160.4 (C), 126.5 (C), 124.6 (CH), 46.0 (CH), 35.4 (C), 34.5 (CH2), 34.3 
(CH2), 32.3 (C112), 29.1 (CH2), 28.3 (CH), 23.2 (CH 3), 23.1 (CH2) and 19.1 (CH3); HRMS 
(ES±) m/z calcd. for C 14H20N0 [M+H] 218.1539, found 218.1539. 
7Hydroxy-(R)5_isopropyI-OCtahydrO-flaphthalefle-(R)-4a-CarbaldehYde (420) 
° YTh 








(R)-5-Isopropyl-7-oxo-octahydro-naphthalene-(R)-4a-CarbOflitrile (380) (149 mg, 0.69 mmol) 
and CeC13 .7H20 (383 mg, 1.03 mmol) were dissolved in methanol (5 mL) and cooled to 0°C 
before NaBH4  (30 mg, 0.79 mmol) was added portionwise and the reaction stirred for 10 min at 
0°C. NH,Cl (ca. 0.2 g) was added and the solution concentrated in vacuo. The resulting slurry 
was partitioned between water (5 mL) and DCM (5 mL) and the aqueous phase was extracted 
with DCM (3 x 10 mL). The combined organics were washed with brine (20 mL), dried 
(MgSO4) and concentrated in vacuo to yield 5-isopropyl-7-ol-octahydro-naphthalene-4a-
carbonitrile (419) (124 mg, 83 %) as a colourless solid. The compound was taken onto the next 
step without further purification. 
(R)5Isopropyl-7-ol-octahydro-naphthalene-(R)-4a-CarbOnitflle (419) (124 mg, 0.57 mmol) was 
dissolved in diethyl ether (10 mL) and cooled to -40°C before DIBAL-H (1.7 mL, 1.7 mmol, 1M 
toluene) was added dropwise and the reaction was stirred for 3 h at -40°C. Acetic acid (5 mL, 
6% aq. sol.) was added and the solution was allowed to warm to RT and stirred for a further 20 
mm. The aqueous phase was extracted with diethyl ether (3 x 10 mL) and the combined organics 
were washed with water (10 mL), NaHCO 3 (10 mL, sat.), brine (10 mL), dried (MgSO 4) and 
concentrated in vacuo to give a yellow oil. Column chromatography (Si0 2, 20 % ethyl acetate in 
hexanes) afforded the title compound (118 mg, 94 %) as a colourless oil; laiD25 = +88.0° (c 0.55, 
CHC1 3); IR (neat)/cm' U ( 3399 (OH'), 1727 (CO); 'H NMR 5 (3 60 MHz, CDC13) 9.19 (1H, 
s, CHO), 5.70 (1H, s, CCH), 4.28 (1H, m, CHOH), 2.20-2.17 (211, m, CH2), 2.01 (1H, m, CH), 
1.87-1.78 (211, m, CH2), 1.74-1.53 (4H, m, 2 x CH2), 1.47-1.24 (3H, m, CH2 and CH), 0.87 (3H, 
d, J 1.6 Hz, CH(CH3)2), 0.85 (3H, d, J = 1.6 Hz, CH(CH3)2); 13C NMR 6 (91 MHz, CDC13) 
203.1 (CH), 139.7 (C), 128.9 (CH), 68.4 (CH), 57.7 (C), 40.3 (CH), 34.8 (CH 2), 28.9 (CH2), 
28.7 (CH2), 28.1 (CH2), 25.5 (CH), 23.9 (CH3), 22.6 (CH2) and 18.9 (CH3). 
7Hydroxy(R)5isopropy1-octahydro-naPhtha1efle-(R)-4a-Carba1dehYde (421) 
HO,, TBSO J 
0 
420 	 421 
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7-Hydroxy-(R)-5-isopropyl-octahydro-naphthalene-(R)-4a-carbaldehyde (420) (16 mg, 0.07 
mmol), TBSC1 (22 mg, 0.15 mmol), imidazole (10 mg, 0.15 mmol) and DMAP (cat.) were 
dissolved in DCM (5 mL) and the resulting solution was stirred at RT for 18 h. Aqueous NH 4C1 
(5 mL, sat.) was added and the aqueous phase was extracted with DCM (3 x 10 mL). The 
combined organics were washed with brine (10 mL), dried (MgSO 4) and concentrated in vacuo. 
The yellow oil was filtered through silica, washed with 5% ethyl acetate in hexanes (3 x 10 ML) 
and concentrated in vacuo to afford the title compound (19 mg, 76 %) as a colourless oil. 
Analysis showed the compound to be pure so it was taken onto the next step without further 
purification: laiD = +10. 1 0  (c 1.0, CHC13); IR (neat)/cm' 1730 (C=O); 'H NMR ö (360 
MHz, CDC13) 9.76 (1H, s, CHO), 5.60 (1H, s, C=rCH), 4.19 (1H, m, CH), 2.19-2.02 (211, m, 
CH2), 1.89-1.78 (3H, m, CH2 and CH), 1.69-1.54 (5H, m, 2 x CH2 and CH), 1.43-1.22 (2H, m, 
CH2), 0.96 (3H, d, J = 6.8 Hz, CH(CH3)2), 0.92 (9H, s, SiC(CH3)3), 0.82 (3H, d, J = 6.8 Hz, 
CH(CH3)2), 0.10 (3H, s, SiCH3), 0.10 (3H, s, SiCH3); 13C NMR 8 (91 MHz, CDC1 3) 201.4 (C), 
141.0 (C), 131.7 (CH), 69.6 (CH), 46.1 (C), 39.9 (CH), 32.3 (CH 2), 30.5 (CH2), 29.4 (CH2), 28.3 





'Brady, S. F.; Singh, M. P.; Janso, J. E.; Clardy, J., J. Am. Chem. Soc. 2000, 122, 2116. 
2  Brady, S. F.; Bondi, S. M.; Clardy, J., I Am. Chem. Soc. 2001, 123, 9900. 
Singh, M. P.; Janso, J. E.; Luckman, S. W.; Brady, S. F.; Clardy, J.; Greenstein, M.; Maiese, W. M., J. 
Antibiot. 2000, 53, 256. 
For reviews, see: (a) Mischne, M., Curr. Org. Synth. 2005, 2, 261. (b) Maifeld, S. V.; Lee, D., Synlett 
2006, 1623. 
Lin, S. N.; Dudley, G. B.; Tan, D. S.; Danishefsky, S. J.,Angew. Chem., mt. Ed 2002, 41, 2188. 
6  Shi, B.; Hawryluk, N. A.; Snider, B. B., I Org. Chem. 2003, 68, 1030. 
Boyer, F. D.; Hanna, I.; Ricard, L., Org. Lett. 2004, 6, 1817. 
8  Shipe, W. D.; Sorensen, E. J., J. Am. Chem. Soc. 2006, 128, 7025. 
Mehta, G.; Pallavi, K.; Umarye, J. D., Chem. Commum. 2005, 4456. 
' ° Iimura, S.; Overman, L. E.; Paulini, R.; Zakarian, A., I Am. Chem. Soc. 2006, 128, 13095. 
Miller, A. K.; Hughes, C. C.; Kennedy-Smith, J. J.; Gradl, S. N.; Trauner, D., J. Am. Chem. Soc. 2006, 
128, 17057. 
12  Dudley, G. B.; Tan, D. S.; Kim, G.; Tanski, J. M.; Danishefsky, S. J., Tetrahedron. Lett. 2001, 42, 6789. 
13  Dudley, G. B.; Danishefsky, S. J., Org. Lett. 2001, 3, 2399. 
14  Tan, D. S.; Dudley, G. B.; Danishefsky, S. J.,Angew. Chem., mt. Ed 2002, 41, 2185. 
15  Cheong, P. H.; Yun, H.; Danishesky, S. J.; Houk, K. N., Org. Lett. 2006, 8, 1513. 
16  Mandal, M.; Yun, H. D.; Dudley, G. B.; Lin, S. N.; Tan, D. S.; Danishefsky, S. J., J. Org. Chem. 2005, 
70, 10619. 
17  Snider, B. B.; Hawryluk, N. A., Org. Lett. 2001, 3, 569. 
IS  Snider, B. B.; Shi, B., Tetrahedron Lett. 2001, 42, 9123. 
19  Boyer, F. D.; Hanna, I., Tetrahedron Lett. 2002, 43, 7469. 
20 Boyer, F. D.; Hanna, I., Eur. I Org. Chem. 2006,471. 
21  Shipe, W. D.; Sorensen, E. J., Org. Lett. 2002, 4, 2063. 
171 
References 
22  Mehta, G.; Umarye, J. D.; Gagliardini, V., Tetrahedron Left. 2002, 43, 6975. 
23  Mehta, G.; Umarye, J. D, Org. Lett. 2002, 4, 1063. 
24  Mehta, G.; Umarye, J. D.; Srinivas, K., Tetrahedron Lett. 2003, 44, 4233. 
25  Overman, L. E.; Rucker, P. V., Tetrahedron Left. 1998, 39, 4643. 
26  Hughes, C. C.; Kennedy-Smith, J. J.; Trauner, D., Org. Lett. 2003, 5, 4113. 
27  Magnus, P.; Waring, M. J.; 011ivier, C.; Lynch, V., Tetrahedron Left. 2001, 42, 6977. 
28  Magnus, P.; 011ivier, C., Tetrahedron Lett. 2002, 43, 9605. 
29 Nakazaki A.; Sharma, U.; Tius, M. A., Org. Left. 2002, 4, 3363. 
30  Chiu, P.; Li, S. L., Org. Left. 2004, 6,613. 
' Srikrishna, A.; Dethe, D. H., Org. Lett. 2004, 6,165. 
32 Nguyen, T. M.; Lee, D., Tetrahedron Left. 2002, 43, 4033. 
33 Du, X.; Chu, H. V.; Kwon, 0., Org. Lett. 2003, 5, 1923. 
34 Du, X.; Chu, H. V.; Kwon, 0., Tetrahedron Lett. 2004, 45, 8843. 
35 Brummond, K. M.; Gao, D. Org. Lett. 2003, 5, 3491. 
36  Li, C. C.; Liang, S.; Zhang, X. H.; Xie, Z. X.; Chen, J. H.; Wu, Y. D.; Yang, Z., Org. Left. 2005, 7, 
3709. 
37  Li, C. C.; Wang, C. H.; Liang, B.; Zhang, X. H.; Deng, L. J.; Liang, S.; Chen, J. H.; Wu, Y. D.; Yang, 
Z., J. Org. Chem. 2006, 71, 6892. 
38  Bodforss, S., Chem. Ber. 1918, 51, 214. 
39 Johnson, C. K.; Dominy, B.; Reusch, W., J. Am. Chem. Soc. 1963, 85, 3894. 
40 Zimmerman, H. E.; Cowley, B. R.; Tseng, C. Y.; Wilson, J. W., I Am. Chem. Soc. 1964, 86, 947. 
41  Jeger, 0.; Schaffner, K.; Wehrli, H., Pure Appi. Chem. 1964, 9,555. 
42  Paquette, L. A.; Nitz, J. T.; Ross, R. J.; Springer, J. P., 1 Am. Chem. Soc. 1984, 106, 1446. 
43  Paquette, L. A.; Lin, H.-S.; Belmont, D. T.; Springer, J. P., J. Org. Chem. 1986, 51, 4807. 
44 Heathcock, C. H.; Ellis, J. E, Tetrahedron Left., 1971, 52, 4995. 
u Kuehne, M. E.; Nelson, J. A., J. Org. Chem. 1970, 35, 161. 
172 
References 
46 Luche, J. I Am. Chem. Soc. 1978, 100, 2226. 
47 Jung, M. E.; Hatfield, G. L. Tetrahedron Lett. 1983, 24, 3175. 
48 Utaka, M.; Matsushita, S.; Takeda, A. Chem. Lett. 1980, 779. 
49 K1ix, R. C.; Bach, R. D., I Org. Chem. 1987, 52, 580. 
° Sands R. D., Botteron D. G., J. Org. Chem. 1963, 28, 2690. 
51 Pati, L. C.; Roy, A.; Mukherjee, D., Tetrahedron Lett. 2000, 41, 10353. 
52 Posner, G. H.; Loomis, G. L., Tetrahedron Lett. 1978, 44,4213. 
53  R. E. Gawley, Synthesis 1976, 777. 
54 Scanio, C. J. V.; Starrett, R. M., .1 Am. Chem. Soc. 1971, 93, 1539. 
55  Liu, H. J.; Ly, T. W.; Tai, C. L.; Wu, J. D.; Liang, J. K.; Guo, J. C.; Tseng, N. W.; Shia, K. S., 
Tetrahedron 2003, 59, 1209. 
56 Chan, T.; Brownbridge, P., J. Am. Chem. Soc. 1980, 102, 3534. 
57  Antonioletti, R.; Bovicelli, P.; Malancona, S., Tetrahedron 2002, 58, 589. 
58 Meyers, A. I.; Temple, D. L.; Haidukewych, D.; Mihelich, E. D., J. Org. Chem. 1974, 39, 2787. 
59 D. A. Peak, R. Robinson, J. Chem. Soc. 1937, 1581. 
60 p Wieland, K. Miescher, Helv. Chim. Acta. 1950, 33, 2215. 
61 Langlois, N.; Dahuron, N., Tetrahedron Lett. 1990, 31, 7433. 
62 MCMW J. E.; Blaszczak, L. C., J. Org. Chem. 1974, 39, 2217. 
63  Miyashita, M.; Yamaguchi, R.; Yoshikoshi, A., J. Org. Chem. 1984, 49, 2857. 
64 T. Motoo, H. Furuta, Y. Asakawa, J. Chem. Soc. Perkin Trans. 11991, 1919. 
61 Kim J., Cho D. H., Jang D. 0., Tetrahedron Lett., 2004, 45, 3031. 
66 Osborn, J. A.; Jardine, F. H.; Young, J. F.; Wilkinson, G., J. Chem. Soc. A, 1966, 1711. 
67  McGowan, C. A.; Schmieder, A.; Roberts, L.; Greaney, M. F., Org. Biomol. Chem. 2007, 1522. 
68 Cheong, P. H. Y.; Yun, H.; Danishefsky, S. J.; Houk, K. N., Org. Lett. 2006, 8, 1513. 
69 Dunlap, N. K.; Sabol, M. R.; Watt, D. S. Tetrahedron Lett. 1984, 25, 5839. 
70 Bolm, C.; Gladysz, J. A., Chem. Rev. 2003, 103, 2761. 
173 
References 
' Taylor, M. S.; Jacobsen, E. N., J. Am. Chem. Soc. 2003, 125, 11204. 
72  Taylor, M. S.; Zalatan, D. N.; Lerchner, A. M.; Jacobsen, E. N., I Am. Chem. Soc. 2005, 127, 1313. 
73  Schaefer, J. P.; Bloomfield, J. J. Org. React. 1967, 15, 1. 
74 Davis, B. R.; Garrett, P. J. Comp. Org. Syn. 1991, 2, 806. 
" Galatsis, P. "Diisobutylaluminum Hydride" in Encyclopaedia of Reagents for Organic Synthesis John 
Wiley & Sons: New York, 2001. 
76 Braese, S.; Wertal, H.; Frank, D.; Vidovic, D.; Meij ere, A. Eur. J. Org. Chem. 2005, 19,4167. 
77  White, J. D.; Jeffery, S. C., J. Org. Chem. 1996, 61, 2600. 
78  Kito, M.; Sakai, T.; Shirahama, H.; Miyashita, M.; Matsuda, F. Synlelt 1997, 219. 
79 Kang, H. Y.; Song, S. E., Tetrahedron Left. 2000, 41, 937. 
80 Molander, G. A.; Harris, C. R., Chem. Rev. 1996, 96, 307. 
81  Snyder, S. A.; Corey, E. J., J. Am. Chem. Soc. 2006, 128, 740. 
82 Marshall, J. A.; Flynn, K. E. J. Am. Chem. Soc. 1982, 104, 7430. 
83  Kuehne, M.; Nelson, J. A. J. Org. Chem. 1970, 35, 161. 
84 M Utaka, S. Matsushita, A. Takeda, Chem. Lett. 1980, 779. 




2,2-DMP - 2,2-dimethoxypropane 
CSA - camphour sulfonic acid 
d - doublet 
d.r. - diastereomeric ratio 
dba - dibenzylideneacetone 
DCE - dichioroethane 
DCM - dichloromethane 
DIAD - diisopropyl azodicarboxylate 
DIBALH - diisobutyl aluminium hydride 
DMAP - dimethyl amino pyridine 
DMDO - dimethyl dioxirane 
DMF - dimethyl formamide 
DMSO - dimethyl sulfoxide 
Dppb - 1 ,4-Bis(diphenylphosphino)butane 
Dppf - 1, 1'-Bis(diphenylphosphino)ferrocene 
e.e. - enantiomeric excess (% major isomer - % minor isomer) 
EDCI - 1 -ethyl-3-(3-dimethylamino-propyl)-carbodiimide 
EOMCI - chloromethyl ethyl ether 
Et - ethyl 
HMPA - Hexamethyl phosphoric acid triamide 
HPLC - high pressure liquid chromatography 
Hz - hertz 
IMDA - intramolecular Diels Alder 
IPA - isopropyl alcohol, propan-2-ol 
ER - infrared 
LAH - lithium aluminium hydride 
LilA - lithium diisopropylamine 
LHMDS - lithium hexamethyl disilazide 
mCPBA - meta-chloro perbenzoic acid 
Me - methyl 
mg - milligrams 
mm - minutes 
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Abbreviations 
mL - millilitres 
Ms - mesylate, methane sulfonate 
MYK - methyl vinyl ketone, 
Nf - nonaflate 
NMO - N-morpholine oxide 
NMP - N-Methyl-2-pyrrolidone 
NMR - Nuclear Magnetic Resonance 
P - unspecified protecting group 
PCC - Pyridiunium chioro chromate 
PDC - pyridinium dichioro chromate 
Ppm - parts per million 
PPTS - pyridiump-toluenesulfonic acid 
PTSA - p-toluenesulfonic acid 
q - quartet 
RCM - ring closing metathesis 
R - retention time 
rt - room temperature 
S - singlet 
SM - starting material 
t - triplet 
TBAF - tetrabutyl ammonium fluoride 
TBDMS, TBS - tert-butyl dimethyl silyl 
TEMPO - 2,2,6,6-Tetramethylpiperidine-1 -oxyl 
Tf - triflate, trifluoromethane sulfonate 
THF - tetra-hydrofuran 
TMS - trimethyl silyl 
TPAP - tetra propyl ammonium per-rutherate 
UV - ultraviolet 
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Appendix 1: X-ray crystal structure data 
1.1. Crystal structure data for 325. 
Figure 1.1 Crystal structure of 325. 
Part A: Crystal data 
Empirical formula C13H1804 
Formula weight 238.28 
Wavelength 0.71073 A 
Temperature 150 K 
Crystal system Orthorhombic 
Space group P 21 21 21 
Unit cell dimensions a = 7.2231(3) A a = 900 
b=9.3503(4)Af3=90° 
c = 17.2474(62 A y = 90
0 
 
Volume 1164.86(8) A 
Number of reflections for cell 2243 (2 <0 <26 deg.) 
Z 4 
Density (calculated) 1.359 Mg/M3 
Absorption coefficient 10.100 mm 
F(000) 1 512 
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Part B: Data collection 
Crystal description colourless lath 
Crystal size 0.57 x 0.49 x 0.18 mm 
Theta range for data collection 2.362 to 28.881 deg. 
Index ranges -9<=h<=9, 12<=k<=1 1, 
-22<=l<=22 
Reflections collected 8602 
Independent reflections 1693 [R(int) = 0.03] 
Scan type \w 
Absorption correction Semi-empirical from equivalents 
(Tmin= 0.725, Tmaxl .000) 
Part C: Solution and refinement 
Solution direct (S1R92) 
Refinement type Full-matrix least-squares on F 2 
Program used for refinement SHELXL-97 
Hydrogen atom placement geom 
Hydrogen atom treatment riding 
Data 1693 
Parameters 154 
Goodness-of-fit on F 2 0.8705 
R R1=0.0501 [1320 data] 
Rw 0.1074 
Absolute structure parameter  
Final maximum delta/sigma 0.000 192 
Weighting scheme Sheidrick weights 
Largest diff. peak and hole 0.33 and -0.27 e.A 3 
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Table 1.1: Atomic coordinates (x104) and equivalent isotropic displacement parameters (A 2 x 
1 O) for 325. U(eq) is defined as one third of the trace of the orthogonalised Uij tensor. 
x  z U(eg) 
C(1) 1496(5) 532(3) 6612(2) 27 
0(2) -1802(3) 702(3) 6518(1) 37 
 -437(4) 522(3) 69 18(2) 24 
 -682(4) 341(3) 7780(2) 21 
0(5) -231(3) -1073(2) 8070(1) 24 
C(6) 900(4) 126(3) 8299(2) 16 
C(7) 2865(4) 132(3) 7977(2) 19 
C(8) 2857(4) -287(3) 7113(2) 23 
C(9) 4079(4) -967(3) 8405(2) 27 
C(10) 646(4) 646(3) 9139(2) 21 
C(11) 1503(5) 2111(3) 9221(2) 29 
C(12) 3488(5) 2168(3) 8930(2) 30 
C(13) 3620(4) 1660(3) 8095(2) 25 
0(14) -1263(3) 725 (2) 9335(1) 27 
 -1755(4) -594(3) 9699(2) 1 	30 
 56(5) -1255(4) 9931(2) 41 
0(17) 1438(3) -310(2) 9679(1) 31 
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Table 1.2: Bond lengths (A) for 325. 
Bond Length (A) Bond Length (A) 
C(1)-C(3) 1.493(4) C(9)-H(93) 0.999 
C(1)-C(8) 1.517(4) C(10)-C(11) 1.509(4) 
C(1)-C(8) 1.517(4) C(10)-0(14) 1.421(3) 
C(1)-H(12) 1.000 C(10)-O(17) 1.412(3) 
0(2)-C(3) 1.216(3) C(1 1)-C(12) 1.520(4) 
C(3)-C(4) 1.506(4) C(1 1)-H(1 11) 1.000 
C(4)-0(5) 1.451(3) C( 1 1)-H(1 12) 0.999 
C(4)-C(6) 1.466(4) C( 1 2)-C( 13) 1.520(4) 
C(4)-H(41) 1.000 C(12)-H(121) 1.000 
0(5)-C(6) 1.442(3) C(12)-H(122) 1.000 
C(6)-C(7) 1.524(4) C(1 3)-H( 131) 1.000 
C(6)-C(10) 1.539(4) C(13) H( 132) 1.000 
C(7)-C(8) 1.541(4) 0(14)-C(15) 1.429(4) 
C(7)-C(9) 1.539(4) C(1 5)-C(16) 1.501(5) 
C(7)-C(13) 1.542(4) C(1 5)-H(1 51) 1.000 
C(8)-H(8 1) 1.000 C(1 5)-H(1 52) 1.000 
C(8)-H(82) 1.000 C(16)-0(17) 1.402(4) 
C(9)-H(91) 1.000 C(16)-H(161) 1.000 
C(9)-H(92) 1.001 C(16)-H(162) 1.000 
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Table 1.3: Bond angles (degrees) for 325. 
Bond Angle (deg) Bond Angle (deg) 
C(3)-C(I)-C(8) 113.7(2) H(92)-C(9)-H(93) 109.478 
C(3)-C(1)-H(1 1) 108.347 C(6)-C(10)-C(II) 109.0(2) 
C(8)-C(1)-H(l 1) 108.452 C(6)-C(10)-0(14) 110.8(2) 
C(3)-C(I)-H(12) 108.394 C(1 1)-C(10)-O(14) 109.2(2) 
C(8)-C(1)-H(1 2) 108.458 C(6)-C(10)-0(17) 111.8(2) 
H(1 1)-C(1)-H(12) 109.471 C(1 1)-C(10)-O(17) 110.3(2) 
C(I)-C(3)-0(2) 123.8(2) 0(14)-C(10)-0(1 7) 105.6(2) 
C(1)-C(3)-C(4) 117.4(2) C(10)-C(1 1)-C(12) 112.8(3) 
0(2)-C(3)-C(4) 118.8(3) C(10)-C(1 1)-H(1 11) - 08.559 
C(3)-C(4)-0(5) 114.6(2) C(12)-C(1 1)-H(1 11) - 08.611 
C(3)-C(4)-C(6) 121.8(2) C(10)-C(1 I)-H(1 12) 108.637 
0(5)-C(4)-C(6) 59.27(16) C(12)-C(1 1)-H(1 12) - 08.657 
C(3)-C(4)-H(41) 92.289 11(11 1)-C(1 1)-H(1 12) 109.533 
0(5)-C(4)-H(41) 138.546 C(1 1)-C(12)-C(13) 111.2(3) 
C(6)-C(4)-H(41) 132.265 C(1 1)-C(12)-H(1 21) 109.056 
C(4)-0(5)-C(6) 60.88(16) C(13)-C(12)-H(121) 109.063 
C(4)-C(6)-0(5) 59.85(17) C(1 1)-C(12)-H(1 22) 109.009 
C(4)-C(6)-C(7) 1120.2(2) C(13)-C(12)-H(122) 109.072 
0(5)-C(6)-C(7) 115.5(2) H(121)-C(12)-H(122) 109.434 
C(4)-C(6)-C(10) 116.0(2) C(7)-C(13)-C(12) 113.1(2) 
0(5)-C(6)-C(10) 115.9(2) C(7)-C(13)-H(131) 108.592 
C(7)-C(6)-C(10) 116.9(2) C(12)-C(13)-H(131) 108.527 
C(6)-C(7)-C(8) 110.3(2) C(7)-C(13)-H(132) 108.570 
C(6)-C(7)-C(9) 110.7(2) C(12)-C(13)-H(132) 108.525 
C(8)-C(7)-C(9) 107.2(2) H(131)-C(13)-H(132) 109.514 
C(6)-C(7)-C(13) 106.5(2) C(10)-0(14)-C(1 5) 107.5(2) 
C(8)-C(7)-C(13) 111.3(2) 0(14)-C(1 5)-C(16) 104.8(2) 
C(9)-C(7)-C(13) 110.8(2) 0(14)-C(15)-H(151) 110.569 
C(7)-C(8)-C(1) 115.2(2) C(16)-C(15)-H(151) 110.666 
C(7)-C(8)-H(8 1) 107.985 0(14)-C(15)-H(1 52) 110.587 
C(l )-C(8)-H(8 1) 108.082 C(16)-C(15)-H(1 52) 110.683 
C(7)-C(8)-H(82) 107.982 H(1 5 1)-C(15)-H(1 52) 109.436 
C(1)-C(8)-H(82) 108.057 C(1 5)-C(16)-0(1 7) 106.1(2) 
H(8 1)-C(8)-H(82) 109.465 C(1 5)-C(1 6)-H(161) 110.224 
C(7)-C(9)-H(91) 109.482 0(17)-C(16)-H(161) 110.392 
C(7)-C(9)-H(92) 109.422 C(1 5)-C( 16)-H(162) 110.192 
H(9 1)-C(9)-H(92) 109.416 0(17)-C(16)-H(162) 110.366 
C(7)-C(9)-H(93) 109.506 H(161)-C(16)-H(162) 109.485 
H(9 1)-C(9)-H(93) 109.524 C(10)-0(17)-C(16) 108.4(2) 
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Table 1.4: Anisotropic displacement parameters (A'2 x 10"3) for X. The anisotropic 
displacement factor exponent takes the form: -2 it2 [ h2 a*2  Ui 1 + + 2 h k a* b* U12] 
Ui! U22 U33 U23 U13 U12 
C(i) 36(2) 27 (2) 18(i) -2(i) 5(i) 1(2) 
0(2) 38 (1) 42(1) 30(1) -3(1) -17(i) 6(1) 
 34(2) 16(1) 21(i) -3(1) -6(1) 3(1) 
 16(1) i8(1) 28(i) 5(1) -2(i) i(1) 
0(5) 22(1) 2i(i)_ 27(i) 2(1) -3(1) -4(1) 
 17(1) i5(1) 17(1) 2(1) 1(1) 0(1) 
 18(1) 20(1) 19(i) 3(1) 2(1) i(1) 
 21(1) 22(1) 27(1) -1(1) 8(1) 3(1) 
 17(1) 29(2) 34(2) 3(1) 0(1) 5(1) 
C(iO) 18(i) 26(i) 18(i) 2(1) i(i) i(1) 
C(l1) 39(2) 27(2) 22 (1) -7(1) 6(2) -6(2) 
C(12) 33(2) 27(2)_ 31 2 -4(i) 0(2) -12(2) 
C(i3) 19(1) 27(1) 28(2) 1(i) 3(1) -3(1) 
0(14) 25(1) 31(1) 26(i) 3(i) 8(1) 




C(i6) 37(2) 43(2) 17(2) -10(2) 
0(i7) 24(1) 44(1) 25(i) 13(1) -1(1) 
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Table 1.5: Anisotropic displacement parameters (A2x1 03) for 325. The anisotropic displacement 
factor exponent takes the form: -27t 2  [h2a*2  Ui 1+... .+2hka*b*U 12]. 
x y  U(eg) 
 1920 1548 6576 33 
 1489 95 6083 33 
11(41) -1744 1028 7793 25 
H(81) 2548 -1327 7077 28 
H(82) 4129 -121 6902 28 
11(91) 5361 -946 8186 32 
 4125 -723 8970 32 
 3542 -1944 8338 32 
H(111) 1491 2383 9782 35 
H(112) 746 2809 8918 35 
H(121) 4277 1541 9264 36 
11(122) 3944 3176 8962 36 
H(131) 4949 1678 7934 29 
H(132) 2892 2329 7761 29 
11(151) -2547 -416 10165 36 
11(152) 1 	-2432 -1228 9328 36 
11(161) 113 -1372 10507 49 
H(162) 207 -2209 9677 49 
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Figure 1.2 Crystal structure of 351. 
Part A: Crystal data 
Empirical formula C13H1803 
Formula weight 222.28 
Wavelength 0.7 1073 A 
Temperature 150 K 
Crystal system Monoclinic 
Space group P 1 21/c 1 
Unit cell dimensions a = 6.0186(2) A a = 900 
b = 14.4410(4) A 3 = 91.465(2) 0 
c = 26.8635(8) A 	= 90° 
Volume 2334.07(12) A3 
Number of reflections for cell 3167 (3 <0 <27 deg.) 
Z 8 
Density (calculated) 1.265 Mg/rn3 




Part B: Data collection 
Crystal description colourless plate 
Crystal size 0.53 x 0.13 x 0.09 mm 
Theta range for data collection 1.601 to 26.935 deg. 
Index ranges -7<=h<7, 	-18<k<18,  
34<=I<=33 
Reflections collected 16695 
Independent reflections 5050 [R(int) = 0.029] 
Scan type \f&\w scans 
Absorption correction Semi-empirical from equivalents 
(Tmin= 0.81, Tmax=0.99) 
Part C: Solution and refinement 
Solution direct (S1R92) 
Refinement type Full-matrix least-squares on F 2 
Program used for refinement CRYSTALS 
Hydrogen atom placement Geom. 
Hydrogen atom treatment Noref 
Data 5050 
Parameters 289 
Goodness-of-fit on F 2 0.8325 
R RI = 0.0553 [3264 data] 
Rw 0.1060 
Absolute structure parameter 
Final maximum delta/sigma 0.000409 
Weighting scheme Sheldrick Weights 
Largest diff. peak and hole 0.54 and -0.48 e.A 3 
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Table 1.6: Atomic coordinates (x10 4 ) and equivalent isotropic displacement parameters (A 2 x 
10) for 351. U(eq) is defined as one third of the trace of the orthogonalised Uij tensor. 
x  Z U(eq) 
C(11) 13493(4) 1672(2) 10095(1) 25 
C(12) 12625(4) 2620(2) 9965(1) 23 
C(13) 10312(4) 2596(2) 9714(1) 20 
C(14) 10232(3) 1945(2) 9249(1) 18 
C(15) 7776(4) 1747(2) 9100(1) 27 
C(16) 7453(4) 978(2) 8714(1) 29 
C(17) 8495(4) 86(2) 8901(1) 31 
C(18) 10961(4) 234(2) 9024(1) 30 
C(110) 12733(4) 915(2) 9776(1) 25 
C(111) 9635(4) 3578(2) 9576(1) 24 
C(112) 6635(4) 4586(2) 9407(1) 39 
C(113) 11422(4) 2391(2) 8809(1) 27 
C(19) 11360(4) 1030(2) 9379(1) 21 
 4104(4) 1486(2) 7540(1) 23 
 5018(4) 2379(2) 7752(1) 22 
C(23) 7254(4) 2642(2) 7536(1) 19 
C(24) 7166(4) 2680(2) 6955(1) 18 
C(25) 9559(4) 2712(2) 6760(1) 26 
C(26) 9754(4) 2539(2) 6201(1) 29 
C(27) 8752(5) 1601(2) 6065(1) 32 
C(28) 6333(4) 1576(2) 6215(1) 30 
C(29) 6014(4) 1806(2) 6757(1) 20 
C(210) 4721(4) 1265 (2) 7032(1) 23 
C(211) 8027(4) 3541 (2) 7784(1) 22 
C(212) 11027(4) 4576(2) 7915(1) 37 
C(213) 5841(4) 3537(2) 6772(1) 25 
0(11) 14886(3) 1555(1) 10430(1L 36 
0(12) 10907(3) 4192(1) 9479(1) 38 
0(13) 7428(3) 3685(1) 9569(1) 30 
0(21) 2818(3) 1006(1) 7774(1) 36 
0(22) 1 	6887(3) 4019(1) 8040(1) 34 
0(23) 1 10165(3) 3722(1) 7701(1) 29 
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Table 1.7: Bond lengths (A) for 351. 
Bond Length (A) Bond Length (A) 
C(1 1)-C(12) 1.503(3) C(2 I)-C(22) 1.509(3) 
C(1 1)-C(1 10) 1.456(3) C(21)-C(210) 1.459(3) 
C(1 1)-0(11) 1.227(3) C(21)-0(21) 1.224(3) 
C(12)-C(13) 1.531(3) C(22)-C(23) 1.528(3) 
C(1 2)-H(1 11) 1.000 C(22)-H(221) 1.000 
C( 1 2)-H( 112) 1.000 C(22)-H(222) 1.000 
C(13)-C(14) 1.562(3) C(23)-C(24) 1.562(3) 
C(13)-C(1 11) 1.518(3) C(23)-C(21 1) 1.528(3) 
C(13)-H(131) 1.000 C(23)-H(231) 1.000 
C(14)-C(15) 1.549(3) C(24)-C(25) 1.546(3) 
C(1 4)-C(1 13) 1.540(3) C(24)-C(29) 1.530(3) 
C(14)-C(19) 1.522(3) C(24)-C(213) 1.544(3) 
C(1 5)-C(1 6) 1.528(3) C(25)-C(26) 1.530(3) 
C(1 5)-H(15 1) 1.000 C(25)-H(25 1) 1.000 
C(15)-H(152) 1.000 C(25)-H(252) 1.000 
C(16)-C(17) 1.512(3) C(26)-C(27) 1.523(3) 
C(16)-H(161) 1.000 C(26)-H(261) 1.000 
C(16)-H(162) 1.000 C(26)-H(262) 1.000 
C(17)-C(1 8) 1.528(3) C(27)-C(28) 1.521(3) 
C(1 7)-H(1 71) 1.000 C(27)-H(27 1) 1.000 
C( 1 7)-H( 172) 1.000 C(27)-H(272) 1.000 
C(1 8)-C(1 9) 1.509(3) C(28)-C(29) 1.509(3) 
C(1 8)-H(1 81) 1.000 C(28)-H(28 1) 1.000 
C(18)-H(182) 1.000 C(28)-H(282) 1.000 
C(110)-C(19) 1.341(3) C(29)-C(210) 1.338(3) 
C(110)-H(110) 1.000 C(210)-H(210) 1.000 
C(1 1 1)-O(1 2) 1.204(3) C(211)-0(22) 1.202(3) 
C(1 1 1)-O(13) 1.337(3) C(211)-0(23) 1.337(3) 
C(112)-H(113) 1.000 C(212)-H(116) 1.000 
C(1 12)-H(1 14) 1.000 C(212)-H(1 17) 1.000 
C(112)-H(115) 1.000 C(212)-H(118) 1.000 
C(1 12)-0(13) 1.448(3) C(212)-0(23) 1.451(3) 
C(1 13)-H(122) 1.000 C(213)-H(1 19) 1.000 
C(1 13)-H(123) 1 	1.000 1 	C(213)-H(120) 1.000 
C(113)-H(124) 1.000 C(213)-H(121) 1.000 
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Table 1.8: Bond angles (degrees) for 351. 
Bond Angle (deg) Bond Angle (deg) 
C(12)-C(1 1)-C(1 10) 116.4(2) C(22)-C(21)-O(21) 121.3(2) 
C(12)-C(1 1)-O(1 1) 121.5(2) C(210)-C(21)-O(21) 122.4(2) 
C(1 10)-C(1 1)-0(11) 121.9(2) C(21)-C(22)-C(23) 112.61(18) 
C(1 1)-C(12)-C(13) 112.88(19) C(21)-C(22)-H(221) 108.682 
C(1 1)-C(12)-H(1 11) 108.612 C(23)-C(22)-H(221) 108.682 
C(13)-C(12)-H(111) 108.612 C(21)-C(22)-H(222) 108.682 
C( 1 1)-C(12)-H(1 12) 108.614 C(23)-C(22)-H(222) 108.682 
C(13)-C(12)-H(112) 108.613 H(221)-C(22)-H(222) 109.466 
H(1 1 1)-C(1 2)-H(1 12) 109.467 C(22)-C(23)-C(24) 112.46(18) 
C(12)-C(13)-C(14) 111.99(17) C(22)-C(23)-C(21 1) 107.82(18) 
C(12)-C(13)-C(l 11) 108.78(19) C(24)-C(23)-C(21 1) 114.08(18) 
C(14)-C(13)-C(I11) 111.41(18) C(22)-C(23)-H(23 1) 107.389 
C(12)-C(13)-H(13 1) 108.181 C(24)-C(23)-H(23 1) 107.390 
C(14)-C(13)-H(13 1) 108.179 C(21 1)-C(23)-H(23 1) 107.389 
C(1 1 1)-C(13)-H(13 1) 108.179 C(23)-C(24)-C(25) 109.36(18) 
C(1 3)-C(1 4)-C( 15) 109.18(17) C(23)-C(24)-C(29) 108.70(17) 
C(13)-C(14)-C(113) 10.91(18) C(25)-C(24)-C(29) 108.97(18) 
C(15)-C(14)-C(1 13) - 09.73(18) C(23)-C(24)-C(213) 110.50(18) 
C(13)-C(14)-C(19) 09.55(18) C(25)-C(24)-C(213) 110.31(18) 
C(1 5)-C( 14)-C(19) 08.40(19) - C(29)-C(24)-C(213) 108.96(18) 
C(1 13)-C(14)-C(19) 09.04(17) - C(24)-C(25)-C(26) 115.02(19) 
C(1 4)-C(l 5)-C(1 6) - 	 14.50(19) C(24)-C(25)-H(251) 108.068 
C(14)-C(15)-H(151) 108.201 C(26)-C(25)-H(25 1) 108.068 
C(1 6)-C( 1 5)-H(1 51) 108.201 C(24)-C(25)-H(252) 108.069 
C(14)-C(15)-H(1 52) 108.201 C(26)-C(25)-H(252) 108.069 
C(16)-C(15)-H(152) 108.199 H(25 I)-C(25)-H(252) 109.468 
H(1 5 1)-C(1 5)-H(1 52) 109.466 C(25)-C(26)-C(27) - 109.93(19) 
C(1 5)-C(1 6)-C(17) 110.5(2) C(25)-C(26)-H(261) 109.356 
C(15)-C(16)-H(161) 109.224 C(27)-C(26)-H(261) 109.358 
C( 1 7)-C( 1 6)-H( 161) 109.222 C(25)-C(26)-H(262) 109.357 
C(1 5)-C( 16)-H(162) 109.222 C(27)-C(26)-H(262) 109.356 
C(17)-C(16)-H(162) 109.222 H(261)-C(26)-H(262) 109.467 
H(161)-C(16)-H(162) 109.469 C(26)-C(27)-C(28) 109.4(2) 
C(16)-C(17)-C(18) 110.2(2) C(26)-C(27)-H(27 1) 109.480 
C(16)-C(17)-H(171) 109.296 C(28)-C(27)-H(271) 109.483 
C( 1 8)-C( 1 7)-H(1 71) 109.295 C(26)-C(27)-H(272) 109.482 
C(16)-C(17)-H(172) 109.296 C(28)-C(27)-H(272) 109.485 
C(1 8)-C(1 7)-H(1 72) 109.297 H(271)-C(27)-H(272) 109.466 
H(1 71 )-C(1 7)-H( 172) 109.468 C(27)-C(28)-C(29) 113.4(2) 
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C(17)-C(18)-C(19) 112.5(2) C(27)-C(28)-H(281)__  108.480 
C(1 7)-C( 1 8)-H(1 81) 108.721 C(29)-C(28)-H(281)__  108.482 
C(1 9)-C(1 8)-H(1 81) 108.723 C(27)-C(28)-H(282) 108.479 
C(1 7)-C( 1 8)-H(1 82) 108.721 C(29)-C(28)-H(282) 108.482 
C(1 9)-C( 1 8)-H(1 82) 108.723 H(281)-C(28)-H(282) 109.467 
H( 18 1)-C( 1 8)-H( 182) 109.465 C(24)-C(29)-C(28) 116.62(19) 
C( 11 )-C(1 10)-C(19) 123.5(2) C(24)-C(29)-C(210) 123.72 
C(1 1)-C(1 l0)-H(1 10) 118.261 C(28)-C(29)-C(210) 119.6(2) 
C(1 9)-C( 11 0)-H( 110) 118.262 C(2 1)-C(2 1 0)-C(29) 1123.7(2) 
C(13)-C(1 1 1)-O(12) 124.9(2) C(21)-C(210)-H(210) 118.166 
C(13)-C(1 1 1)-O(13) 111.9(2) C(29)-C(210)-H(210) 1118.170 
1 2)-C(1 1 1)-O(1 3) 123.2(2) C(23)-C(211)-0(22) 124.5(2) 
j13)-C(1 12)-H(1 14) 109.477 C(23)-C(211)-0(23)__  112.12(19) 
i!(i1 3)-C(1 12)-H(1 15) 109.476 0(22)-C(211)-0(23) 123.4(2) 
H(1 14)-C(1 12)-H(1 15) 109.474 H(1 16)-C(212)-H(1 17) 109.476 
H(1 13)-C(1 12)-0(13) 09.468 - H(1 16)-C(212)-H(1 18) 109.475 
H(1 14)-C(1 12)-0(13) 09.467 - H(1 17)-C(212)-H(1 18) 109.476 
H(1 1 5)-C(1 12)-0(13) 09.466 - H(1 16)-C(212)-0(23) 109.467 
C(14)-C(113)-H(122) 09.466 - H(1 17)-C(212)-0(23) 109.467 
C(14)-C(113)-H(123) 09.466 - 11(11 8)-C(212)-0(23) 109.467 
H(122)-C(1 13)-H(123) 09.475 - C(24)-C(213)-H(1 19) 109.466 
C(14)-C(113)-H(124) 109.467 C(24)-C(213)-H(120) 109.467 
H(122)-C(113)-H(124) 109.477 H(119)-C(213)-H(120) 109.476 
H(1 23)-C(1 1 3)-H(124) 109.476 C(24)-C(213)-H(121) 109.467 
C(14)-C(19)-C(18) 117.0(2) H(119)-C(213)-H(121) 109.476 
C(14)-C(19)-C(110) 123.5(2) H(120)-C(213)-H(121) 109.477 
C(18)-C(19)-C(1 10) 119.5(2) C(1 12)-0(13)-C(1 11) 115.34(19) 
C(22)-C(21)-C(210) 116.19(19) C(212)-0(23)-C(211 115.83(19) 
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Table 1.9: Anisotropic displacement parameters (AA2  x  10A3)  for X. The anisotropic 
displacement factor exponent takes the form: -2 TI2 [ h 2 a*2  UI 1 + ... + 2 h k a* b* U121 
Ull U22 U33 U23 U13 U12 
C(11) 24(1) 30(1) 23(1) 3(1) 0(1) 1(1) 
C(12) 24(1) 23(1) 21(1) -3(1) 0(1) -2(1) 
C(13) 20(1) 22(1) 18(1) -1(1) 3(1) 1(1) 
C(14) 17(1) 20(1) 16(1) 1(1) 3(1) 
C(15) 20(1) 29(1) 32(1)  -3(1) 3(1) 




C(17) 37(2) 25(1) 32(1)  -5(1) -3(1) 
C(18) 33(1) 24(1) 33(1)  -5(1) 5(1) 
 25(1) 19(1) 30(1) 4(1) -3(1) 3(1) 
 24(1) 23(1) 26(1) -4(1) 3(1) 0(1) 
 28(1) 24(1) 66(2) 5(1) 1(1) 9(1) 
 32(1) 26(1) 23(1) 0(1) 4(1) -2(1) 
C(19) 20(1) 22(1) 23(1) 1(1) 3(1) 0(1) 
 19(1) 25(1) 25(1) 4(1) 0(1) -1(1) 
 21(1) 23(1) 21(1) 0(1) 2(1) 0(1) 
 19(1) 18(1) 19(1) 1(1) 0(1) 2(1) 
 19(1) 18(1) 19(1) 2(1) 0(1) -1(1) 
 22(1) 31(1) 25(1) -1(1) 1(1) -1(1) 
 30(1) 34(2) 25(1) 0(1) 7(1) -5(1) 
 45(2) 28(1) 23(1) -2(1) 1(1) 2(1) 
 42(2) 28(1) 21(1) -3(1) 0(1) -8(1) 
 18(1) 21(1) 0(1) 3(1) 
 22(1)  25(1) -1(1) -1(1) 
 23(1)  20(1) 2(1) -2(1) 
PI 
 29(1)  59(2) -9(1) -3(1) 
 28(1) J22(1) 25(1) 5(1) -2(1) ) 
0(11) 37(1)  31(1) 2(1) -15(1) 3(1) 
0(12) 26(1) 63(1) 5(1) 4(1) -2(1) 
0(13) 24(1)  45(1) 4 	) 2 	) 5(1) 
0(21) 41(1) 36(1) 32(1) 1(1) 10(1) -16(1) 
0(22) 33(1) 29(1) 39(1) -12(1) 8(1) -1(1) 
0(23) 20(1) 25(1) 41(1) -10(1) -1(1) -4(1) 
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Table 1.10: Hydrogen coordinates (x 1O"4) and isotropic displacement parameters (A2 x 
103  ) for 
351. 
x  z U(eq) 
11(1 10) 13263 274 9856 29 
 12544 2992 10278 28 
 13678 2922 9733 28 
11(113) 4975 4599 9414 47 
H(114) 7126 4706 9060 47 
H(1 5) 7258 5074 9635 47 
H(1 6) 10882 4558 8285 44 
H(1 7) 10165 5112 7776 44 
H(1 8) 12629 4644 7832 44 
H(1.9) 6574 4112 6903 30 
 4289 3501 6895 30 
 5801 3551 6400 30 
11(122) 11332 1966 8515 32 
H(123) 10689 2993 8721 32 
11(124) 13016 2504 8904 32 
11(131) 9237 2355 9960 24 
 6975 1565 9406 32 
 7111 2328 8960 32 
11(161) 5827 877 8650 35 
11(1 62) 8168 1166 8398 35 
H(171) 7726 -121 9207 37 
11(172) 8330 -400 8637 37 
H(181) 11577 -344 9179 36 
H(182) 11748 365 8708 36 
11(210) 4146 676 6881 27 
11(221) 5212 2309 8121 26 
H(222) 3930 2887 7677 26 
H(231) 8342 2148 7636 22 
H(251) 10191 3338 6836 31 
H(252) 10455 2230 6941 31 
11(261) 11357 2547 6112 35 
H(262) 8940 3036 6012 35 
H(271) 9597 1101 6244 39 
11(272) 8839 1501 5697 39 
H(281) 5735 941 6150 1 	36 
11(282) 5480 2035 6007 1 36 
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1.3. Crystal structure data for 337. 
11. 
Kul 
Figure 1.3 Crystal structure of 337. 
Part A: Crystal data 
Empirical formula C 14H2202 
Formula weight 222.33 
Wavelength 0.71073 A 
Temperature 150 K 
Crystal system Monoclinic 
Space group P 1 c 1 
Unit cell dimensions a = 6.8884(2) A a = 90° 
b = 8.7287(3) A 3 = 103.724(2) 0 
c = 10.4626(3) A y = 90° 
Volume 611.12(3) A3 
Number of reflections for cell 6283 (3 <0 < 31 deg.) 
Z 2 
Density (calculated) 1.208 Mg/rn3 




Part B: Data collection 
Crystal description colourless block 
Crystal size 0.78 x 0.34 x 0.25 mm 
Theta range for data collection 2.333 to 30.638 deg. 
Index ranges 9<=h<=9, -12<=k<=12, 
-14<=l<=14 
Reflections collected 11221 
Independent reflections 1885 [R(int) = 0.049] 
Scan type \f&\w scans 
Absorption correction Semi-empirical 	from 	equivalents 
(Tmin= 0.75, Tmax=0.98) 
Part C: Solution and refinement 
Solution direct (S1R92) 
Refinement type Full-matrix least-squares on FA2 
Program used for refinement CRYSTALS 
Hydrogen atom placement geom 
Hydrogen atom treatment mixed 
Data 1885 
Parameters 149 
Goodness-of-fit on F 2 0.9682 
R RI = 0.0335 [1788 data] 
Rw 0.0801 
Absolute structure parameter 138(19) 
Final maximum delta/sigma 0.000191 
Weighting scheme Sheidrick Weights 
Largest diff. peak and hole 0.24 and -0.22 e.A 3 
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Table 1.11: Atomic coordinates (x10 4) and equivalent isotropic displacement parameters (A 2 x 
10 
3  )  for 337. U(eq) is defined as one third of the trace of the orthogonalised Uij tensor. 
x  z U(eg) 
C(1) -2737(2) 4636(2) 477(2) 22 
0(1) -4455(2) 4512(1) -420(1) 29 
C(2) -2620(2) 6017(2) 1337(2) 28 
C(3) -731(2) 6984(2) 1467(2) 27 
C(4) 1196(2) 6266(2) 2283(2) 26 
C(5) 1976(2) 4868(2) 1665(2) 22 
C(6) 725(2) 3388(1) 1561(1) 18 
C(61) 393(2) 2907(2) 2908(2) 23 
C(7) -1284(2) 3533(2) 576(1) 19 
C(8) -1693(2) 2221(2) -260(2) 22 
0(8) -3272(2) 1989(1) 1126(1) 30 
C(9) 34(2) 1130(2) 75(2) 27 
C(10) 1758(2) 2066(1) 922(2) 20 
C(11) 3288(2) 1024(2) 1838(2) 24 
C(12) 4028(3) -206(2) 1015(2) 34 
C(13) 5098(2) 1864(2) 2664(2) 30 
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Table 1.12: Bond lengths (A) for 337. 
Bond Length (A) Bond Length (A) 
C(1)-O(1) 1.3289(16) C(61)-H(612) 0.941 
C(1)-C(2) 1.495(2) C(61)-H(613) 0.951 
C(1 )-C(7) 1.3742(18) C(7)-C(8) 1.4282(18) 
0(l)-H(l) 0.86(2) C(8)-0(8) 1.2560(16) 
C(2)-C(3) 1.529(2) C(8)-C(9) 1.499(2) 
C(2)-H(2 1) 0.952 C(9)-C(10) 1.5376(19) 
C(2)-H(22) 0.970 C(9)-H(91) 0.959 
C(3)-C(4) 1.532(2) C(9)-H(92) 0.976 
C(3)-H(3 1) 0.981 C(10)-C(1 1) 1.5418(18) 
C(3)-H(32) 0.988 C(10)-H(101) 0.984 
C(4)-C(5) 1.5359(19) C(1 1)-C(12) 1.537(2) 
C(4)-H(41) 0.974 C(11)-C(13) 1.526(2) 
C(4)-H(42) 0.970 C(1 1)-H(1 11) 0.975 
C(5)-C(6) 1.5423(17) C(12)-H(121) 0.967 
C(5)-H(51) 0.969 C(12)-H(122) 0.974 
C(5)-H(52) 0.966 C(12)-H(123) 0.965 
C(6)-C(61) 1.5382(17) C(13)-H(1 31) 0.970 
C(6)-C(7) 1.5224(16) C(13)-H(132) 0.945 
C(6)-C(10) 1.5844(17) C(13)-H(133) 0.970 
C(61)-H(61 1) 0.982  
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Table 1.13: Bond angles (degrees) for 337. 
Bond Angle (deg) Bond Angle (deg) 
0(1)-C(1)-C(2) 113.70(12) H(611)- (6l)-H(613) 107.3 
0(I)-C(I)-C(7) 120.45(12) H(6 1 2)-C(6 1 )-H(6 13) 107.7 
C(2)-C(1)-C(7) 125.83(12) C(6)-C(7)-C(1) 129.63(11) 
C(1)-O(1)-H(1) 103.5(16) C(6)-C(7)-C(8) 111.31(11) 
C(1)-C(2)-C(3) 114.96(12) C(I)-C(7)-C(8) 1118.78(12) 
C(1)-C(2)-H(2 1) 107.5 C(7)-C(8)-0(8) 125.63(13) 
C(3)-C(2)-H(2 1) 110.8 C(7)-C(8)-C(9) 109.62(12) 
C(I)-C(2)-H(22) 107.8 0(8)-C(8)-C(9) 124.73(12) 
C(3)-C(2)-H(22) 108.0 C(8)-C(9)-C( 10) 105.00(11) 
H(2 1 )-C(2)-H(22) 107.5 C(8)-C(9)-H(91) 110.8 
C(2)-C(3)-C(4) 115.49(12) C( 1 0)-C(9)-H(9 1) 111.5 
C(2)-C(3)-H(3 1) 107.5 C(8)-C(9)-H(92) 108.9 
C(4)-C(3)-H(3 1) 107.6 C(10)-C(9)-H(92) 109.8 
C(2)-C(3)-H(32) 107.7 H(91)-C(9)-H(92) 110.7 
C(4)-C(3)-H(32) 108.9 C(9)-C(10)-C(6) 105.51(10) 
H(3 1)-C(3)-H(32) 109.5 C(9)-C(1 0)-C( 11) 111.42(11) 
C(3)-C(4)-C(5) 115.69(11) C(6)-C(10)-C(1 1) 118.48(10) 
C(3)-C(4)-H(41) 108.1 C(9)-C(1 0)-H(10 1) 106.0 
C(5)-C(4)-H(41) 106.2 C(6)-C(10)-H(101) 106.3 
C(3)-C(4)-H(42) 108.9 C(1 1)-C(10)-H(1 01) 108.3 
C(5)-C(4)-H(42) 109.7 C(10)- 	(11)-C(12) 109.43(11) 
H(41)-C(4)-H(42) 108.0 C(10)-C(1 1)-C(1 3) 114.47(11) 
C(4)-C(5)-C(6) 116.74(11) C(12)-C(1 1)-C(13) 108.57(12) 
C(4)-C(5)-H(5 1) 108.6 C(1 0)-C(1 I)-H(1 11) 109.3 
C(6)-C(5)-H(5 1) 107.9 C(12)-C(1 1)-H(1 11) 107.7 
C(4)-C(5)-H(52) 107.4 C(13)-C(1 1)-H(1 11) 107.2 
C(6)-C(5)-H(52) 109.2 C(1 1 )-C(12)-H(1 21) 107.7 
H(5 l)-C(5)-H(52) 106.6 C(11)-C(12)-H(122) 111.0 
C(5)-C(6)-C(6 1) 111.44(10) 11(12 1)-C(1 2)-H(1 22) 109.7 
C(5)-C(6)-C(7) 112.39(10) C(1 1)-C(12)-H(1 23) 113.6 
C(61)-C(6)-C(7) 109.54(10) H(121)-C(12)-H(123) 106.7 
C(5)-C(6)-C(1 0) 109.91(9) H(122)-C(12)-H(123) 108.2 
C(61)-C(6)-C(10) 111.52(10) C(1 1)-C(13)-H(13 1) 111.2 
C(7)-C(6)-C(10) 101.67(10) C(1 1)-C(13)-H(132) 113.1 
C(6)-C(61)-H(61 1) 111.8 H(131)-C(13)-H(132) 107.3 
C(6)-C(61)-H(612) 112.1 C(1 1)-C(13)-H(133) 108.7 
H(61 1)-C(61)-H(612) 106.3 H(131)-C(13)-H(133) 108.4 
C(6)-C(61)-H(613) 111.3 H(132)-C(13)-H(133) t 	108.0 
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Table 1.14: Anisotropic displacement parameters (A"2 x IO"3) for X. The anisotropic 
displacement factor exponent takes the form: -2 w 2 [ h 2 a*2  U11 + ... + 2 h k a* b* U121 
Ui! U22 U33 U23 U13 U12 
 23(1) 24(1) 19(1) 3(1) 5(1) 1(1) 
0(1) 23(1) 35(1) 27(1) 3(1) 0(1) 3(1) 
 29(1) 26(1) 30(1) -2(1) 9(1) 7(1) 
 37(1) 19(1) 27(1) -1(1) 9(1) 2(1) 
 32(1) 21(1) 24(1) -5(1) 4(1) -4(1) 
 23(1) 20(1) 23(1) -2(1) 4(1) -4(1) 
 19(1) 18(1) 16(1) 1(1) 3(1) -1(1) 
C(61) 25(1) 27(1) 17(1) 3(1) 5(1) 1(1) 
 19(1) 21(1) 17(1) 1(1) 3(1) -2(1) 
 26(1) 20(1) 19(1) 1(1) 3(1) -4(1) 
0(8) 31(1) 30(1) 23(1) -2(1) -2(1) -6(1) 
 32(1) 20 (1) 26(1) -3(1) 1(1) 0(1) 
 23(1) 18(1) 20(1) 1(1) 5(1) 2(1) 
 25(1) 22(1) 24 (1) 4(1) 6(1) 3(1) 
 38(1) 28(1) 35(1) 2(1) 10(1) 12(1) 
 23(1) 31(1) 34(1) 7(1) 2(1) 2(1) 
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Table 1.15: Hydrogen coordinates (x 1O"4) and isotropic displacement parameters (A2 x 
103  ) for 
337. 
x  z U(eq) 
H(1) -4370(30) 3630(20) -770(20) 43 
H(21) -3784 6616 1001 35 
11(22) -2673 5672 2209 34 
H(31) -942 7952 1889 34 
H(32) -565 7190 570 32 
H(41) 2249 7035 2404 32 
H(42) 1000 5997 3143 30 
H(51) 3315 4636 2170 26 
11(52) 2094 5164 798 26 
H(611) -217 1886 2876 35 
H(612) -468 3583 3208 35 
11(613) 1619 2873 3558 35 
H(91) 367 754 -708 31 
11(92) -312 285 591 33 
H(101) 2429 2570 302 25 
H(111) 2638 500 2446 29 
11(121) 5021 -817 1608 51 
 4619 260 351 51 
 2994 -902 578 50 
H(131) 6046 1154 3185 44 
H(132) 4758 2584 3249 43 
11(133) 5757 1 	2409 2078 44 
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Appendix 2: Chiral HPLC 
2.1. Chiral HPLC data for 391 
D.Ir 
RT Height Area Atea % 
1 1 	4.74 20.741 2.21 21.38 
2 1 5.17 77.691 9.640 78.62 
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2.2. Chiral HPLC data for 395 
Miutes 
Peak Results 
Name RT Area I-Ieght % Area 
1 13.246 2705670 63836 495 
2 16.675 1 2710462 48470 50.05 
Mnues 
Peak Results 
Name RI Area Heht %Area 
1 14.696 42756 1055 1,63 
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The A-B hydrazulene ring system of the guanacastepenes has 
been synthesised using a photochemical ring transposition of 
a 6-6 bicycle. 
In 2000 Clardy and co-workers reported the isolation of gua-
nacastepene A, 1, from an endophytic fungal strain growing 
in a branch of a Daphnopsis americana tree in the Guanacaste 
rainforest of Costa Rica (Fig. 1).' The natural product was isolated 
as part of a screening program which assayed fungal extracts for 
activity against drug-resistant strains of Staphylococcus aureus 
and Enterococcus faecium. Following the initial report on gua-
nacastepene A, Clardy reported the isolation and characterisation 
of an additional fourteen structurally and chemically diverse 
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Fig. 1 Guanacastepene A. 
The novel carbon skeleton coupled with the highly promising 
antibiotic activity of guanacastepene A made the guanacastepenes 
excellent targets for chemical synthesis, and an intense level of 
synthetic activity ensued. Completed total syntheses of members 
of the guanacastepene family have been reported by Danishefsky 
(A), 3 Mehta (C), 4 Sorensen (E),' Overman (N) 6 and Trauner (E) 7 
in addition to three formal syntheses and a variety of synthetic 
approaches.' 
Our strategy for the synthesis of guanacastepene A is based 
upon the transposition of a 6-6 bicycle to the relevant 5-7 
hydrazulene system found in the guanacastepenes. Accordingly, 
the tricyclic natural product is first disconnected back to the 
hydrazulene 2. This AB —+ ABC strategy has proven to be popular, 
with the stereocontrolled installation of the third C ring from 
ketones such as 2 having being demonstrated by the Danishefsky 
and Snider research groups. 3 ' The 5-7 bicycle arises from the 
simpler hydrazulene 3, which is the product of the key ring 
transposition: a photochemical rearrangement of keto-epoxide 
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Electronic supplementary information (ESI) available: General proce-
dures, synthesis of individual compounds, NMR spectra and ORTEP 
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4. The decalin structure can be synthesised through a Robinson 
condensation of 2-methyl-cyclohexanone and 5-methyl-hex-3-en-
2-one, or their synthetic equivalents (Scheme 1). 
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Scheme I Synthetic plan for guanacastepene A. 
Initial work focussed on simple epoxy-ketone models of the key 
photochemical transposition—a reaction developed extensively by 
Jeger in the steroid field.' ° Paquette was the first to explore the re-
action in the synthesis of non-steroidal natural products, using the 
transposition to synthesise the isoingenane and dolastane natural 
product skeletons .' 1"2 Outside of these reports, this potentially 
powerful reaction has seen little application in complex molecule 
synthesis. We began by preparing the known epoxy-ketone 8 and 
were encouraged to find that irradiation in ethanol through a 
pyrex filter produced smooth transposition to the hydrazulene 
9 in 50% isolated yield (Scheme 2). The chromophore-containing 
1 ,3-diketone product 9 appears to undergo slow photodegradation 
under the reaction conditions, necessitating a compromise between 
conversion and isolated yield, an observation inline with previous 
studies on this reaction." A brief screen of solvents established 
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Solvent Yield of 9 (%) Recov'd SM (%) 
EtOH 50 25 
MeCN 28 7 
hexane 22 6 
dioxane 49 16 
MeCN/acetone 0 0 
(9:1) 
Scheme 2 Photochemical transposition of simple epoxy-ketone 8. 
We next prepared the ketal-containing epoxy-ketone 11 via a 
five-step procedure starting from the diosphenol 10, verifying the 
cis-arrangement of the epoxide and C  1 methyl group in 11 with 
15221 Org. Biomol. Chem., 2007,5, 1522-1524 	 This journal is © The Royal Society of Chemistry 2007 
an X-ray structure (Scheme 3)4 The aim here was to incorporate 
protected carbonyl functionality into C3 of the nascent 13-ring 
that could be used as a starting point for future C-ring synthesis. 
Disappointingly, all efforts to transpose 11 into the corresponding 
hydrazulene met with failure. Extensive degradation of the keto-
enol starting material was observed and no clean products could 
be isolated from the photoreactor. On the basis of this negative 
result, we turned our attention to synthesising a more highly-
functionalised A-ring precursor, with the intention of oxidising 
the C3 position at a later point in the synthesis. 





Me 	 Me Me 
10 	 11 	 12 
Seheme 3 Attempted transposition of ketal-containing epoxy-ketone 11. 
Construction of the guanacastepene A AB bicycle via the 
transposition route calls for the preparation of a 6-6 system having 
the cis isopropyl and methyl groups at C1  and C12 in place. This 
arrangement of a tertiary branched group adjacent to a quaternary 
centre is beyond the scope of Robinson annulation chemistry, as 
the initial Michael addition is very slow due to severe steric hin-
drance. As expected, all attempts to implement the reaction using 
the unactivated precursors 6 and 7 were unsuccessful. Activation 
at one, or both, of the isopropyl and methyl group appendages 
is required. After numerous trials, the literature condensation 
of enone-oate .13 with 2-methyl-cyclohexanone proved to be the 
most effective synthetic method (Scheme 4)." Whilst the yield of 
this procedure is a modest 20%, the operational simplicity and 
scalability of the reaction, being the first step in the route, made  
it the preferred method. In addition, the Robinson annulation 
product 15 is formed as a 10: 1 mixture of diastereoisomers, in 
favour of the desired cis Cl l—C12 stereochemistry. Acid-catalysed 
epimerisation places the ester group in the more stable pseudo-
equatorial position, confirmed by X-ray diffraction4 
Functionalisation of 15 to the requisite ring transposition 
substrate 18 began with protection of the ketone as a ketal, 
accompanied by concomitant double bond migration. The ester 
moiety was then transformed into an isopropenyl group by 
treatment with two equivalents of MeLi followed by elimination 
of the resulting alcohol with POCI 3 . Deketalisation gave an 
enone, which could be selectively hydrogenated (15 bar) at the 
isopropenyl group using Wi.lkinson's catalyst to afford enone 17. 
The required epoxy-ketone photosubstrate 18 could be accessed 
through treatment of 17 with basic peroxide, but only in mediocre 
yield. It proved more efficient to first reduce the ketone, epoxidise 
the allylic alcohol with mCPBA, then reoxidise, producing keto-
epoxide 18 as essentially a single diastereoisomer. The epoxide 
stereochemistry is assigned as l in line with the stereoselectivity 
observed in the analogous sequence during the synthesis of keto-
epoxide 11. 
We were pleased to observe that irradiation of an ethanolic solu-
tion of 18 through a pyrex filter produced a clean transformation 
to the desired hydrazulene 19, in similar yield to the simple model 
8 (56% yield with 23% recovered SM). The expected retention of 
stereochemistry at the migrating C 11 centre was confirmed by the 
X-ray crystal structure shown in Scheme 4. The enol oxidation 
level at C2 is found in the majority of the guanacastepenes, and 
may provide a useful functional handle for future elaboration of 
19. For the present time, however, we thought it prudent to reduce 
to the enone oxidation level via hydrogenolysis of the derived 
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Scheme 4 Synthesis of 12. Reagents and Conditions: (a) TsOH (cat), benzene, Dean—Stark, 48 h, (b) HO(CH 2)20H, TsOH (cat), benzene, Dean—Stark, 
(c) MeLi (2.5 equiv), THF, 0°C, 18 h, (d) POd 3 (3 equiv), pyridine, rt, 18 h, (e)TsOH (cat), acetone, reflux, 2.5 h, (1) (PPh) 3 RhCl (10 mol%), MeOH, 
H2,15 bar, rt, 12 h, (g) NaBH (1.1 equiv), CeC1 3 -7H20 (2.2 equiv), MeOH, 0°C, 1 h, (h)mCPBA (1.5 equiv), NaHCO 3 (2 equiv), DCM, 0 °C, 1.5 h, 
(i) PDC (2 equiv), DCM, 0 °C, 18 h, (j) hv (Hanovia 400 W medium pressure Hg lamp), EtOR, 0 °C, 9 h, (k) Tf 20 (2 equiv), iPr2EtN (2 equiv), DCM, 
0°C, 1 h, (I) Pd(OAc)2 (Cat), PPh3 (cat), Et3 N (3 equiv), HCO2 H (2 equiv), DMF, 60 °C, 4 h. 
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co-workers in their approach to guanacastepene A, and demon-
strated to be a good substrate for allylic oxidation—providing a 
handle for eventual introduction of the C-ring. 14 
In conclusion, we have developed a novel approach to the 
guanacastepene AB hydrazulene using a photochemical transpo-
sition of a 6-6 system as the key step. Future work will examine 
functionalisation of the product hydrazulenones for the synthesis 
of the guanacastepene family of diterpenes. 
We thank the EPSRC and Pfizer for the award of a studentship 
to CM and acknowledge the EPSRC mass spectrometry service at 
Swansea. Stuart Tindal is thanked for preliminary investigations 
into the conversion of 16 into 17. 
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